Malignant neoplasm of breast, HER-positive

C3_BREAST_ERPLUS

No definition available.

Endpoint definition

↥

Endpoint definition steps	FinnGen
Phenotype data	520210
1. Apply sex-specific rule only females	293373
2. Check conditions RX_ERPLUS	15625
3. Check pre-conditions, main-only, mode, registry filters Registry filters: Cause of death: ICD-10 — C50 Cause of death: ICD-9 — 174 Cause of death: ICD-8 — 174 Cancer registry: Topography ICD-O-3 — C50 Cancer registry: Morphology ICD-O-3 — ANY Cancer registry: Behaviour codes — [23] 2 out of 7 registries used, show all original rules.	14782
4. Check minimum number of events None	14782
5. Include endpoints None	14782
6. Filter based on genotype QC (FinnGen only)	14782

Control definitions (FinnGen only)

Control conditions: not RX_ERPLUS

Extra metadata

Level in the ICD hierarchy: 2
First used in FinnGen datafreeze: DF9

NAME	C3_BREAST_ERPLUS
CONTROL_EXCLUDE
CONTROL_PRECONDITIONS
CONTROL_CONDITIONS	!RX_ERPLUS
SEX	2
INCLUDE
PRE_CONDITIONS
CONDITIONS	RX_ERPLUS
OUTPAT_ICD
OUTPAT_OPER
HD_MAINONLY
HD_ICD_10_ATC
HD_ICD_10
HD_ICD_9
HD_ICD_8
HD_ICD_10_EXCL
HD_ICD_9_EXCL
HD_ICD_8_EXCL
COD_MAINONLY
COD_ICD_10	C50
COD_ICD_9	174
COD_ICD_8	174
COD_ICD_10_EXCL
COD_ICD_9_EXCL
COD_ICD_8_EXCL
OPER_NOM
OPER_HL
OPER_HP1
OPER_HP2
KELA_REIMB
KELA_REIMB_ICD
KELA_ATC_NEEDOTHER
KELA_ATC
KELA_VNRO_NEEDOTHER
KELA_VNRO
CANC_TOPO	C50
CANC_TOPO_EXCL
CANC_MORPH	ANY
CANC_MORPH_EXCL
CANC_BEHAV	[23]

Similar endpoints

↥

List of similar endpoints to Malignant neoplasm of breast, HER-positive based on the number of shared cases.

Similar with more cases:

Similar with less cases:

None

Case counts by codes

↥

FinnGen case counts by registry codes:

Upset plot

Full data table

Summary Statistics

↥

-FinRegistry-

This endpoint is excluded from FinRegistry analyses (omitted endpoint).

-FinnGen-

Key figures

	All	Female	Male
Number of individuals	14782	14782	-
Unadjusted period prevalence (%)	5.04	5.04	-
Median age at first event (years)	60.07	60.07	-

-FinnGen-

Age distribution of first events

-FinnGen-

Year distribution of first events

-FinnGen-

Cumulative Incidence Function

Not a core endpoint, no data to show.

CodeWAS (R11)

↥

CodeWAS is a tool for exploring the associations between an endpoint and all of the medical codes and drug codes.

This is a new tool, please reach out using the contact form for feedback and improvement ideas.

First, a cohort is built by matching controls to the endpoint cases using year of birth and sex. Then, a Fisher test is done for all the medical codes and drug codes between the cases and controls of this cohort. Codes are reported in the table below if they have −log₁₀(p-value) ≥ 6.

Matched cohort

Matched cases
12439: Matched controls
124295

Code

Vocabulary

Description

Odds Ratio

-log₁₀(p)

N matched cases

N matched controls

8500/3-C50.4

ICD-O-3

Infiltrating duct carcinoma, NOS, of upper-outer quadrant of breast

31.4

323.0

2069

786

X76

ICPC

Malignant neoplasm breast female

40.0

323.0

1879

550

PJW99

NOMESCO Finland

Other operation on lymphatic system

55.5

323.0

419

A04AA01

ATC

ondansetron; systemic, rectal

4.0

323.0

1612

4474

C50.42

ICD-10 Finland

Malignant tumor of the upper outer quadrant of the mammary gland, lobular tumor

49.0

323.0

1699

400

C50.81

ICD-10 Finland

Overall malignant tumor of the mammary gland, ductal tumor

38.5

323.0

1507

443

A04AA55

ATC

palonosetron, combinations; systemic

21.2

323.0

2224

1265

M05BX04

ATC

denosumab; parenteral

4.1

323.0

1393

3712

C50.99

ICD-10 Finland

Breast, unspecified

25.3

323.0

2470

1204

8520/3-C50.9

ICD-O-3

Lobular carcinoma, NOS, of breast, NOS

47.9

323.0

1491

353

PJ5AN

NOMESCO Finland

Localisation of sentinell lymphnode with isotope imaging

20.8

323.0

1803

1005

WD205

NOMESCO Finland

Therapy of methastized malignancy with hormones

86.1

323.0

496

NK6QA

NOMESCO Finland

Measurement of bone density from tow or more locations with X-ray

9.5

323.0

3185

4328

1CD02

NOMESCO Finland

61.2

323.0

695

120

ZX120

NOMESCO Finland

Intravenous

4.1

323.0

2106

5842

HA003

NOMESCO Finland

Radiotherapy after partial ablation of mammary gland

26.3

323.0

3908

2127

8500/3-C50.2

ICD-O-3

Infiltrating duct carcinoma, NOS, of upper-inner quadrant of breast

28.9

323.0

728

267

C50.82

ICD-10 Finland

Overall malignant tumor of the mammary gland, lobular tumor

84.1

323.0

758

Z85.3

ICD-10 Finland

Personal history of malignant neoplasm of breast

27.3

323.0

603

231

Z80.3

ICD-10 Finland

Family history of malignant neoplasm of breast

12.6

323.0

861

732

C79.5

ICD-10 Finland

Secondary malignant neoplasm of bone and bone marrow

16.4

323.0

575

366

L01XE33

ATC

[U] palbociclib; oral

1028.4

323.0

399

A03FA01

ATC

metoclopramide; systemic, rectal

8.3

323.0

7160

17531

HA6BA

NOMESCO Finland

Breast tomosynthesis specimen

17.0

323.0

739

460

1501

Kela drug reimbursment

Palbociclib

475.7

323.0

549

R4110

NOMESCO Finland

Physiotherapy

2.5

323.0

4424

22651

A12AX

ATC

Calcium, combinations with vitamin D and/or other drugs

6.9

323.0

9268

37141

XX2AT

NOMESCO Finland

Other injection with ultrasound examination

12.9

323.0

718

587

WB113

NOMESCO Finland

Multiple adjuvant cytostatic therapy

24.2

323.0

3809

2227

WB103

NOMESCO Finland

Simple adjuvant cytostatic therapy

20.0

323.0

2585

1613

C50.22

ICD-10 Finland

Malignant tumor of the upper inner quadrant of the mammary gland,lobular tumor

39.3

323.0

462

122

HA1AA

NOMESCO Finland

X-ray mammography

26.3

323.0

6540

5027

192

Kela drug reimbursment

Fulvestrant

+∞

323.0

529

A04AD12

ATC

aprepitant; systemic

24.3

323.0

1441

668

YX9AD

NOMESCO Finland

Other CT eamination for dose design of radiotherapy

11.7

323.0

838

761

HA1DG

NOMESCO Finland

Very extensive MRI examination of mammary gland with high intensity magnet

21.1

323.0

675

337

8520/3-C50.4

ICD-O-3

Lobular carcinoma, NOS, of upper-outer quadrant of breast

57.3

323.0

606

111

L02BA03

ATC

fulvestrant; parenteral

+∞

323.0

560

N63

ICD-10 Finland

Unspecified lump in breast

4.4

323.0

1865

4777

C50.91

ICD-10 Finland

Malignant tumor in another specified localization in ductal mammary gland

25.3

323.0

1179

513

C50.21

ICD-10 Finland

Malignant tumor of the upper inner quadrant of the mammary gland,ductal tumor

27.1

323.0

1976

859

ZX012

NOMESCO Finland

Radiotherapy with large shaped fields - isocentric therapy

21.9

323.0

3450

2143

THW99

NOMESCO Finland

Other minor procedure in surgery of mammary gland

34.1

323.0

1991

690

XX3DW

NOMESCO Finland

Time consuming IT work

6.9

323.0

3220

5952

PJD52

NOMESCO Finland

Block dissection of axillary lymph nodes

51.8

323.0

4264

1237

L03AA14

ATC

lipegfilgrastim; parenteral

14.3

323.0

1026

774

C50.51

ICD-10 Finland

Malignant tumor of the lower outer quadrant of the mammary gland, ductal tumor

28.7

323.0

1362

529

HAB50

NOMESCO Finland

Partial excision of mammary gland with reconstructive operation

23.8

323.0

1682

811

HAE10

NOMESCO Finland

Reconstruction of breast using graft or flap

27.2

323.0

1258

512

ZX080

NOMESCO Finland

Image guided radiotherapy

16.6

323.0

1142

751

C50.40

ICD-10 Finland

Malignant tumor of the upper outer quadrant of the mammary gland, no histological veryfication

28.5

323.0

1865

764

TQW20

NOMESCO Finland

Tatoe

28.5

323.0

952

360

HAE20

NOMESCO Finland

Reconstruction of areola and mamilla using graft or flap

27.7

323.0

1131

447

C50.11

ICD-10 Finland

Malignant tumor of the central part of the mammary gland,ductal tumor

29.1

323.0

1257

478

HAB40

NOMESCO Finland

Wedge excision of mammary gland

25.2

323.0

4782

2999

8500/3-C50.5

ICD-O-3

Infiltrating duct carcinoma, NOS, of lower-outer quadrant of breast

31.6

323.0

466

153

HA1AE

NOMESCO Finland

Ultrasound examination of mammary glands

25.4

323.0

5678

3977

L02BG04

ATC

letrozole; oral

282.6

323.0

8193

844

115

Kela drug reimbursment

Breast cancer

7176.9

323.0

12347

2132

HA013

NOMESCO Finland

Radiotherapy after total ablation of mammary gland

41.9

323.0

1331

354

H02AB02

ATC

dexamethasone; systemic

18.8

323.0

5936

5759

HAC20

NOMESCO Finland

Total mastectomy

44.8

323.0

4588

1599

C50.31

ICD-10 Finland

Malignant tumor of the lower inner quadrant of the mammary gland, ductal tumor

24.3

323.0

876

387

Z31.5

ICD-10 Finland

Genetic counselling

6.3

323.0

1424

2485

XX1XN

NOMESCO Finland

Other isotope examination

17.3

323.0

549

331

WB203

NOMESCO Finland

Simple adjuvant hormone therapy of malignancy

190.4

323.0

3358

241

WZC30

NOMESCO Finland

Teaching

3.1

323.0

2411

8950

YG1BD

NOMESCO Finland

Extensive CT examination of thorax for dose design of radiotherapy

26.2

323.0

2837

1388

C50.49

ICD-10 Finland

Malignant tumor of the upper outer quadrant of the mammary gland, other or undeterminated histology

24.1

323.0

1392

646

C50.89

ICD-10 Finland

Overall malignant tumor of the mammary gland, other or undeterminated histology

34.2

323.0

509

155

C50.41

ICD-10 Finland

Malignant tumor of the upper outer quadrant of the mammary gland, ductal tumor

48.3

323.0

6475

2728

L02BA01

ATC

tamoxifen; oral

587.2

323.0

6080

202

WB401

NOMESCO Finland

Simple antibody therapy of primary tumour

17.0

323.0

723

449

PJA12

NOMESCO Finland

Sentinel node biopsy

47.2

323.0

7790

4260

L03AA13

ATC

pegfilgrastim; parenteral

20.1

323.0

2608

1618

L02BG03

ATC

anastrozole; oral

619.8

323.0

2080

HA1CG

NOMESCO Finland

Extensive MRI examination of mammary gland with high intensity magnet

26.1

323.0

1303

555

C50

ICD-10 Finland

Malignant neoplasm of breast

27.3

323.0

2087

912

C50.90

ICD-10 Finland

Malignant tumor in other or unspecified location in mammary gland without histology

25.5

323.0

1377

603

HAE99

NOMESCO Finland

Other reconstruction of breast

20.0

323.0

528

275

JN4BD

NOMESCO Finland

Extensive body CT

4.5

323.0

2503

6555

WX404

NOMESCO Finland

Intravenous generell anesthesy

4.3

323.0

5102

17419

HAD30

NOMESCO Finland

Reduction mammoplasty with transposition of areola

6.5

323.0

1440

2455

HAB99

NOMESCO Finland

Other partial excision of mammary gland

14.3

323.0

1643

1309

HA6AA

NOMESCO Finland

Extra corporeal mammography of operated mammary gland

18.7

323.0

2460

1615

HA4AT

NOMESCO Finland

Labeling mammary gland pathology with ultrasound guidance

18.7

323.0

1971

1241

HA1AT

NOMESCO Finland

Biopsy of mammary glands with ultrasound guidance

18.7

323.0

1585

962

NK6AN

NOMESCO Finland

Total body bone isotope imaging

33.4

323.0

1429

481

WF003

NOMESCO Finland

Adjuvant radiotherapy

12.6

323.0

1661

1507

A04AA02

ATC

granisetron; systemic, transdermal

15.6

323.0

3343

2860

ZX090

NOMESCO Finland

Other technic of radiotherapy

14.8

323.0

1293

967

8500/3-C50.9

ICD-O-3

Infiltrating duct carcinoma, NOS, of breast, NOS

28.4

323.0

4771

2664

394

Kela drug reimbursment

Palbociclib

387.4

323.0

488

L02BG06

ATC

exemestane; oral

548.3

323.0

1797

YG1AD

NOMESCO Finland

CT examination of thorax for dose design of radiotherapy

16.1

323.0

1113

754

WZC00

NOMESCO Finland

Planning of intervention or health care consultation

3.8

323.0

6471

27497

C50.4

ICD-10 Finland

Malignant neoplasm: Upper-outer quadrant of breast

19.7

323.0

681

365

ZZF00

NOMESCO Finland

Graft of adipose tissue

18.4

317.0

503

284

ZZR10

NOMESCO Finland

Flap of skin and muscle

19.6

315.2

489

259

C50.29

ICD-10 Finland

Malignant tumor of the upper inner quadrant of the mammary gland, other or undeterminated histology

22.5

315.1

467

215

C50.12

ICD-10 Finland

Malignant tumor of the central part of the mammary gland,lobular tumor

53.7

312.1

376

WB123

NOMESCO Finland

Demanding adjuvant cytostatic therapy

11.9

308.5

587

513

C50.00

ICD-10 Finland

Malignant tumor of nipple and areola, no histological veryfication

23.8

303.5

442

192

I97.2

ICD-10 Finland

Postmastectomy lymphoedema syndrome

35.8

303.0

396

114

TQB05

NOMESCO Finland

Puncture of skin of trunk

19.0

302.5

474

258

ZX112

NOMESCO Finland

Subcutaneous

9.2

300.9

658

749

C79.8

ICD-10 Finland

Secondary malignant neoplasm of other specified sites

6.7

297.2

803

1267

PJD42

NOMESCO Finland

Excision of axillary lymph nodes

13.5

295.9

531

408

L01EF01

ATC

palbociclib; oral

593.5

294.2

291

D70.82

ICD-10 Finland

Drug-induced neutropenia

10.3

291.5

597

603

HAE05

NOMESCO Finland

Reconstruction of breast using soft tissue and prosthesis

25.0

289.4

415

171

Z51.0

ICD-10 Finland

Radiotherapy session

15.2

280.5

479

327

8500/3-C50.1

ICD-O-3

Infiltrating duct carcinoma, NOS, of central portion of breast

40.7

280.2

356

C50.52

ICD-10 Finland

Malignant tumor of the lower outer quadrant of the mammary gland, lobular tumor

49.8

278.5

340

C50.20

ICD-10 Finland

Malignant tumor of the upper inner quadrant of the mammary gland,no histological veryfication

25.6

277.3

395

159

D05.1

ICD-10 Finland

Intraductal carcinoma in situ

5.8

272.0

822

1497

PJ3AT

NOMESCO Finland

Cytology of lymphnode with ultrasound guidance

13.0

268.5

491

393

C50.92

ICD-10 Finland

Malignant tumor in another specified localization in lobular gland, lobular tumor

35.0

267.3

351

103

HA1TE

NOMESCO Finland

Supplementary or limited ultrasound examination of mammary glands

10.5

261.9

531

525

WX702

NOMESCO Finland

Supraglottic ventilation device

4.0

258.6

1145

3104

HAC15

NOMESCO Finland

Subcutaneous mastectomy with excision of mamilla

15.7

258.2

435

287

WD105

NOMESCO Finland

Cystostatic therapy of methastized malignancy

5.2

256.1

850

1726

HA3AT

NOMESCO Finland

Pucture of mammary gland cyst with ultrasound examination

18.8

255.0

401

220

ZX013

NOMESCO Finland

Radiotherapy with large shaped fields - SSD therapy

28.4

246.6

341

123

C50.80

ICD-10 Finland

Overall malignant tumor of the mammary gland, no histological veryfication

43.3

246.5

309

QB2S1

NOMESCO Finland

Photography of skin or subcutaneous tissue in chest

22.3

245.1

364

168

FM1FN

NOMESCO Finland

Heart function isotope examination

22.0

244.2

364

170

L03AA02

ATC

filgrastim; parenteral

6.0

240.6

701

1216

HWD00

NOMESCO Finland

Reoperation for deep haemorrhage in surgery of mammary gland

16.4

239.8

396

248

ZXA05

NOMESCO Finland

Left side

2.0

232.1

3907

23051

HA1BG

NOMESCO Finland

MRI examination of mammary gland with high intensity magnet

15.0

232.1

398

274

WD225

NOMESCO Finland

Demanding therapy of methastized malignancy with hormones

29.6

228.1

312

108

WX402

NOMESCO Finland

General anaesthesia

2.3

227.8

2489

12137

ZSH00

NOMESCO Finland

Procedure related to previous procedure classified in chapter H

20.3

227.0

347

175

C50.59

ICD-10 Finland

Malignant tumor of the lower outer quadrant of the mammary gland, other or undeterminated histology

27.1

223.7

313

118

QBB10

NOMESCO Finland

Major dressing of wound of skin of trunk

4.8

221.0

793

1747

WZC20

NOMESCO Finland

Multidisciplinary treatment meeting

3.6

219.3

1075

3161

ZXA00

NOMESCO Finland

Right side

1.9

218.6

4091

25005

C50.19

ICD-10 Finland

Malignant tumor of the central part of the mammary gland, other or undeterminated histology

21.9

216.6

323

151

WF049

NOMESCO Finland

Radiotherapy of metastasis

5.7

214.1

650

1184

8500/3-C50.8

ICD-O-3

Infiltrating duct carcinoma, NOS, of overlapping lesion of breast

37.0

210.0

272

HA1BA

NOMESCO Finland

Extensive X-ray mammography

15.3

209.2

355

238

C50.10

ICD-10 Finland

Malignant tumor of the central part of the mammary gland, no histological veryfication

23.8

208.6

303

130

1XC03

NOMESCO Finland

37.6

208.4

269

HA1HA

NOMESCO Finland

Tomosynthesis mammography

17.4

205.5

332

196

8500/3-C50.3

ICD-O-3

Infiltrating duct carcinoma, NOS, of lower-inner quadrant of breast

24.0

204.3

296

126

L02AE03

ATC

goserelin; implant

12.2

199.1

374

316

N02BE01

ATC

paracetamol; systemic, rectal

2.3

198.1

11238

99434

L01BC06

ATC

capecitabine; oral

4.4

195.3

756

1794

WB402

NOMESCO Finland

Demanding antibody therapy of primary tumour

16.9

193.5

316

192

L02AE02

ATC

leuprorelin; implant, parenteral

10.5

192.9

390

382

ZZQ00

NOMESCO Finland

Free microvascular graft of skin

18.0

191.5

305

173

C50.9

ICD-10 Finland

Malignant neoplasm: Breast, unspecified

15.2

191.1

325

219

A79

ICPC

Malignancy NOS

9.8

187.4

393

412

N06AX16

ATC

venlafaxine; oral

2.2

185.4

2142

10602

WX408

NOMESCO Finland

General anesthesy, balanced

1.9

184.5

3594

21979

C50.50

ICD-10 Finland

Malignant tumor of the lower outer quadrant of the mammary gland, no histological veryfication

34.8

182.0

239

HAE00

NOMESCO Finland

Reconstruction of breast using prosthesis

20.7

180.6

274

135

PH1AE

NOMESCO Finland

Ultrasound examination of upper extremity veins

8.4

178.7

411

505

XZZ00

NOMESCO Finland

Active surveillance of a diagnosed cancer

9.5

178.1

380

411

HAC25

NOMESCO Finland

Radical mastectomy

18.7

176.9

278

152

WB133

NOMESCO Finland

Very demanding adjuvant cytostatic therapy

25.2

176.5

252

102

8522/3-C50.9

ICD-O-3

Infiltrating duct and lobular carcinoma of breast, NOS

86.6

174.7

196

HAD99

NOMESCO Finland

Other plastic operation on breast

13.9

173.4

306

225

X21

ICPC

Breast sympt/compl female other

5.3

172.5

562

1109

Z42.1

ICD-10 Finland

Follow-up care involving plastic surgery of breast

12.5

172.1

319

262

WD505

NOMESCO Finland

Simple enzyme inhibitor or similar therapy of methastized malignancy

12.0

171.3

323

275

HAD40

NOMESCO Finland

Mastopexy

16.1

171.1

284

180

WD305

NOMESCO Finland

Simple therapy of methastized malignancy with biomodifiers

9.2

169.3

368

411

ZZQ10

NOMESCO Finland

Free microvascular graft of skin and muscle

20.7

168.8

256

126

B01AB05

ATC

enoxaparin; parenteral

1.8

165.4

4325

28929

L01CA04

ATC

vinorelbine; systemic

13.3

163.7

294

225

HA2AT

NOMESCO Finland

Cytology of mammary gland with ultrasound guidance

16.7

159.6

261

159

HA1SA

NOMESCO Finland

Expansion mammography

17.3

158.5

256

151

HWA00

NOMESCO Finland

Repair of wound dehiscence in surgery of mammary gland

20.7

158.3

240

118

GD1AA

NOMESCO Finland

Thorax X-ray examination

1.7

157.5

5400

38970

A49.9

ICD-10 Finland

Bacterial infection, unspecified

2.5

155.5

1396

6054

X19

ICPC

Breast lump/mass female

5.8

154.3

463

828

C50.8

ICD-10 Finland

Malignant neoplasm: Overlapping lesion of breast

34.6

153.0

201

HA1CM

NOMESCO Finland

Mammary gland extensive MRI examination with 3 Tesla magnet

25.2

151.5

216

Z08.0

ICD-10 Finland

Follow-up examination after surgery for malignant neoplasm

5.2

146.9

478

940

QBE20

NOMESCO Finland

Excision and repair of scar or web of skin of trunk

10.3

146.5

298

295

C50.39

ICD-10 Finland

Malignant tumor of the lower inner quadrant of the mammary gland, other or undeterminated histology

22.4

146.2

216

YX9BD

NOMESCO Finland

Other extensive CT eamination for dose design of radiotherapy

10.6

143.1

286

274

HWH99

NOMESCO Finland

Other reoperation in surgery of mammary gland

21.5

141.8

212

100

L02BA02

ATC

toremifene; oral

1399.1

140.8

137

8520/3-C50.2

ICD-O-3

Lobular carcinoma, NOS, of upper-inner quadrant of breast

50.3

139.1

169

JN4AD

NOMESCO Finland

Body CT examination

2.6

137.9

1081

4333

C50.32

ICD-10 Finland

Malignant tumor of the lower inner quadrant of the mammary gland, lobular tumor

37.3

134.1

173

HAB00

NOMESCO Finland

Excision of lesion of mammary gland

3.5

130.9

654

1931

PJ2AT

NOMESCO Finland

Biopsy of lymphnode with ultrasound guidance

9.1

128.3

280

315

M05BA02

ATC

clodronic acid; systemic

24.5

128.2

184

WB121

NOMESCO Finland

Demanding neoadjuvant cytostatic therapy

7.1

127.7

327

473

C50.93

ICD-10 Finland

Malignant tumor in other specified localization in mammary gland other or unspecified histology

24.9

123.9

177

A02BC02

ATC

pantoprazole; systemic

1.6

119.8

8426

70884

HA1RA

NOMESCO Finland

Combined assessment of mammary gland (mammography and ultrasound)

4.1

117.8

485

1212

NK6AQ

NOMESCO Finland

Whole body bone SPET with low dose CT

33.3

117.2

155

8520/3-C50.8

ICD-O-3

Lobular carcinoma, NOS, of overlapping lesion of breast

99.4

116.1

128

R50.9

ICD-10 Finland

Fever, unspecified

2.0

116.0

1590

8319

YG1CD

NOMESCO Finland

Very extensive CT examination of thorax for dose design of radiotherapy

12.2

113.1

211

176

9707

FHL

Ablation of mammae and removal of axillary lymph nodes

8.0

111.1

262

335

ZX070

NOMESCO Finland

Intensity modified radiotherapy

5.9

111.0

324

559

X26

ICPC

Fear of breast cancer female

8.2

110.8

256

317

JN4CD

NOMESCO Finland

Very extensive body CT

3.3

109.5

598

1886

QBE30

NOMESCO Finland

Excision and repair of surgical scar in trunk

9.8

109.5

228

236

GA1AE

NOMESCO Finland

Ultrasound examination of thorax

4.9

108.5

375

787

C77.3

ICD-10 Finland

Secondary and unspecified malignant neoplasm: Axillary and upper limb lymph nodes

17.8

108.0

172

WD125

NOMESCO Finland

Demanding cystostatic therapy of methastized malignancy

3.0

107.9

666

2290

HAD60

NOMESCO Finland

Replacement of prosthetic implant in breast

17.4

105.9

170

XX1AD

NOMESCO Finland

Other CT-examination

11.6

104.8

200

175

WB223

NOMESCO Finland

Demanding adjuvant hormone therapy of malignancy

38.4

103.9

133

C50.2

ICD-10 Finland

Malignant neoplasm: Upper-inner quadrant of breast

16.9

103.0

167

100

1744A

ICD-9 Finland

Malignant neoplasm of female breast, Upper-outer quadrant

7.2

102.9

259

366

C50.30

ICD-10 Finland

Malignant tumor of the lower inner quadrant of the mammary gland, no histological veryfication

23.6

101.4

147

8480/3-C50.9

ICD-O-3

Mucinous adenocarcinoma of breast, NOS

30.1

101.1

137

8520/3-C50.1

ICD-O-3

Lobular carcinoma, NOS, of central portion of breast

50.0

98.0

119

D48.6

ICD-10 Finland

Neoplasm of uncertain or unknown behaviour: Breast

3.7

97.0

454

1268

8520/3-C50.5

ICD-O-3

Lobular carcinoma, NOS, of lower-outer quadrant of breast

47.6

96.4

118

ZSZ10

NOMESCO Finland

Secondary repair operation

54.7

95.4

114

A46

ICD-10 Finland

Erysipelas

1.9

94.9

1549

8615

AA1BD

NOMESCO Finland

Extensive CT of head and brain

3.6

94.6

457

1310

QXB05

NOMESCO Finland

Skin wound assessment, unspecified location

11.2

93.6

181

163

T81.4

ICD-10 Finland

Infection following a procedure, not elsewhere classified

1.9

90.7

1389

7536

NK6BQ

NOMESCO Finland

Whole body extensive bone SPET with low dose CT

14.5

88.3

152

106

QBE10

NOMESCO Finland

Excision of other lesion extending through all layers of skin of trunk

2.3

87.5

890

4055

HAD50

NOMESCO Finland

Removal of prosthetic implant from breast

9.7

87.4

182

189

QBJ00

NOMESCO Finland

Liposuction in trunk

9.1

87.1

189

211

PJ1AN

NOMESCO Finland

Lymphsystem isotope imaging

23.5

87.1

126

Z08.7

ICD-10 Finland

Follow-up examination after combined treatment for malignant neoplasm

8.0

87.0

203

256

WD115

NOMESCO Finland

Multiple cystostatic therapy of methastized malignancy

4.7

86.9

308

664

3AA13

NOMESCO Finland

21.0

86.0

129

J01DB01

ATC

cefalexin; oral

1.5

85.1

9781

87599

8522/3-C50.4

ICD-O-3

Infiltrating duct and lobular carcinoma of upper-outer quadrant of breast

36.3

83.5

108

N62

ICD-10 Finland

Hypertrophy of breast

2.5

82.4

705

2942

C50.1

ICD-10 Finland

Malignant neoplasm: Central portion of breast

17.5

80.1

128

8500/2-C50.9

ICD-O-3

Intraductal carcinoma, noninfiltrating, NOS, of breast, NOS

3.8

78.1

349

937

HAF00

NOMESCO Finland

Excision of local recurrence of breast cancer

57.9

77.9

Z51.1

ICD-10 Finland

Chemotherapy session for neoplasm

4.8

77.4

272

582

N95.1

ICD-10 Finland

Menopausal and female climacteric states

0.5

76.6

522

10716

XX1XT

NOMESCO Finland

Other puncture with other radiological guidance

14.2

76.1

132

HA6HA

NOMESCO Finland

Tomosynthesis assessment of mammary gland specimen

13.5

73.5

130

WB303

NOMESCO Finland

Simple adjuvant therapy of malignancy with biomodifiers

16.6

72.0

117

J01MA12

ATC

levofloxacin; systemic

1.6

68.5

2002

13203

C50.5

ICD-10 Finland

Malignant neoplasm: Lower-outer quadrant of breast

15.3

68.0

114

JN3KE

NOMESCO Finland

Abdominal ultrasound with added contrast

8.5

67.1

151

180

C50.01

ICD-10 Finland

Malignant tumor of nipple and areola, ductal tumor

15.8

66.5

110

M01AE01

ATC

ibuprofen; systemic, rectal

1.6

64.0

10845

100977

WD415

NOMESCO Finland

Demanding antibody therapy of methastized malignancy

3.9

63.7

274

713

ZZQ70

NOMESCO Finland

Free microvascular graft of lymph nodes

58.0

63.6

TQW99

NOMESCO Finland

Other minor procedure on skin

2.3

63.6

649

2953

XX1AT

NOMESCO Finland

Other puncture with ultrasound guidance

4.9

63.5

215

443

WC205

NOMESCO Finland

Simple therapy of local tumor recidive with hormone

318.5

63.4

JN1AE

NOMESCO Finland

Ultrasound examination of upper part of abdomen

1.9

63.3

1073

5999

N02AA05

ATC

oxycodone; systemic

1.7

62.4

1613

10269

Z51.5

ICD-10 Finland

Palliative care

2.2

60.5

647

3006

WF004

NOMESCO Finland

Palliative radiotherapy

4.0

60.2

250

630

QX2XE

NOMESCO Finland

Ultrsound examination of soft tissue not elsewhere classified

2.9

60.0

376

1303

PG1BD

NOMESCO Finland

Extensive CT angiography of tissue graft, e.g. assessment of TRAN graft

45.2

58.5

HA1DA

NOMESCO Finland

Restricted mammography

16.6

58.0

XX9AQ

NOMESCO Finland

Supplementary SPECT-CT or additional scan

21.7

56.9

QBA00

NOMESCO Finland

Puncture of skin of trunk

8.3

56.8

129

157

SPAT1144

SPAT

Treatment of reopened or infected surgical wound

1.9

56.8

851

4544

B01AB10

ATC

tinzaparin; parenteral

1.9

56.2

894

4879

SPAT1269

SPAT

Other puncture and/or drainage

6.5

55.9

149

230

C78.7

ICD-10 Finland

Secondary malignant neoplasm of liver and intrahepatic bile duct

3.3

55.5

290

885

B29

ICPC

Lymph/immune mech sympt/complt other

8.2

55.4

127

157

G03CA03

ATC

estradiol; nasal, systemic, rectal, transdermal, vaginal

0.7

53.3

6858

77379

WX110

NOMESCO Finland

Local anesthesy

1.3

52.9

7777

68805

HAC10

NOMESCO Finland

Subcutaneous mastectomy with preservation of mamilla

14.4

52.1

HAD20

NOMESCO Finland

Liposuction of breast

13.5

51.7

HA4ST

NOMESCO Finland

Labeling mammary gland pathology with sterotactic guidance

6.7

51.1

133

199

HA3ST

NOMESCO Finland

Removal of lesion of breast with radiological guidance

7.4

51.0

124

168

S18

ICPC

Laceration/cut

1.3

50.3

4734

38990

8520/3-C50.3

ICD-O-3

Lobular carcinoma, NOS, of lower-inner quadrant of breast

59.2

50.3

GD1BD

NOMESCO Finland

Thorax extensive CT-examination

2.1

49.2

595

2914

J70.0

ICD-10 Finland

Acute pulmonary manifestations due to radiation

15.0

48.8

XX3AT

NOMESCO Finland

Other labeling with ultrasound guidance

11.3

48.2

AA1CD

NOMESCO Finland

Very extensive CT of head and brain

3.2

48.0

263

832

ZSP00

NOMESCO Finland

Procedure related to previous procedure classified in chapter P

26.5

47.6

WX704

NOMESCO Finland

Intubation

1.8

46.6

804

4507

LCA06

NOMESCO Finland

Biopsy of endometrium

1.5

45.9

1923

13665

HAD00

NOMESCO Finland

Augmentation mammoplasty

16.5

45.8

9703

FHL

Breast resection

3.5

45.7

223

646

C78.0

ICD-10 Finland

Secondary malignant neoplasm of lung

3.5

45.2

219

631

WD405

NOMESCO Finland

Simple antiboidy therapy of methastized malignancy

2.8

44.5

304

1113

1742A

ICD-9 Finland

Malignant neoplasm of female breast, Upper-inner quadrant

9.5

44.2

WB101

NOMESCO Finland

Simple cytostatic neoadjuvant therapy

11.6

44.1

Z01.4

ICD-10 Finland

Gynaecological examination (general)(routine)

1.4

43.0

2268

16845

QBB05

NOMESCO Finland

Revision of wound of skin of trunk

4.5

42.2

154

345

WX400

NOMESCO Finland

Inhalation anesthesy

2.1

42.2

502

2441

RD211

NOMESCO Finland

2.0

41.9

532

2659

N64.9

ICD-10 Finland

Disorder of breast, unspecified

3.4

41.1

205

606

T81.0

ICD-10 Finland

Haemorrhage and haematoma complicating a procedure, not elsewhere classified

1.8

40.7

695

3879

N61

ICD-10 Finland

Inflammatory disorders of breast

2.8

40.6

277

1015

SPAT1152

SPAT

Removal of foreign body from under the skin

2.4

39.9

353

1496

HAA10

NOMESCO Finland

Biopsy of mammary gland

3.7

39.9

181

496

LAF11

NOMESCO Finland

Laparoscopic bilateral salpingo-oophorectomy

1.7

39.5

888

5402

HA1DM

NOMESCO Finland

Mammary gland very extensive MRI examination with 3 Tesla magnet

27.1

39.3

5BX04

NOMESCO Finland

57.6

39.2

D24

ICD-10 Finland

Benign neoplasm of breast

2.4

38.9

340

1433

WF002

NOMESCO Finland

Radical radiotherapy

2.4

38.8

336

1406

C50.3

ICD-10 Finland

Malignant neoplasm: Lower-inner quadrant of breast

12.6

38.8

1DB03

NOMESCO Finland

86.3

38.8

YN7BD

NOMESCO Finland

Extensive CT examination of spine for dose design of radiotherapy

9.5

38.4

Z40.0

ICD-10 Finland

Prophylactic surgery for risk-factors related to malignant neoplasms

14.5

38.4

N05CF01

ATC

zopiclone; oral

1.3

38.3

3862

31767

N84.0

ICD-10 Finland

Polyp of corpus uteri

1.5

38.0

1232

8243

ZZS55

NOMESCO Finland

Distension of tissue expander

46.1

37.8

1515

Kela drug reimbursment

102.8

37.7

3030

Kela drug reimbursment

Abemaciclib

102.8

37.7

PD1BD

NOMESCO Finland

Extensive CT of abdominal aorta and branches

5.4

37.5

116

218

8523/3-C50.9

ICD-O-3

Infiltrating duct mixed with other types of carcinoma of breast, NOS

29.5

37.2

TPH04

NOMESCO Finland

Cathetrisation of vein

1.4

37.2

2109

15822

EP1AE

NOMESCO Finland

Neck ultrasound examination

1.8

37.0

676

3857

C78.2

ICD-10 Finland

Secondary malignant neoplasm of pleura

8.6

36.3

1XC13

NOMESCO Finland

26.4

36.2

OAA41

NOMESCO Finland

Health check based on individual needs

11.6

35.8

Y83.9

ICD-10 Finland

Surgical procedure, unspecified as the cause of abnormal reaction of the patient, or of later complication, without mention of misadventure at the time of the procedure

2.3

35.1

326

1416

D05.9

ICD-10 Finland

Carcinoma in situ of breast, unspecified

5.6

34.8

103

184

JN3AE

NOMESCO Finland

Abdominal ultrasound examination

1.5

34.4

1300

8989

QBE00

NOMESCO Finland

Excision of loose skin or fold of skin from trunk

4.9

34.3

114

233

XX2ET

NOMESCO Finland

28.8

34.1

JN5AN

NOMESCO Finland

Total body isotope imaging

26.2

34.0

D70.89

ICD-10 Finland

Neutropenic splenomegaly

3.3

33.4

172

522

8211/3-C50.9

ICD-O-3

Tubular adenocarcinoma of breast, NOS

18.9

33.4

8507/3-C50.9

ICD-O-3

Invasive micropapillary carcinoma of breast of breast, NOS

38.3

33.3

Z80.4

ICD-10 Finland

Family history of malignant neoplasm of genital organs

5.9

32.9

161

HA1AE

SPAT

2.7

32.9

235

888

D05.0

ICD-10 Finland

Lobular carcinoma in situ

7.2

32.7

111

XX9TE

NOMESCO Finland

Compementary ultrasound examination

4.4

32.7

120

272

C50.09

ICD-10 Finland

Malignant tumor of nipple and areola, other or undeterminated histology

14.5

32.6

8524/3-C50.4

ICD-O-3

Infiltrating lobular mixed with other types of carcinoma of upper-outer quadrant of breast

72.3

31.8

Y83

ICD-10 Finland

Surgical operation and other surgical procedures as the cause of abnormal reaction of the patient, or of later complication, without mention of misadventure at the time of the procedure

1.6

31.8

813

5116

1BC02

NOMESCO Finland

43.4

31.8

L01EF03

ATC

abemaciclib; oral

87.7

31.7

QCJ00

NOMESCO Finland

Liposuction in upper limb

18.2

31.7

8523/3-C50.4

ICD-O-3

Infiltrating duct mixed with other types of carcinoma of upper-outer quadrant of breast

22.0

31.7

HA4MT

NOMESCO Finland

Labeling mammary gland pathology with X-ray guidance

6.1

31.5

143

TPX10

NOMESCO Finland

Implantation of vascular injection port

2.3

31.4

313

1408

YX9CD

NOMESCO Finland

Other very extensive CT eamination for dose design of radiotherapy

12.8

31.0

I89.0

ICD-10 Finland

Lymphoedema, not elsewhere classified

3.8

30.8

135

361

ZX001

NOMESCO Finland

Simple adjustment of radiotherapy with simulator or with therapeutic device - SSD therapy

35.5

30.5

HAD10

NOMESCO Finland

Augmentation of breast using prosthesis

6.2

30.2

132

JN6AD

NOMESCO Finland

CT of torso and neck

3.3

30.2

159

492

WB610

NOMESCO Finland

Demanding neoadjuvant therapy of tumour with antibodies

11.2

30.1

T81.8

ICD-10 Finland

Other complications of procedures, not elsewhere classified

2.5

29.8

245

1002

WB201

NOMESCO Finland

Simple neoadjuvant hormone therapy of malignancy

106.9

29.6

PJA10

NOMESCO Finland

Exploration of lymph nodes

3.2

29.3

159

503

8480/3-C50.4

ICD-O-3

Mucinous adenocarcinoma of upper-outer quadrant of breast

26.7

29.2

M87.1

ICD-10 Finland

Osteonecrosis due to drugs

7.7

29.0

1749X

ICD-9 Finland

Malignant neoplasm of female breast, Breast (female), unspecified

7.2

28.8

Y83.4

ICD-10 Finland

Other reconstructive surgery as the cause of abnormal reaction of the patient, or of later complication, without mention of misadventure at the time of the procedure

8.8

28.7

R2130

NOMESCO Finland

Counselling and guidance which enhance independent living

1.6

28.3

770

4919

L95

ICPC

Osteoporosis

1.8

28.1

493

2771

8507/3-C50.4

ICD-O-3

Invasive micropapillary carcinoma of breast of upper-outer quadrant of breast

39.0

28.0

R93.5

ICD-10 Finland

Abnormal findings on diagnostic imaging of other abdominal regions, including retroperitoneum

2.4

27.7

235

978

XX9AW

NOMESCO Finland

Production of copy from X-ray picture

2.0

27.6

370

1889

Z31.6

ICD-10 Finland

General counselling and advice on procreation

8.6

27.5

8524/3-C50.9

ICD-O-3

Infiltrating lobular mixed with other types of carcinoma of breast, NOS

53.4

27.1

8522/3-C50.1

ICD-O-3

Infiltrating duct and lobular carcinoma of central portion of breast

62.1

26.9

FB1BD

NOMESCO Finland

Extensive CT examination of arteria pulmonalis

1.6

26.7

795

5196

WE200

NOMESCO Finland

Profylactive therapy of malignancy with hormones

140.2

26.6

8010/3-C50.9

ICD-O-3

Carcinoma, NOS, of breast, NOS

6.3

26.2

111

J90

ICD-10 Finland

Pleural effusion, not elsewhere classified

2.3

26.0

254

1132

C50.61

ICD-10 Finland

Malignant tumor of the scapula of the mammary gland, ductal tumor

21.2

26.0

SPAT1256

SPAT

Intramuscular and subcutaneous injection

1.2

25.9

4552

39583

THA00

NOMESCO Finland

Needle biopsy of mamilla

7.6

25.6

YL1BD

NOMESCO Finland

Extensive CT examination of pelvis for dose design of radiotherapy

3.2

25.3

138

440

HAA01

NOMESCO Finland

Suture of mammary gland

25.0

25.2

WF099

NOMESCO Finland

Other radiotherapy

4.6

25.1

192

M05BA06

ATC

ibandronic acid; systemic

2.0

25.1

329

1670

GA5AA

NOMESCO Finland

Rib X-ray examination

5.2

25.0

150

SPAT1153

SPAT

Removal of sutures

1.3

25.0

3511

29736

G03FA14

ATC

dydrogesterone and estrogen; systemic (progestogens and estrogens, fixed comb.)

0.6

25.0

476

7475

A21

ICPC

Risk factor for malignancy

8.4

24.9

166

Kela drug reimbursment

Dalteparin and tinzaparin (treatment for more than 6 months)

3.6

24.6

112

311

206

Kela drug reimbursment

Chronic coronary artery disease and dyslipidaemia associated with chronic coronary artery disease

0.7

24.1

591

8808

PD1AD

NOMESCO Finland

CT of abdominal aorta and branches

5.3

24.0

137

5702

FHL

Local lymph node removal (eg armpit, groin)

4.4

23.9

198

QBA10

NOMESCO Finland

Incision of skin of trunk

3.4

23.8

118

351

TPH07

NOMESCO Finland

Cathetrisation of artery

1.5

23.6

941

6561

8522/3-C50.2

ICD-O-3

Infiltrating duct and lobular carcinoma of upper-inner quadrant of breast

31.0

23.6

9706

FHL

Ablation mammae, includes axillary exploration

5.8

23.2

114

L04AX03

ATC

methotrexate; systemic (immunosuppressants)

0.6

23.2

527

7978

N05CB02

ATC

barbiturates in combination with other drugs

1.8

23.1

410

2318

FN1AC

NOMESCO Finland

Angiography of heart and/or coronary arteries

0.7

23.0

1049

14039

ZSZ00

NOMESCO Finland

Primary repair operation

10.8

23.0

HA1ST

NOMESCO Finland

Biopsy of mammary gland with sterotactic guidance

7.7

22.9

JN6BD

NOMESCO Finland

Extensive CT of torso and neck

3.5

22.3

107

311

QBE99

NOMESCO Finland

Other excision or repair of lesion of skin of trunk

2.3

22.2

209

916

L02AB02

ATC

medroxyprogesterone; systemic (progestogens)

3.4

22.1

109

324

B01AC04

ATC

clopidogrel; oral

0.7

22.0

644

9287

C79.30

ICD-10 Finland

Secondary malignant tumor of the cerebrum

3.4

22.0

110

330

C10AA05

ATC

atorvastatin; oral

0.8

22.0

2942

34439

156

Kela drug reimbursment

Lapatinib

17.0

21.7

5BA08

NOMESCO Finland

4.0

21.7

218

QBJ99

NOMESCO Finland

Other aesthetic correction of skin of trunk

14.4

21.6

8480/3-C50.2

ICD-O-3

Mucinous adenocarcinoma of upper-inner quadrant of breast

43.3

21.4

202

Kela drug reimbursment

Connective tissue diseases, rheumatoid arthritis and comparable disease

0.7

21.2

721

10133

WB131

NOMESCO Finland

Very demanding neoadjuvant cytostatic therapy

13.4

20.9

LCB25

NOMESCO Finland

Hysteroscopic excision of lesion

1.5

20.8

686

4591

A08

ICPC

Swelling

1.7

20.6

469

2860

A14AB01

ATC

nandrolone; parenteral

6.6

20.6

QX3HE

NOMESCO Finland

Ultrsound examination of lesion close to skin

2.6

20.6

156

615

1741A

ICD-9 Finland

Malignant neoplasm of female breast, Central portion

9.8

20.5

YN7AD

NOMESCO Finland

CT examination of spine for dose design of radiotherapy

9.0

20.5

ULC02

NOMESCO Finland

Hysteroscopy

1.5

20.5

745

5094

L90.5

ICD-10 Finland

Scar conditions and fibrosis of skin

2.9

20.5

122

416

J94.8

ICD-10 Finland

Other specified pleural conditions

2.7

20.4

139

514

C10AA01

ATC

simvastatin; oral

0.8

20.4

3561

40691

Z08.9

ICD-10 Finland

Follow-up examination after unspecified treatment for malignant neoplasm

4.2

20.4

187

L01XE07

ATC

[U] lapatinib; oral

16.9

20.4

NK6CT

NOMESCO Finland

Bone biopsy with CT guidance

5.3

20.4

117

I80.8

ICD-10 Finland

Phlebitis and thrombophlebitis of other sites

2.5

20.2

156

620

SPAT1149

SPAT

Suture or treatment of traumatic wound

1.4

20.2

1152

8585

WD315

NOMESCO Finland

Multiple therapy of methastized malignancy with biomodifiers

6.9

20.1

Z80.8

ICD-10 Finland

Family history of malignant neoplasm of other organs or systems

5.4

20.1

111

QX4YT

NOMESCO Finland

Puncture of superficial collection under ultrasound guidance

6.9

19.8

WW200

SPAT

0.7

19.7

513

7560

C79.2

ICD-10 Finland

Secondary malignant neoplasm of skin

9.8

19.5

I25.1

ICD-10 Finland

Atherosclerotic heart disease

0.7

19.4

852

11484

M05BA04

ATC

alendronic acid; oral

1.4

19.1

1143

8579

NK6SN

NOMESCO Finland

Bone SPECT

16.7

19.1

S76

ICPC

Skin infection other

1.6

19.1

469

2922

QWF00

NOMESCO Finland

Reoperation for insufficiency of suture in plastic surgery of skin

13.9

19.0

N60.9

ICD-10 Finland

Benign mammary dysplasia, unspecified

3.2

18.9

101

320

EB1HA

NOMESCO Finland

Panorama tomography of teeth and jaws or similar X-ray examination

1.2

18.7

4197

37048

1745A

ICD-9 Finland

Malignant neoplasm of female breast, Lower-outer quadrant

7.2

18.4

M05.8

ICD-10 Finland

Other seropositive rheumatoid arthritis

0.6

18.3

294

4800

1CD01

NOMESCO Finland

6.0

18.2

QXB99

NOMESCO Finland

Other procedure to treat skin wound, unspecified location

2.4

18.1

159

678

B04

ICPC

Blood symptom/complaint

4.1

17.9

168

F43.22

ICD-10 Finland

Adaptation disorder with mixed anxiety and depression

1.7

17.8

365

2164

ZZR00

NOMESCO Finland

Flap of skin

2.0

17.6

219

1094

X79

ICPC

Benign neoplasm breast female

8.8

17.6

C01DA08

ATC

isosorbide dinitrate; oral, oral aerosol, sublingual, transdermal

0.8

17.5

1328

16625

WD325

NOMESCO Finland

Demanding therapy of methastized malignancy with biomodifiers

3.1

17.2

309

R22.9

ICD-10 Finland

Localized swelling, mass and lump, unspecified

1.5

17.2

685

4772

L09

ICPC

Arm symptom/complaint

1.6

17.1

438

2758

LC2DE

NOMESCO Finland

Demanding ultrsound examination of uterus, parametrium and lower part of abdomen with speciel methods

1.6

17.0

478

3086

WW500

NOMESCO Finland

Blood transfusion

1.7

16.9

343

2025

J01CE08

ATC

benzathine benzylpenicillin; parenteral

2.8

16.8

109

394

8522/3-C50.5

ICD-O-3

Infiltrating duct and lobular carcinoma of lower-outer quadrant of breast

21.8

16.8

WD135

NOMESCO Finland

Demanding cystostatic therapy of methastized malignancy

3.0

16.8

337

T85.4

ICD-10 Finland

Mechanical complication of breast prosthesis and implant

5.1

16.7

102

C08CA01

ATC

amlodipine; oral

0.8

16.7

2833

32602

C507

ICD-10 Finland

15.0

16.6

C79.39

ICD-10 Finland

Secondary malignant tumor of the meninges, ventricle or other part of the brain

8.8

16.6

8246/3-C50.9

ICD-O-3

Neuroendocrine carcinoma, NOS, of breast, NOS

90.1

16.5

SPAT1148

SPAT

Treatment of chronic ulcer or burn

1.3

16.5

1233

9571

L02AB01

ATC

megestrol; oral (progestogens)

170.1

16.5

PJ5YQ

NOMESCO Finland

17.9

16.4

WB321

NOMESCO Finland

Multiple adjuvant therapy of malignancy with biomodifiers

10.7

16.4

QX4AT

NOMESCO Finland

Ultrsound guided needle biopsy of skin

4.0

16.4

163

NF3AA

NOMESCO Finland

Femur X-ray examination

2.1

16.3

188

909

X62

ICPC

Female Genital, Administrative procedure

40.1

16.3

AN1

Coronary angiography

0.7

16.3

455

6625

TQW40

NOMESCO Finland

Remowal of suture of skin

1.4

16.3

715

5079

N05CF02

ATC

zolpidem; oral

1.2

16.2

1978

16355

1748X

ICD-9 Finland

Malignant neoplasm of female breast, Other specified sites of female breast

6.4

16.2

T81.9

ICD-10 Finland

Unspecified complication of procedure

2.1

16.1

177

840

Z00.4

ICD-10 Finland

General psychiatric examination, not elsewhere classified

1.4

16.1

692

4898

R92

ICD-10 Finland

Abnormal findings on diagnostic imaging of breast

3.2

16.1

264

XX2VW

NOMESCO Finland

Radiologic consultation

3.4

16.0

227

FM1EE

NOMESCO Finland

Extensive structural and functional ultrasound examination of heart

1.2

16.0

1906

15718

Z08

ICD-10 Finland

Follow-up examination after treatment for malignant neoplasms

10.0

15.9

PJ4AT

NOMESCO Finland

Labeling lymphnode with ultrasound guidance

9.7

15.6

M54.4

ICD-10 Finland

Lumbago with sciatica

0.8

15.5

1149

14443

WD215

NOMESCO Finland

Multiple therapy of methastized malignancy with hormones

13.7

15.4

R22.2

ICD-10 Finland

Localized swelling, mass and lump, trunk

1.7

15.4

300

1752

E0000UV

ATC

1.2

15.3

4256

38096

SPAT1211

SPAT

Application of soft bandage

1.4

15.2

869

6470

L04AX01

ATC

azathioprine; systemic

0.5

15.2

141

2650

M75.1

ICD-10 Finland

Rotator cuff syndrome

0.8

14.9

1787

21302

C01DA02

ATC

glyceryl trinitrate; oral, oral aerosol, sublingual, transdermal

0.8

14.8

1102

13846

8522/3-C50.8

ICD-O-3

Infiltrating duct and lobular carcinoma of overlapping lesion of breast

56.7

14.8

WB111

NOMESCO Finland

Multiple neoadjuvant cytostatic therapy

5.1

14.6

GD1AD

NOMESCO Finland

Thorax CT examination

1.6

14.6

350

2169

XX9XW

NOMESCO Finland

3.3

14.6

218

TQW11

NOMESCO Finland

Vacuum treatment of wound

2.1

14.5

163

780

M51.1

ICD-10 Finland

Lumbar and other intervertebral disc disorders with radiculopathy

0.8

14.5

877

11314

GAA10

NOMESCO Finland

Intercostal insertion of pleural drainage tube

2.3

14.4

131

569

SPAT1324

SPAT

Screening procedure

0.8

14.4

1551

18687

C10AA07

ATC

rosuvastatin; oral

0.8

14.3

1880

22207

G03AC03

ATC

levonorgestrel; systemic

1.2

14.1

1677

13811

HAD55

NOMESCO Finland

Incision of periprosthetic capsule of breast

11.9

14.0

L58.9

ICD-10 Finland

Radiodermatitis, unspecified

15.7

13.9

A04AA03

ATC

tropisetron; systemic

3.7

13.8

159

ZXF00

NOMESCO Finland

Interruption caused by intraoperative deterioration of general condition

4.3

13.8

116

ZX100

NOMESCO Finland

Oral

2.3

13.8

124

537

2393A

ICD-9 Finland

Neoplasm of unspecified nature, Breast

2.9

13.8

289

LCB98

NOMESCO Finland

Other transluminal endoscopic excision of lesion of uterus

2.3

13.8

124

538

L01BA01

ATC

methotrexate; systemic (folic acid analog.)

0.6

13.6

185

3142

P01BA02

ATC

hydroxychloroquine; oral

0.7

13.6

600

8096

C50.62

ICD-10 Finland

Malignant tumor of the scapula of the mammary gland, lobular tumor

75.1

13.6

TPX15

NOMESCO Finland

Removal of vascular injection port

3.6

13.5

163

1514

Kela drug reimbursment

140.0

13.4

3002

Kela drug reimbursment

Ribociclib

140.0

13.4

C50.02

ICD-10 Finland

Malignant tumor of nipple and areola, lobular tumor

16.2

13.4

F43.29

ICD-10 Finland

Adaptation disorder UNS

2.0

13.4

179

923

8140/3-C50.9

ICD-O-3

Adenocarcinoma, NOS, of breast, NOS

7.0

13.3

WC105

NOMESCO Finland

Simple cytostatic therapy of local tumor recidive

4.1

13.2

122

WZB00

NOMESCO Finland

Telephone receipt or other advice

1.2

13.1

2750

23958

WE100

NOMESCO Finland

Profylactic cytostatic therapy

11.5

12.8

HAD57

NOMESCO Finland

Resection of periprosthetic capsule of breast

11.5

12.8

9702

FHL

Breast exploration and possible tumor removal

1.8

12.7

221

1251

N81.1

ICD-10 Finland

Cystocele

0.7

12.7

629

8344

313

Kela drug reimbursment

Abatacept, adalimumab, anakinra, certolizumab pegol, etanercept, golimumab, infliximab, ixekizumab, sarilumab, secukinumab, tocilizumab and ustekinumab (rheumatoid diseases)

0.5

12.7

1645

Z44.3

ICD-10 Finland

Fitting and adjustment of external breast prosthesis

17.3

12.5

Y83.8

ICD-10 Finland

Other surgical procedures as the cause of abnormal reaction of the patient, or of later complication, without mention of misadventure at the time of the procedure

1.8

12.5

228

1311

8524/3-C50.2

ICD-O-3

Infiltrating lobular mixed with other types of carcinoma of upper-inner quadrant of breast

130.0

12.4

QWD00

NOMESCO Finland

Reoperation for superficial haemorrhage in surgery of skin

4.6

12.4

HAB30

NOMESCO Finland

Excision of mamilla or areola

7.6

12.3

N64.8

ICD-10 Finland

Other specified disorders of breast

2.9

12.3

259

C78.1

ICD-10 Finland

Secondary malignant neoplasm of mediastinum

10.5

12.2

8480/3-C50.1

ICD-O-3

Mucinous adenocarcinoma of central portion of breast

37.5

12.2

YA1BD

NOMESCO Finland

Extensive CT examination of head and neck for dose design of radiotherapy

2.7

12.1

295

281

Kela drug reimbursment

Abatacept, adalimumab, anakinra, certolizumab pegol, etanercept, golimumab, infliximab, ixekizumab, sarilumab, secukinumab and tocilizumab

0.5

12.1

1522

HAA00

NOMESCO Finland

Incision of mammary gland

6.0

12.0

WB323

NOMESCO Finland

Demanding adjuvant therapy of malignancy with biomodifiers

8.1

12.0

C01DA14

ATC

isosorbide mononitrate; oral

0.8

12.0

693

8996

9719

FHL

Other measure in this category

4.0

11.9

115

205

Kela drug reimbursment

Chronic hypertension

0.8

11.9

2000

23148

8523/3-C50.2

ICD-O-3

Infiltrating duct mixed with other types of carcinoma of upper-inner quadrant of breast

46.6

11.9

TQX05

NOMESCO Finland

Skin puncture, unspecified location

4.9

11.8

A10AA02

ATC

0.5

11.7

1506

OAB38

NOMESCO Finland

Psychosocial guidance and counselling

5.4

11.7

N64.5

ICD-10 Finland

Other signs and symptoms in breast

1.7

11.7

254

1538

AA1CG

NOMESCO Finland

Extensive MRI examination of brain with high intensity magnet

1.3

11.7

703

5281

WB213

NOMESCO Finland

Adjuvant hormone therapy of malignancy

64.9

11.6

8507/3-C50.5

ICD-O-3

Invasive micropapillary carcinoma of breast of lower-outer quadrant of breast

64.9

11.6

PJ5AQ

NOMESCO Finland

Sentinell lymphnode SPECT with low dose CT

3.8

11.6

123

A10AC01

ATC

insulin (human); parenteral (insulins and analog. for injection, intermediate-acting)

0.7

11.5

259

3925

I70.2

ICD-10 Finland

Atherosclerosis of arteries of extremities

0.7

11.4

264

3984

N81.6

ICD-10 Finland

Rectocele

0.8

11.4

624

8168

M49.5*C79.5

ICD-10 Finland

Metastatic fracture of vertebra

6.7

11.4

NK6PA

NOMESCO Finland

Measurement of bone density from one location with X-ray

3.3

11.3

162

L71

ICPC

Malignant neoplasm musculoskeletal

10.5

11.2

G47.3

ICD-10 Finland

Sleep apnoea

0.8

11.2

1146

13910

ZX121

NOMESCO Finland

Central venous catheter

3.6

11.2

132

103

Kela drug reimbursment

Diabetes, insulin-treated

0.8

11.1

1699

19850

8480/3-C50.5

ICD-O-3

Mucinous adenocarcinoma of lower-outer quadrant of breast

25.0

11.1

I63.9

ICD-10 Finland

Cerebral infarction, unspecified

0.7

11.1

424

5850

WB600

NOMESCO Finland

Neoadjuvant therapy of primary tumour with antibodies

12.7

11.1

PH2AE

NOMESCO Finland

Ultrasound examination of lower leg veins

1.3

11.1

1068

8568

1AA01

NOMESCO Finland

7.6

11.1

TPH90

NOMESCO Finland

Removal of fixed intravenous catheter

2.2

11.1

109

498

17402

ICD-8 Finland

Malignant neoplasm of breast, Glandulae

3.1

11.0

192

A10AB01

ATC

insulin (human); parenteral (insulins and analog. for injection, fast-acting)

0.5

11.0

1527

C10AX09

ATC

ezetimibe; oral

0.7

11.0

582

7652

L03.3

ICD-10 Finland

Cellulitis of trunk

2.7

11.0

278

XX9CN

NOMESCO Finland

13.9

10.9

ZX050

NOMESCO Finland

Stereotactic radiotherapy

3.1

10.9

188

A50

ICPC

General and Unspecified, Medication/prescr/renewal

1.6

10.9

277

1748

A41.9

ICD-10 Finland

Sepsis, unspecified

1.6

10.8

242

1480

XLD00

NOMESCO Finland

Sytologyspecimen from mouth of uterus

1.2

10.8

1368

11330

TLC02

NOMESCO Finland

Simple extraction of IUD

1.5

10.8

390

2671

I20.81

ICD-10 Finland

Other angina pectoris stenosed coronary artery

0.6

10.7

168

2752

8211/3-C50.4

ICD-O-3

Tubular adenocarcinoma of upper-outer quadrant of breast

10.5

10.7

WE198

NOMESCO Finland

Palliative cystotatic therapy

8.8

10.7

N06AX11

ATC

mirtazapine; oral

1.2

10.7

3395

30497

N02AB03

ATC

fentanyl; nasal, sublingual, transdermal

1.5

10.7

313

2046

HA1DT

NOMESCO Finland

Mammary gland biopsy with MRI guidance

21.4

10.7

QX3AT

NOMESCO Finland

Ultrasound guided biopsy of subcutaneous tissue

2.9

10.7

219

JN1CG

NOMESCO Finland

Extensive MRI examination of upper part of abdomen with high intensity magnet

1.7

10.7

213

1261

ZX000

NOMESCO Finland

Simple adjustment of radiotherapy with simulator or with therapeutic device - isocentric therapy

12.9

10.6

N95.2

ICD-10 Finland

Postmenopausal atrophic vaginitis

1.3

10.5

865

6803

ZXF20

NOMESCO Finland

Interruption caused by problems of surgical technique

6.5

10.4

A07EC01

ATC

sulfasalazine; oral, rectal

0.7

10.4

461

6216

1XC0V

NOMESCO Finland

110.0

10.4

ZXA10

NOMESCO Finland

Bilateral

1.2

10.4

1942

16703

8500/2-C50.4

ICD-O-3

Intraductal carcinoma, noninfiltrating, NOS, of upper-outer quadrant of breast

5.2

10.4

XF603

NOMESCO Finland

Direct intraarterial blood pressure measurement

1.5

10.3

304

1991

T81.3

ICD-10 Finland

Disruption of operation wound, not elsewhere classified

1.7

10.3

190

1097

H02AB04

ATC

methylprednisolone; systemic

0.8

10.3

1117

13483

PJW20

NOMESCO Finland

Lymphovenous shunt

18.8

10.2

M75.4

ICD-10 Finland

Impingement syndrome of shoulder

0.7

10.2

374

5189

213

Kela drug reimbursment

Fat metabolism disorder associated with chronic coronary artery disease

0.6

10.2

177

2829

M48.0

ICD-10 Finland

Spinal stenosis

0.8

10.2

810

10109

RF210

NOMESCO Finland

1.6

10.1

258

1633

Z08.8

ICD-10 Finland

Follow-up examination after other treatment for malignant neoplasm

3.7

10.1

113

J01FF01

ATC

clindamycin; systemic

1.2

10.1

2638

23341

M53.1

ICD-10 Finland

Cervicobrachial syndrome

0.8

10.0

704

8914

ZXC90

NOMESCO Finland

Use of absorbable mesh in surgery

14.5

10.0

L04AA13

ATC

leflunomide; oral

0.6

10.0

117

2053

I25.2

ICD-10 Finland

Old myocardial infarction

0.6

9.9

121

2108

C79.31

ICD-10 Finland

Secondary malignant tumor of the cerebellum

4.7

9.9

N39.3

ICD-10 Finland

Stress incontinence

0.8

9.9

666

8478

8097/3-C44.3

ICD-O-3

Basal cell carcinoma, nodular of skin of other and unspecified parts of face

7.6

9.9

R10.1

ICD-10 Finland

Pain localized to upper abdomen

0.8

9.8

1230

14642

A06AH03

ATC

naloxegol; oral

2.2

9.8

412

8523/3-C50.5

ICD-O-3

Infiltrating duct mixed with other types of carcinoma of lower-outer quadrant of breast

26.0

9.8

1740A

ICD-9 Finland

Malignant neoplasm of female breast, Nipple and areola

8.1

9.8

R06AE07

ATC

cetirizine; oral

1.1

9.7

4908

45420

G45.9

ICD-10 Finland

Transient cerebral ischaemic attack, unspecified

0.7

9.6

395

5387

WB221

NOMESCO Finland

Demanding neoadjuvant hormone therapy of malignancy

55.0

9.6

8523/3-C50.8

ICD-O-3

Infiltrating duct mixed with other types of carcinoma of overlapping lesion of breast

55.0

9.6

A10AA01

ATC

0.4

9.6

1121

8520/2-C50.9

ICD-O-3

Lobular carcinoma in situ, NOS, of breast, NOS

5.0

9.5

AAG50

NOMESCO Finland

Stereotactic intracranial radiotherapy

3.0

9.5

168

OAB39

NOMESCO Finland

Sexual health guidance

17.5

9.4

XX9KE

NOMESCO Finland

Ultrasound examination with contrast

7.5

9.4

8523/3-C50.3

ICD-O-3

Infiltrating duct mixed with other types of carcinoma of lower-inner quadrant of breast

+∞

9.4

R10.3

ICD-10 Finland

Pain localized to other parts of lower abdomen

0.8

9.3

1667

19239

203

Kela drug reimbursment

Chronic asthma and similar chronic obstructive pulmonary diseases

0.8

9.3

1401

16410

M17.1

ICD-10 Finland

Other primary gonarthrosis

0.9

9.3

1895

21645

R60.0

ICD-10 Finland

Localized oedema

1.2

9.2

1063

8710

XW1AT

NOMESCO Finland

Biopsy from other organ close to skin with ultrasound quidance

2.5

9.2

265

9710

FHL

Existence of a relapse

13.6

9.2

335

Kela drug reimbursment

Lapatinib

13.6

9.2

R59.0

ICD-10 Finland

Localized enlarged lymph nodes

1.6

9.1

233

1479

FM1DE

NOMESCO Finland

Doppler ultrasound examination of heart

1.3

9.1

780

6168

LC2BE

NOMESCO Finland

Transvaginal ultrasound examination of uterus, parametria and lower abdomen

1.1

9.0

3389

30735

1XC14

NOMESCO Finland

15.6

9.0

PJ2AE

NOMESCO Finland

Lymphnode ultrasound examination

2.3

9.0

337

NK4XE

NOMESCO Finland

Joint ultrasound examination not elsewhere classified

0.7

9.0

393

5303

M70.6

ICD-10 Finland

Trochanteric bursitis

0.8

9.0

1187

14065

N05BA04

ATC

oxazepam; oral

1.2

8.9

2614

23297

I15.1

ICD-10 Finland

Hypertension secondary to other renal disorders

0.2

8.9

378

HAC99

NOMESCO Finland

Other mastectomy

18.6

8.9

L88

ICPC

Rheumatoid/seropositive arthritis

0.7

8.9

206

3101

I20.09

ICD-10 Finland

Unstable angina

0.6

8.9

181

2793

KMAK

NOMESCO Finland

0.9

8.9

4590

49317

ACC59

NOMESCO Finland

Decompression and freeing of adhesions of peripheral nerve: other or unspecified

0.7

8.9

283

4020

TJA10

NOMESCO Finland

Laparocentesis

3.5

8.9

111

T80.8

ICD-10 Finland

Other complications following infusion, transfusion and therapeutic injection

5.7

8.9

N03AG01

ATC

valproic acid; systemic, rectal

0.7

8.8

247

3589

J05AB11

ATC

valaciclovir; oral

1.2

8.8

1338

11277

C10AA04

ATC

fluvastatin; oral

0.8

8.8

495

6451

G43

ICD-10 Finland

Migraine

0.6

8.8

128

2129

LEF13

NOMESCO Finland

Colpoperineoplasty and vaginal hysterectomy

0.7

8.8

216

3213

DM1AA

NOMESCO Finland

Paranasal sinuses X-ray examination without contrast

1.5

8.8

314

2153

J01CR02

ATC

amoxicillin and beta-lactamase inhibitor; systemic

1.1

8.7

5203

48538

N02AJ06

ATC

codeine and paracetamol; systemic

1.1

8.7

3646

33286

E66.8

ICD-10 Finland

Other obesity

0.7

8.7

236

3446

2500A

ICD-9 Finland

Diabetes mellitus without mention of complication[DIABETES MELLITUS SINE COMPLICATIONE,TYYPPI II]

0.4

8.7

877

C77.1

ICD-10 Finland

Secondary and unspecified malignant neoplasm: Intrathoracic lymph nodes

3.9

8.7

J70.1

ICD-10 Finland

Chronic and other pulmonary manifestations due to radiation

14.0

8.7

8523/3-C50.1

ICD-O-3

Infiltrating duct mixed with other types of carcinoma of central portion of breast

50.0

8.7

N81.2

ICD-10 Finland

Incomplete uterovaginal prolapse

0.7

8.6

428

5676

NB6AA

NOMESCO Finland

Humerus X-ray examination

1.6

8.6

193

1184

HA3RT

NOMESCO Finland

Coagulation of mammary neoplasm under radiological guidance

7.6

8.6

OAB47

SPAT

0.5

8.6

1290

I10

ICD-10 Finland

Essential (primary) hypertension

0.9

8.6

5648

59904

B01AB04

ATC

dalteparin; parenteral

1.4

8.6

439

3216

E10.9

ICD-10 Finland

Type 1 diabetes mellitus, Without complications

0.6

8.6

100

1754

OAB42

SPAT

0.6

8.5

166

2586

NA049

NOMESCO Finland

Radiotherapy of methastasis in spine

11.5

8.5

JJ2AT

NOMESCO Finland

Biopsy of liver with ultrasound guidance

1.7

8.5

182

1103

QWA00

NOMESCO Finland

Repair of wound dehiscence in surgery of skin

2.9

8.5

175

TNX10

NOMESCO Finland

Arthrocentesis, unspecified region, unspecified region

0.7

8.4

431

5689

WC401

NOMESCO Finland

Simple antibody therapy of local recurrence of tumour

7.3

8.4

HAF10

NOMESCO Finland

Repair after excision of local recurrence of breast cancer using graft or flap

90.0

8.4

UJD10

NOMESCO Finland

Esophagoscopy, gastroscopy and duodenoscopy

0.9

8.4

2442

27202

YX8VG

NOMESCO Finland

Stereotactic MRI exmaination with high intensity magnet for dose design of radiotherapy

3.8

8.4

J01.0

ICD-10 Finland

Acute maxillary sinusitis

0.9

8.4

1785

20330

G62.0

ICD-10 Finland

Drug-induced polyneuropathy

3.7

8.4

YL1AD

NOMESCO Finland

CT examination of pelvis for dose design of radiotherapy

2.4

8.3

287

HA1S1

NOMESCO Finland

Photography of breasts

4.4

8.3

8503/2-C50.9

ICD-O-3

Noninfiltrating intraductal papillary adenocarcinoma of breast, NOS

5.0

8.3

L03.9

ICD-10 Finland

Cellulitis, unspecified

1.7

8.3

148

851

N05BA06

ATC

lorazepam; systemic, sublingual

1.4

8.3

433

3188

RF190

NOMESCO Finland

9.4

8.3

R10.4

ICD-10 Finland

Other and unspecified abdominal pain

0.9

8.2

3057

33535

E10.7

ICD-10 Finland

Type 1 diabetes mellitus, With multiple complications

0.4

8.2

875

A10AB05

ATC

insulin aspart; parenteral (insulins and analog. for injection, fast-acting)

0.7

8.2

273

3846

Z73.3

ICD-10 Finland

Stress, not elsewhere classified

1.9

8.2

115

612

QBE35

NOMESCO Finland

Repair of skin defect in trunk after surgery or injury

4.4

8.2

215

Kela drug reimbursment

Diabetes, non-insulin-treated

0.9

8.2

1609

18440

L04AA06

ATC

mycophenolic acid; systemic

0.4

8.2

752

WD515

NOMESCO Finland

Demanding therapy of malignancy with enzyme inhibitors and similar treatments

3.2

8.1

125

N95.0

ICD-10 Finland

Postmenopausal bleeding

1.2

8.1

1258

10626

N02AA01

ATC

morphine; systemic, rectal

2.2

8.1

358

HAF99

NOMESCO Finland

Other operation for local recurrence of breast cancer

33.3

8.1

8507/3-C50.1

ICD-O-3

Invasive micropapillary carcinoma of breast of central portion of breast

33.3

8.1

8503/3-C50.9

ICD-O-3

Intraductal papillary adenocarcinoma with invasion of breast, NOS

22.0

8.0

M51.3

ICD-10 Finland

Other specified intervertebral disc degeneration

0.8

8.0

505

6482

L04AB01

ATC

etanercept; parenteral

0.4

7.9

787

Z80.0

ICD-10 Finland

Family history of malignant neoplasm of digestive organs

2.4

7.9

274

C78.8

ICD-10 Finland

Secondary malignant neoplasm of other and unspecified digestive organs

3.4

7.9

106

G43.0

ICD-10 Finland

Migraine without aura [common migraine]

0.7

7.9

207

3040

WX725

NOMESCO Finland

Noninvasive ventilation

1.4

7.9

362

2606

Y84.9

ICD-10 Finland

Medical procedure, unspecified as the cause of abnormal reaction of the patient, or of later complication, without mention of misadventure at the time of the procedure

2.6

7.9

197

25000

ICD-8 Finland

Diabetes mellitus, Sine complicatione

0.6

7.9

1509

Z01.6

ICD-10 Finland

Radiological examination, not elsewhere classified

1.2

7.8

876

7155

B99

ICD-10 Finland

Other and unspecified infectious diseases

1.8

7.8

135

771

M54.2

ICD-10 Finland

Cervicalgia

0.7

7.7

386

5113

E66.01

ICD-10 Finland

Obesity due to excess calories

0.8

7.7

408

5357

C09AA05

ATC

ramipril; oral

0.9

7.7

1644

18729

E66.00

ICD-10 Finland

Metabolic syndrome

0.7

7.7

220

3176

J02AC01

ATC

fluconazole; systemic

1.1

7.6

5217

48915

OAB44

SPAT

0.6

7.6

108

1803

R51.80

ICD-10 Finland

Headache

0.8

7.6

986

11707

R5110

SPAT

1.5

7.6

236

1573

D22.5

ICD-10 Finland

Melanocytic naevi of trunk

1.4

7.6

393

2891

XX3XT

NOMESCO Finland

Other labeling with other radiological guidance

25.0

7.6

8541/3-C50.9

ICD-O-3

Paget disease and infiltrating duct carcinoma of breast of breast, NOS

25.0

7.6

C50.0

ICD-10 Finland

Malignant neoplasm: Nipple and areola

6.7

7.6

HAD35

NOMESCO Finland

Reduction mammoplasty with transplantation of areola

4.2

7.6

1743A

ICD-9 Finland

Malignant neoplasm of female breast, Lower-inner quadrant

4.9

7.5

QB9S1

NOMESCO Finland

Photography of skin or subcutaneous tissue in torso, unspecified

2.5

7.5

225

R31

NOMESCO Finland

Adaptation training

4.5

7.5

WYA05

NOMESCO Finland

Emergency visit or other similar visit involving procedures

0.9

7.5

4285

45919

JDF11

NOMESCO Finland

Laparoscopic gastric bypass

0.4

7.5

783

WX707

NOMESCO Finland

Fiberoscopic intubation

3.3

7.5

106

P20

ICPC

Memory disturbance

0.8

7.5

750

9133

R03AC02

ATC

salbutamol; inhalant

0.9

7.5

5144

54589

YX8BD

NOMESCO Finland

Stereotactic extensive CT examination for dose design of radiotherapy

3.1

7.4

123

HAD41

NOMESCO Finland

Transposition of areola

80.1

7.4

A55

ICPC

General and Unspecified, Local injection/infiltration

2.2

7.4

319

ZXC82

NOMESCO Finland

Microsurgical

5.9

7.3

K30

ICD-10 Finland

Functional dyspepsia

0.8

7.3

758

9199

158

Kela drug reimbursment

Everolimus

5.6

7.3

A10BA02

ATC

metformin; oral

0.9

7.3

1881

21158

FNA01

NOMESCO Finland

Anastomosis to coronary artery from internal mammary artery, one distal anastamosis

0.5

7.3

1091

L01EF02

ATC

ribociclib; oral

+∞

7.3

I69.3

ICD-10 Finland

Sequelae of cerebral infarction

0.7

7.3

261

3627

U07.1

ICD-10 Finland

Emergency use of U07.1 | COVID-19, virus identified

0.8

7.2

777

9393

318

Kela drug reimbursment

Teriparatide

0.2

7.2

368

Z01.5

ICD-10 Finland

Diagnostic skin and sensitization tests

0.8

7.2

623

7698

M06.9

ICD-10 Finland

Rheumatoid arthritis, unspecified

0.6

7.2

146

2248

Y69

ICD-10 Finland

Unspecified misadventure during surgical and medical care

1.9

7.1

491

M84.4

ICD-10 Finland

Pathological fracture, not elsewhere classified

3.5

7.1

WC125

NOMESCO Finland

Demanding cytostatic therapy of local tumor recidive

2.9

7.1

141

N85.9

ICD-10 Finland

Noninflammatory disorder of uterus, unspecified

2.0

7.1

440

PA6BD

NOMESCO Finland

Extensive CT of neck arteries

0.7

7.1

165

2477

ZX002

NOMESCO Finland

Simple dose design for radiotherapy based on tomography - isocentric therapy

7.9

7.1

I42.7

ICD-10 Finland

Cardiomyopathy due to drugs and other external agents

7.9

7.1

2330A

ICD-9 Finland

Carcinoma in situ of breast and genito-urinary system, Breast

6.0

7.0

AN4

Balloon angioplasty and drug eluding stent

0.5

7.0

1130

D50.9

ICD-10 Finland

Iron deficiency anaemia, unspecified

0.8

7.0

384

5020

A02BC05

ATC

esomeprazole; systemic

1.1

7.0

4560

42580

X18

ICPC

Breast pain female

1.7

6.9

146

887

GD5AD

NOMESCO Finland

Thorax and upper abdomen combined CT examination of

2.0

6.9

441

K11.71

ICD-10 Finland

Xerostomy (dry mouth)

1.8

6.9

110

615

G44.2

ICD-10 Finland

Tension-type headache

0.8

6.9

1010

11865

L03

ICPC

Low back symptom/complaint

0.9

6.9

2049

22830

Z71.2

ICD-10 Finland

Person consulting for explanation of investigation findings

1.1

6.9

2353

21158

NBG15

NOMESCO Finland

Acromioplastia, arthroscopic

0.7

6.9

333

4422

A40.1

ICD-10 Finland

Sepsis due to streptococcus, group B

4.0

6.8

E78.0

ICD-10 Finland

Pure hypercholesterolaemia

0.9

6.8

1449

16522

E11.7

ICD-10 Finland

Type 2 diabetes mellitus, with multiple complications

0.6

6.8

129

2016

ZZS50

NOMESCO Finland

Insertion of tissue expander

9.3

6.8

XW3AT

NOMESCO Finland

Biopsy of other superficial organ with ultrasound guidance

2.5

6.8

190

8522/3-C50.3

ICD-O-3

Infiltrating duct and lobular carcinoma of lower-inner quadrant of breast

39.9

6.7

I26.9

ICD-10 Finland

Pulmonary embolism without mention of acute cor pulmonale

1.3

6.7

427

3246

FN1YT

NOMESCO Finland

Percutaneous insertion of coronary artery stent

0.6

6.7

120

1899

I25.0

ICD-10 Finland

Atherosclerotic cardiovascular disease, so described

0.7

6.7

163

2419

J44.1

ICD-10 Finland

Chronic obstructive pulmonary disease with acute exacerbation, unspecified

0.5

6.7

1150

00044

NOMESCO Finland

22.5

6.7

M81.9

ICD-10 Finland

Osteoporosis, unspecified

1.3

6.7

458

3522

JN1DG

NOMESCO Finland

Very extensive MRI examination of upper part of abdomen with high intensity magnet

1.6

6.6

140

852

XPX99

NOMESCO Finland

Other diagnostic examination of periferal vessel

0.7

6.6

261

3569

SGA01

NOMESCO Finland

Tooth opening as first aid

0.8

6.6

871

10328

K58.0

ICD-10 Finland

Irritable bowel syndrome with diarrhoea

0.7

6.6

317

4213

L01XE10

ATC

[U] everolimus; oral

7.8

6.6

TPW99

NOMESCO Finland

Other minor surgical procedure on peripheral vessel or lymphatic system

2.0

6.6

387

BA3AT

NOMESCO Finland

Cytology of thyroid with ultrasound quidance

1.6

6.6

159

1003

RF410

NOMESCO Finland

1.8

6.6

105

588

G30.1

ICD-10 Finland

Alzheimer disease with late onset

0.7

6.5

207

2932

C77.8

ICD-10 Finland

Secondary and unspecified malignant neoplasm: Lymph nodes of multiple regions

3.1

6.5

102

LC2AE

NOMESCO Finland

Ultrasound examination of uterus and parametria

1.2

6.5

1141

9751

D01AC20

ATC

imidazoles/triazoles in combination with corticosteroids; topical

1.1

6.5

2230

20051

M35.3

ICD-10 Finland

Polymyalgia rheumatica

0.7

6.4

202

2865

E10.3

ICD-10 Finland

Type 1 diabetes mellitus, With ophthalmic complications

0.5

6.4

939

ZYC01

SPAT

0.7

6.4

215

3021

L02BG01

ATC

aminoglutethimide; oral

69.8

6.4

I20.99

ICD-10 Finland

Angina pectoris, unspecified

0.7

6.4

259

3532

N03AF01

ATC

carbamazepine; oral, rectal

0.7

6.4

252

3452

E78.5

ICD-10 Finland

Hyperlipidaemia, unspecified

0.8

6.4

533

6615

SPAT1059

SPAT

Spirometry at the office

0.7

6.4

263

3577

S50

ICPC

Skin, Medication/prescr/renewal

2.2

6.4

282

A87

ICPC

Complication of medical treatment

2.1

6.4

341

I20.90

ICD-10 Finland

Angina pectoris, unspecified

0.6

6.4

112

1773

C08CA13

ATC

lercanidipine; oral

0.8

6.4

959

11237

NK1XE

NOMESCO Finland

Other ultrasound examinnation of muscle or tendon

2.0

6.4

378

A26

ICPC

Fear of cancer, NOS

2.2

6.4

250

NGF25

NOMESCO Finland

Operation for osteochondritis of knee, arthroscopic

0.8

6.3

390

5018

M77.1

ICD-10 Finland

Lateral epicondylitis

0.8

6.3

360

4680

A40.8

ICD-10 Finland

Other streptococcal sepsis

2.4

6.3

204

JN4JR

NOMESCO Finland

Whole body extensive metabolic PET with CT

2.2

6.3

263

ZZR70

NOMESCO Finland

Perforator flaps

8.1

6.3

N05AX08

ATC

risperidone; systemic

0.8

6.3

342

4472

K08.80

ICD-10 Finland

Toothache NOS

0.8

6.3

440

5569

NK6BT

NOMESCO Finland

Bone biopsy with X-ray guidance

9.2

6.3

Z95.1

ICD-10 Finland

Presence of aortocoronary bypass graft

0.5

6.3

945

M03BC01

ATC

orphenadrine (citrate); systemic

0.9

6.3

1865

20790

T89

ICPC

Diabetes insulin dependent

0.6

6.3

1557

GAC10

NOMESCO Finland

Removal of foreign body from pleural cavity

18.0

6.3

8503/3-C50.4

ICD-O-3

Intraductal papillary adenocarcinoma with invasion of upper-outer quadrant of breast

18.0

6.3

M907, C5041

ICD-10 Finland

+∞

6.2

8507/3-C50.3

ICD-O-3

Invasive micropapillary carcinoma of breast of lower-inner quadrant of breast

+∞

6.2

3AF02

NOMESCO Finland

+∞

6.2

8507/3-C50.8

ICD-O-3

Invasive micropapillary carcinoma of breast of overlapping lesion of breast

+∞

6.2

LEF03

NOMESCO Finland

Posterior colporrpahy with sutures for primary rectocele

0.8

6.2

353

4587

WC135

NOMESCO Finland

Very demanding cytostatic therapy of local tumor recidive

26.7

6.2

LCA10

NOMESCO Finland

Curettage of body of uterus

1.4

6.2

306

2236

M54.5

ICD-10 Finland

Low back pain

0.9

6.2

2837

30839

WGA10

NOMESCO Finland

Measurement of pain intensity

7.0

6.2

N99.3

ICD-10 Finland

Prolapse of vaginal vault after hysterectomy

0.6

6.2

120

1860

H05AA02

ATC

teriparatide; parenteral

0.2

6.2

333

C08CA05

ATC

nifedipine; systemic

0.7

6.2

301

3991

GA1CG

NOMESCO Finland

Extensive MRI of chest

4.1

6.2

HAC30

NOMESCO Finland

Excision of supernumerary mammary gland or mamilla

5.0

6.2

A10AE04

ATC

insulin glargine; parenteral

0.8

6.2

399

5099

TGA30

NOMESCO Finland

Thoracocentesis

2.5

6.1

183

N06AA09

ATC

amitriptyline; systemic

0.8

6.1

834

9860

MA5AE

NOMESCO Finland

Morphology ultrasound screening, weeks 18+0 to 21+6 of gestation

0.2

6.1

279

Z72.8

ICD-10 Finland

LabWAS

↥

(ID) Name

N Cases

N Controls

-log₁₀(p)

cases

controls

cases

controls

unit

-log₁₀(p)

N cases

N controls

(3015377) Calcium [Moles/volume] in Serum or Plasma

8470

46414

2.87

307.65

6.7

2.9

2.4

mmol/l

48.64

7836

39608

(3001079) Blood group antibody screen [Presence] in Serum or Plasma

8623

57628

2.14

307.65

3.6

3.8

—

(3006588) Cancer Ag 15-3 [Units/volume] in Serum or Plasma

3569

1602

28.64

307.65

4.3

2.3

42.3

29.8

u/ml

2.93

3454

1539

(3043109) Cytology report of Tissue fine needle aspirate Cyto stain

1320

3316

4.21

307.65

1.2

1.3

—

(3035995) Alkaline phosphatase [Enzymatic activity/volume] in Serum or Plasma

13712

99961

5.87

307.65

12.3

7.0

78.4

78.6

u/l

0.24

13499

93071

(3026725) Estradiol (E2) [Moles/volume] in Serum or Plasma

866

1170

7.69

307.65

1.4

1.3

0.2

0.3

nmol/l

3.46

532

811

(1617658) Protocol used for examination of sentinel lymph nodes

1839

575

35.87

307.65

1.0

—

(40758558) Short blood count panel - Blood

6365

32002

2.69

307.65

9.5

6.5

—

(40768793) Breast Pathology biopsy report

3422

2885

14.92

307.65

1.4

1.3

—

(4035726)

4888

10510

6.36

307.65

1.4

—

(40768804) Tissue Pathology biopsy report

8616

55815

2.25

307.65

2.4

2.1

—

(3002256) Pathology report gross observation

4288

16089

3.29

307.65

1.3

1.2

—

(44816752) ERBB2 gene copy number/nucleus in Tissue by FISH

842

521

16.84

307.65

1.1

—

(3044640) Blood type and Crossmatch panel - Blood

6533

39050

2.16

307.65

2.0

2.3

—

(3013650) Neutrophils [#/volume] in Blood by Automated count

11389

72510

3.39

307.65

13.0

8.8

3.5

4.0

e9/l

155.45

10574

62684

(3003785) Carcinoembryonic Ag [Mass/volume] in Serum or Plasma

4054

13442

3.72

307.65

4.1

3.7

13.9

24.3

ug/l

1.91

3135

10671

(42529200) Cancer Ag 15-3 [Units/volume] in Serum or Plasma by Immunoassay

2070

1018

23.15

307.65

4.8

2.2

56.4

40.2

u/ml

1.96

2055

998

(3006140) Bilirubin.total [Moles/volume] in Serum or Plasma

11544

66008

4.31

307.65

9.9

5.4

9.2

10.4

umol/l

42.66

11319

61959

(3016431) Calcium.ionized [Moles/volume] adjusted to pH 7.4 in Serum or Plasma

9214

67600

1.91

298.56

6.8

6.0

1.2

mmol/l

34.12

7569

56856

(40768795) Lymph node Pathology biopsy report

613

1189

5.26

292.34

1.1

1.2

—

(3049539) Genetic diseases [Identifier] in Blood or Tissue by FISH Nominal

482

779

6.27

278.79

1.2

—

(3021347) Calcium.ionized [Moles/volume] in Serum or Plasma

8464

61229

1.85

277.25

5.5

5.3

1.2

mmol/l

51.70

7923

54733

(3037551) Cancer Ag 125 [Units/volume] in Serum or Plasma

2167

10741

2.16

210.80

2.9

3.7

48.5

61.1

u/ml

1.44

2098

10355

(3023368) Bacteria identified in Blood by Culture

4654

30384

1.74

194.64

3.9

4.1

—

(46236098) ABO and Rh group [Type] in Blood by Confirmatory method

4512

29836

1.71

176.47

2.0

2.2

—

(3018418) pH of Serum or Plasma

5790

41098

1.64

171.01

4.6

3.8

7.4

9.83

1471

7168

(3013742) Prealbumin [Mass/volume] in Serum or Plasma

2181

11701

1.98

168.22

1.7

2.1

0.2

g/l

30.09

2098

10853

(40771025) 25-Hydroxyvitamin D3+25-Hydroxyvitamin D2 [Moles/volume] in Serum or Plasma

7640

60503

1.51

124.76

2.2

2.3

82.4

1606.7

nmol/l

0.50

7077

53723

(3048816) Calcium.ionized [Moles/volume] adjusted to pH 7.4 in Blood

1925

10953

1.84

121.08

4.4

3.4

1.2

mmol/l

6.82

1801

9335

(3024561) Albumin [Mass/volume] in Serum or Plasma

7228

57041

1.49

116.96

3.8

4.4

35.7

35.6

g/l

1.02

6753

52511

(40764999) Glomerular filtration rate/1.73 sq M.predicted [Volume Rate/Area] in Serum, Plasma or Blood by Creatinine-based formula (CKD-EPI)

13267

120292

1.85

109.78

17.8

12.8

80.3

78.0

ml/min/173m2

46.24

12049

98143

(3023323) Follitropin [Units/volume] in Serum or Plasma

1147

5669

2.08

108.56

1.5

1.3

41.2

38.9

iu/l

1.50

1000

4978

(3021952) Alkaline phosphatase isoenzymes [Enzymatic activity/volume] in Serum or Plasma by Heat stability

623

2384

2.65

106.57

1.2

—

(42529215) Follitropin [Units/volume] in Serum or Plasma by Immunoassay

527

1863

2.86

105.01

1.4

1.3

43.0

40.5

u/l

0.76

498

1453

(40758358) Immune stain study

19.35

104.39

1.0

—

(3020460) C reactive protein [Mass/volume] in Serum or Plasma

13598

125840

1.82

82.64

16.9

13.9

21.2

21.4

mg/l

0.29

11290

98881

(3001467) Alkaline phosphatase.bone [Enzymatic activity/volume] in Serum or Plasma

437

1591

2.76

82.29

1.2

59.8

58.9

u/l

0.15

275

1070

(3042936) Bacteria identified in Isolate by Culture

2440

16387

1.56

79.22

1.8

1.9

—

(3019225) pH of Specimen

2080

13836

1.56

69.60

4.7

4.0

—

(3003694) ABO and Rh group [Type] in Blood

3938

29817

1.41

68.31

1.3

—

(3047826) Mullerian inhibiting substance [Mass/volume] in Serum or Plasma

204

550

3.69

63.53

1.4

1.7

1.5

7.4

ug/l

1.98

103

321

(3020059) Calcium [Moles/volume] corrected for albumin in Serum or Plasma

3500

26335

1.41

61.80

3.0

2.9

2.5

mmol/l

10.23

3151

22932

(3035062) Alkaline phosphatase.liver 1 [Enzymatic activity/volume] in Serum or Plasma

235

737

3.18

57.82

1.2

1.1

73.9

84.0

u/l

1.25

211

571

(3036185) Alkaline phosphatase.liver 2 [Enzymatic activity/volume] in Serum or Plasma

235

740

3.17

57.43

1.2

1.1

18.0

24.7

u/l

1.26

209

556

(3019550) Sodium [Moles/volume] in Serum or Plasma

13951

131813

1.77

55.20

16.9

15.8

139.8

mmol/l

0.13

13732

128387

(3033658) Prothrombin time (PT) actual/Normal

4091

32125

1.35

54.14

3.3

3.6

95.4

94.8

0.76

3991

31238

(3006923) Alanine aminotransferase [Enzymatic activity/volume] in Serum or Plasma

14144

134431

1.86

51.31

15.9

10.6

24.4

23.8

u/l

2.65

13938

129126

(3023103) Potassium [Moles/volume] in Serum or Plasma

13955

132128

1.74

51.09

17.1

16.0

3.9

mmol/l

4.30

13716

128459

(3019902) Methicillin resistant Staphylococcus aureus [Presence] in Specimen by Organism specific culture

1827

12624

1.49

49.81

3.4

3.3

—

(3020013) Alkaline phosphatase.intestinal [Enzymatic activity/volume] in Serum or Plasma

255

932

2.73

47.73

1.6

1.5

5.5

6.1

u/l

0.21

126

442

(3044889) 12 lead EKG panel

10051

91160

1.27

38.24

3.7

—

(3044938) Influenza virus A RNA [Presence] in Specimen by NAA with probe detection

2524

19262

1.35

38.12

1.7

1.8

—

(3003191) Choriogonadotropin (pregnancy test) [Presence] in Serum or Plasma

296

1314

2.25

36.53

1.2

1.6

—

(43534046) Estradiol (E2) [Moles/volume] in Serum or Plasma by High sensitivity method

6.21

34.71

1.5

1.2

0.2

0.4

nmol/l

0.84

(3045684) Alkaline phosphatase.other fractions [Enzymatic activity/volume] in Serum or Plasma

226

917

2.45

34.28

1.2

15.2

22.9

u/l

1.60

201

775

(3035400) Alkaline phosphatase.liver [Enzymatic activity/volume] in Serum or Plasma

228

934

2.43

33.88

1.2

69.5

83.8

u/l

1.75

209

814

(3001308) Cholesterol in LDL [Moles/volume] in Serum or Plasma

12620

129312

0.74

33.15

4.8

5.2

2.9

mmol/l

0.22

11337

118334

(3048773) Triglyceride [Moles/volume] in Serum or Plasma --fasting

11725

121324

0.77

32.83

3.8

4.1

1.3

mmol/l

1.96

10420

109909

(3013721) Aspartate aminotransferase [Enzymatic activity/volume] in Serum or Plasma

4799

40585

1.25

31.76

4.1

3.1

36.2

32.4

u/l

1.36

4573

38325

(3023602) Cholesterol in HDL [Moles/volume] in Serum or Plasma

12228

125728

0.76

31.47

4.3

4.6

1.6

mmol/l

2.61

10995

114952

(3019900) Cholesterol [Moles/volume] in Serum or Plasma

12342

126711

0.76

31.06

4.3

4.6

4.9

mmol/l

1.48

11157

116445

(3004410) Hemoglobin A1c/Hemoglobin.total in Blood

11528

119165

0.79

28.62

5.4

5.8

39.5

39.6

mmol/mol

0.17

10441

109408

(3018006) Microscopic observation [Identifier] in Cervix by Cyto stain.thin prep

3545

29379

1.25

27.22

1.4

—

(3002385) Erythrocyte distribution width [Ratio]

11110

103499

1.23

25.56

22.4

16.9

13.8

3.29

11004

101205

(3046524) Influenza virus A Ag [Presence] in Nasopharynx by Immunoassay

433

2490

1.74

25.27

1.2

1.3

—

(3043362) Influenza virus B Ag [Presence] in Nasopharynx by Immunoassay

433

2490

1.74

25.27

1.2

1.3

—

(3041942) Cyclic citrullinated peptide Ab [Units/volume] in Serum

2066

25218

0.78

23.93

1.2

1.3

9.8

13.8

u/ml

2.00

769

9513

(3021614) Rheumatoid factor [Units/volume] in Serum or Plasma

2172

26317

0.78

23.65

1.3

33.6

39.3

iu/ml

0.93

688

8629

(3013512) EKG study

4484

38541

1.21

23.53

3.9

3.8

—

(3020682) Albumin/Creatinine [Ratio] in Urine

3431

39438

0.81

23.13

3.5

3.8

6.0

7.3

mg/mmol

0.72

1775

22090

(3052851) Hemolysis interference index of Serum or Plasma

608

3901

1.56

23.01

2.6

3.1

—

(42870588) Differential panel, method unspecified - Blood

5024

43723

1.20

22.96

4.7

6.0

—

(46235759) Influenza virus B RNA [Presence] in Nasopharynx by NAA with probe detection

741

4980

1.49

22.59

1.8

2.0

—

(3018251) Fasting glucose [Moles/volume] in Serum or Plasma

12332

125869

0.79

22.10

4.5

4.8

5.9

mmol/l

0.34

11035

114515

(3051651) Icteric interference index of Serum or Plasma

163

703

2.30

21.74

2.3

3.6

—

(3037522) Nuclear Ab [Titer] in Serum

1552

19421

0.76

21.54

1.3

1.4

541.6

586.5

titre

0.46

344

4481

(3032080) INR in Blood by Coagulation assay

5622

49632

1.19

21.47

7.3

7.8

1.2

inr

1.04

1709

13945

(3021589) Normoblasts [#/volume] in Blood

6311

56330

1.18

21.06

10.9

9.3

0.0

e9/l

1.88

5198

45972

(40768806) Pleura Pathology biopsy report

202

963

2.08

21.02

1.5

—

(3012516) Albumin [Mass/volume] in Urine

3278

37542

0.82

20.78

2.8

3.1

456.4

510.4

mg/l

0.22

1706

20866

(3019150) Specific gravity of Urine by Refractometry

2399

28373

0.80

20.77

4.0

4.7

1.0

kg/l

1.17

383

4391

(36305247) Microscopic observation [Identifier] in Isolate by Gram stain

515

3260

1.58

20.70

1.5

1.6

—

(3013826) Glucose [Moles/volume] in Serum or Plasma

8021

73153

1.18

20.33

3.7

4.2

6.5

6.6

mmol/l

4.46

7641

68397

(3004809) Band form neutrophils/100 leukocytes in Blood

330

1901

1.73

19.23

2.0

3.4

2.5

1.3

5.53

250

1491

(3044254) Respiratory syncytial virus RNA [Presence] in Specimen by NAA with probe detection

670

4572

1.47

18.93

1.7

1.8

—

(3009508) Creatinine [Moles/volume] in Urine

3427

38769

0.83

18.59

2.8

3.0

6.3

mmol/l

0.07

2750

32223

(3003434) Protein [Mass/volume] in Pleural fluid

237

1255

1.88

18.31

1.4

35.8

32.7

g/l

3.99

219

1138

(3026493) Urate [Moles/volume] in Serum or Plasma

2800

32214

0.82

18.10

2.1

2.4

5197.1

4644.0

umol/l

0.27

2347

27417

(3007220) Creatine kinase [Enzymatic activity/volume] in Serum or Plasma

3611

40584

0.84

18.09

1.9

2.1

167.8

162.5

u/l

0.13

3330

37741

(3042194) Human metapneumovirus RNA [Presence] in Specimen by NAA with probe detection

421

2642

1.59

17.61

1.4

1.5

—

(3002030) Lymphocytes/100 leukocytes in Blood

6737

61115

1.16

16.83

5.0

6.2

27.1

28.7

24.99

6258

56471

(3007853) Bacteria identified in Skin by Aerobe culture

1778

14309

1.26

16.76

1.6

1.8

—

(3040853) Adenovirus DNA [Identifier] in Specimen by NAA with probe detection

403

2539

1.58

16.60

1.4

1.6

—

(40765161) Human bocavirus DNA [Presence] in Specimen by NAA with probe detection

323

1933

1.66

16.40

1.4

1.6

—

(40761511) CBC panel - Blood by Automated count

13546

130344

1.29

16.18

16.0

13.1

—

(3019069) Monocytes/100 leukocytes in Blood

6593

59822

1.16

16.17

5.1

6.4

8.6

8.4

5.80

6170

55608

(3001122) Ferritin [Mass/volume] in Serum or Plasma

5031

54592

0.86

15.62

2.5

2.8

142.7

108.2

ug/l

9.56

4593

50128

(3043924) Respiratory syncytial virus RNA [Identifier] in Specimen by NAA with probe detection

1650

13271

1.25

15.58

1.6

1.7

—

(3048689) Calprotectin [Mass/mass] in Stool

1351

16558

0.78

15.48

1.9

2.0

121.2

125.7

ug/g

0.18

1011

12702

(3038288) Influenza virus B RNA [Presence] in Specimen by NAA with probe detection

1646

13272

1.25

15.18

1.7

—

(43055361) Metamyelocytes/Leukocytes [Pure number fraction] in Blood by Manual count

118

523

2.23

14.92

1.9

3.3

—

(3008486) Thyroxine (T4) free [Moles/volume] in Serum or Plasma

10488

107827

0.86

14.83

4.4

4.6

14.9

pmol/l

0.26

9397

98316

(3006504) Eosinophils/100 leukocytes in Blood

6540

59536

1.15

14.82

4.9

6.1

2.7

2.8

4.67

6083

55058

(3003510) Neisseria gonorrhoeae DNA [Presence] in Urine by NAA with probe detection

370

5504

0.65

14.33

1.5

1.6

—

(3024950) Chlamydia trachomatis DNA [Presence] in Urine by NAA with probe detection

436

6274

0.68

14.29

1.5

1.6

—

(3019832) Treponema pallidum Ab [Presence] in Serum

293

4565

0.63

14.05

1.2

1.4

—

(3009201) Thyrotropin [Units/volume] in Serum or Plasma

12088

122719

0.84

13.74

5.3

5.6

2.1

mu/l

0.12

10928

112618

(36304997) Mycobacterium tuberculosis stimulated gamma interferon release by CD4+ and CD8+ T-cells [Units/volume] in Blood

240

3874

0.60

13.39

1.6

0.1

9.1

iu/ml

1.04

837

(3012441) Differential panel - Pleural fluid

176

942

1.85

13.29

1.4

—

(3035509) Tobramycin [Mass/volume] in Serum or Plasma

115

3.61

13.09

1.4

3.0

1.2

1.3

mg/l

0.08

(3008898) HLA-B27 [Presence]

260

4081

0.62

12.90

1.1

—

(40763086) Leukocyte esterase [Presence] in Urine by Automated test strip

4527

48974

0.87

12.58

4.0

4.4

—

(3005719) IgG [Mass/volume] in Serum or Plasma

751

9671

0.75

12.53

2.6

2.9

10.3

g/l

0.02

678

8837

(3022096) Basophils/100 leukocytes in Blood

6322

57838

1.14

12.48

4.9

6.2

0.7

0.75

5883

53477

(3013139) Helicobacter pylori Ag [Presence] in Stool

814

10355

0.76

12.42

1.2

—

(3025023) Rhinovirus RNA [Presence] in Specimen by NAA with probe detection

197

1118

1.75

12.29

1.3

1.6

—

(40761535) Cells panel - Urine sediment

873

10975

0.77

12.17

3.1

3.7

—

(3018010) Neutrophils/100 leukocytes in Blood

6569

60329

1.13

12.04

4.8

6.0

57.1

56.7

1.79

6122

55947

(3016881) Enterovirus RNA [Presence] in Specimen by NAA with probe detection

208

1208

1.71

11.96

1.3

1.6

—

(3035350) Ketones [Presence] in Urine by Test strip

6078

64366

0.88

11.93

3.6

4.1

0.0

estimate

0.69

1215

11401

(3023199) Leukocytes [#/volume] in Pleural fluid

200

1151

1.72

11.89

1.4

4520.8

3036.7

e6/l

0.20

148

827

(3015171) Extractable nuclear Ab [Units/volume] in Serum

448

6199

0.70

11.87

1.2

1.3

1.2

1.0

u/ml

0.07

587

(3021601) Nitrite [Presence] in Urine by Test strip

6159

64954

0.89

10.87

5.0

5.5

0.0

estimate

3.28

1216

11461

(3028308) Erythrocytes [#/volume] in Pleural fluid

180

1040

1.72

10.61

1.4

32568.1

46571.5

e6/l

0.52

103

582

(46235355) HIV 1 and 2 tests - Meaningful Use set

1110

13344

0.81

10.53

1.4

1.6

—

(40763082) Lactate dehydrogenase [Enzymatic activity/volume] in Pleural fluid by Lactate to pyruvate reaction

150

825

1.80

10.49

1.3

444.1

360.4

u/l

0.28

142

780

(3011397) Hemoglobin [Presence] in Urine by Test strip

2890

31937

0.87

10.48

3.3

4.1

—

(3007461) Platelets [#/volume] in Blood

14230

138499

1.35

10.46

27.5

20.7

258.6

263.0

e9/l

14.68

14039

134516

(3009261) Glucose [Presence] in Urine by Test strip

6235

65600

0.89

10.36

3.7

4.1

0.0

estimate

0.05

1227

11551

(3017181) Myelocytes/100 leukocytes in Blood

1319

10817

1.22

10.27

2.8

4.2

1.9

0.9

15.38

516

2766

(3030692) Respiratory virus DNA+RNA [Identifier] in Specimen by NAA with probe detection

234

1460

1.59

10.23

1.4

1.5

—

(3051611) Lipemic interference index of Serum or Plasma

232

1450

1.59

10.08

2.6

3.2

—

(3015399) Transferrin receptor.soluble [Mass/volume] in Serum or Plasma

2858

31527

0.87

10.04

2.2

2.3

3.0

mg/l

0.44

2424

26884

(3000067) Parathyrin.intact [Mass/volume] in Serum or Plasma

1380

11408

1.21

9.91

2.4

3.3

72.0

82.6

ng/l

7.58

1187

9619

(3035941) MCH [Entitic mass]

14230

138559

1.34

9.89

27.3

20.6

30.4

30.2

39.74

14136

136352

(3012158) Parainfluenza virus 2 RNA [Presence] in Specimen by NAA with probe detection

121

635

1.89

9.85

1.3

1.7

—

(3006262) Parainfluenza virus 3 RNA [Presence] in Specimen by NAA with probe detection

121

635

1.89

9.85

1.3

1.7

—

(3025634) Parainfluenza virus 1 RNA [Presence] in Specimen by NAA with probe detection

121

635

1.89

9.85

1.3

1.7

—

(3024731) MCV [Entitic volume]

14230

138568

1.33

9.80

27.4

20.6

92.0

91.2

83.36

14136

136365

(3038297) Parainfluenza virus 4 RNA [Presence] in Specimen by NAA with probe detection

121

637

1.88

9.76

1.3

1.7

—

(3019284) Hepatitis B virus surface Ag [Presence] in Serum

1028

12355

0.81

9.72

1.4

1.5

—

(3012095) Magnesium [Moles/volume] in Serum or Plasma

2374

20596

1.16

9.71

2.9

3.0

0.8

mmol/l

0.08

2198

18991

(3010813) Leukocytes [#/volume] in Blood

14231

138591

1.33

9.69

27.5

20.7

6.2

6.5

e9/l

12.18

14023

134160

(3026361) Erythrocytes [#/volume] in Blood

14230

138580

1.33

9.69

27.5

20.7

4.3

4.4

e12/l

125.40

14024

134128

(3041642) Human coronavirus 229E RNA [Presence] in Specimen by NAA with probe detection

174

1027

1.68

9.53

1.3

1.5

—

(3040359) Human coronavirus NL63 RNA [Presence] in Specimen by NAA with probe detection

174

1027

1.68

9.53

1.3

1.5

—

(3038546) Human coronavirus OC43 RNA [Presence] in Specimen by NAA with probe detection

174

1027

1.68

9.53

1.3

1.5

—

(3019050) Tissue transglutaminase IgA Ab [Units/volume] in Serum

2742

30238

0.87

9.51

1.2

1.3

1.4

1.5

u/ml

0.21

624

7940

(46236952) Glomerular filtration rate/1.73 sq M.predicted [Volume Rate/Area] in Serum, Plasma or Blood by Creatinine-based formula (MDRD)

1262

10386

1.22

9.48

3.7

2.6

67.6

63.6

ml/min/173m2

4.08

520

4189

(3000963) Hemoglobin [Mass/volume] in Blood

14230

138605

1.33

9.46

27.6

20.8

129.8

132.0

g/l

94.00

14139

136444

(3005322) IgE [Units/volume] in Serum or Plasma

670

8431

0.77

9.40

1.2

1.3

192.1

176.6

u/ml

0.24

607

7763

(3017143) Hepatitis C virus Ab [Presence] in Serum

924

11177

0.80

9.27

1.4

1.5

—

(3029879) Epithelial cells.squamous [#/volume] in Urine by Automated count

2227

19291

1.16

9.26

2.5

2.8

3.9

4.8

e6/l

2.18

1115

10003

(36031861) Influenza virus A and B and SARS-CoV-2 (COVID-19) and Respiratory syncytial virus RNA panel - Respiratory system specimen by NAA with probe detection

909

7260

1.25

9.07

1.6

1.7

—

(3021387) Prolactin [Units/volume] in Serum or Plasma

145

2399

0.59

9.07

1.8

1.7

328.6

348.2

mu/l

0.15

134

2148

(3011371) Neisseria gonorrhoeae DNA [Presence] in Specimen by NAA with probe detection

192

2958

0.64

8.90

1.3

1.4

—

(3002434) Lupus erythematosus deoxynucleoproteins IgG Ab [Units/volume] in Serum by Immunoassay

332

4577

0.71

8.69

1.7

1.8

—

(3045788) Cell count panel - Pleural fluid

152

890

1.69

8.63

1.5

—

(3028026) IgM [Mass/volume] in Serum or Plasma

601

7577

0.77

8.57

1.9

1.3

g/l

0.20

535

6862

(3024891) Influenza virus A+B Ag [Presence] in Specimen

392

2814

1.38

8.54

1.1

1.2

—

(4034850)

329

4525

0.71

8.50

11.4

9.5

—

(4010399)

850

10277

0.80

8.49

1.4

1.5

—

(3036782) Glucose [Moles/volume] in Pleural fluid

147

865

1.68

8.21

1.3

6.4

6.5

mmol/l

0.26

136

810

(3046279) Procalcitonin [Mass/volume] in Serum or Plasma

570

4359

1.30

8.14

1.8

1.9

2.1

2.4

ug/l

0.23

488

3809

(3006093) Chlamydia trachomatis DNA [Presence] in Specimen by NAA with probe detection

264

3729

0.69

7.97

1.3

1.5

—

(3029634) Reagin Ab [Titer] in Serum by VDRL

1162

0.46

7.74

1.3

1.5

—

2.1

—

(43054903) Holo-transcobalamin II [Moles/volume] in Serum

5335

56040

0.90

7.72

1.9

2.0

100.2

99.5

pmol/l

0.43

2432

25933

(3015736) pH of Urine

4741

50095

0.90

7.70

3.3

3.9

5.6

5.9

—

(40764126) Parainfluenza virus RNA [Presence] in Specimen by NAA with probe detection

146

875

1.65

7.64

1.5

—

(3002582) Erythrocytes [#/volume] in Urine

4038

36749

1.11

7.62

2.8

3.1

87.0

62.8

e6/l

0.42

2988

27455

(3029511) Human papilloma virus DNA [Presence] in Specimen by NAA with probe detection

781

6259

1.24

7.60

1.3

—

(40768441) Liver Pathology biopsy report

155

945

1.62

7.59

1.1

1.3

—

(3020961) Endomysium IgA Ab [Titer] in Serum

494

6278

0.77

7.53

1.1

390.0

206.0

titre

—

143

(3026782) Osmolality of Urine

2669

23741

1.13

7.43

2.5

2.7

500.3

501.9

mosm/kgh2o

0.15

2272

19944

(3000108) Respiratory syncytial virus B RNA [Presence] in Specimen by NAA with probe detection

501

1.86

7.42

1.4

1.8

—

(3005156) Respiratory syncytial virus A RNA [Presence] in Specimen by NAA with probe detection

501

1.86

7.42

1.4

1.8

—

(3009542) Hematocrit [Volume Fraction] of Blood

11630

111749

1.12

7.37

19.3

15.2

38.6

38.8

2.05

8217

77287

(3007164) IgA [Mass/volume] in Serum or Plasma

2322

25491

0.88

7.29

1.4

1.5

2.3

g/l

0.78

1130

14600

(3009035) Cobalamin (Vitamin B12) [Moles/volume] in Serum or Plasma

2656

28902

0.89

7.23

1.6

1.7

38330640.5

35330057.5

pmol/l

0.09

2108

23544

(3005702) Mycobacterium sp identified in Specimen by Organism specific culture

331

2383

1.38

7.16

1.4

—

(3005785) Creatine kinase.MB [Mass/volume] in Serum or Plasma

869

10294

0.82

7.12

2.0

2.3

3.8

5.7

ug/l

8.19

716

8736

(3042596) Human coronavirus RNA [Presence] in Specimen by NAA with probe detection

186

1202

1.53

7.12

1.5

—

(3021440) Promyelocytes/100 leukocytes in Blood

1226

10341

1.18

7.06

2.9

4.2

0.4

0.1

7.04

466

2559

(21493195) Respiratory pathogens DNA and RNA tested for in Respiratory system specimen by NAA with probe detection

511

1.82

6.99

1.4

1.8

—

(3050380) Cytology report of Cervical or vaginal smear or scraping Cyto stain

441

5628

0.77

6.97

1.5

—

(3024869) Neuronal Ab [Presence] in Serum

205

2.31

6.86

1.1

1.0

—

(3030467) Casts [#/volume] in Urine by Automated count

3757

34220

1.11

6.86

2.7

3.0

0.5

0.4

e6/l

1.33

2745

25357

(3011391) Calcitriol [Moles/volume] in Serum or Plasma

178

1151

1.53

6.82

1.2

—

(3013707) Erythrocyte sedimentation rate by Westergren method

9792

99613

0.91

6.78

3.7

4.4

14.2

13.3

mm/h

6.77

8911

92055

(36304419) Bacteria [Presence] in Urine

3672

33441

1.11

6.69

2.7

3.0

—

(3017766) Complement C4 [Mass/volume] in Serum or Plasma

318

4219

0.74

6.64

1.5

1.7

0.2

g/l

1.04

293

3980

(21494670) JAK2 gene exon 14 targeted mutation analysis in Blood or Tissue by Molecular genetics method

1391

0.55

6.58

1.0

—

(3010421) pH of Blood

401

3015

1.32

6.56

3.1

3.3

7.4

1.72

324

2511

(3000620) Complement C3 [Mass/volume] in Serum or Plasma

330

4337

0.74

6.47

1.5

1.7

1.2

g/l

0.41

304

4113

(3029937) Albumin [Presence] in Urine by Test strip

3240

34645

0.90

6.35

4.0

4.6

0.0

estimate

2.76

1216

11476

(3031040) Bacteria [#/volume] in Urine by Automated count

9125

86852

1.09

6.33

4.7

4.9

1103.1

2433.5

e6/l

1.31

1038

(3022058) Hepatitis B virus DNA [Presence] in Serum or Plasma by NAA with probe detection

314

0.22

6.25

1.3

1.2

—

(3002179) Metamyelocytes/100 leukocytes in Blood

1162

9872

1.17

6.15

2.8

4.0

1.3

0.6

9.94

352

2003

(3022914) Cancer Ag 19-9 [Units/volume] in Serum or Plasma

606

4861

1.24

5.92

2.6

3.3

1272.8

998.4

u/ml

0.14

493

4083

(3036481) Cortisol [Moles/volume] in Serum or Plasma

1092

12456

0.85

5.84

2.2

2.1

383.8

376.6

nmol/l

0.51

994

11373

(3028531) Enolase.neuron specific [Mass/volume] in Serum or Plasma

171

1136

1.49

5.83

1.7

1.8

18.3

25.2

ug/l

1.70

165

1112

(3009595) Pneumocystis jiroveci DNA [Presence] in Specimen by NAA with probe detection

131

821

1.58

5.83

1.4

1.6

—

(43534045) MCM6 gene c.-13910C>T and -13915T>G [Identifier] in Blood or Tissue by Molecular genetics method Nominal

567

6854

0.81

5.72

1.0

1.1

—

(3032836) C peptide [Moles/volume] in Serum or Plasma --fasting

148

2176

0.67

5.66

2.3

1.7

0.9

0.8

nmol/l

0.75

123

1793

(3003284) Neutrophil cytoplasmic Ab.perinuclear [Titer] in Serum by Immunofluorescence

329

4236

0.76

5.63

1.5

1.6

87.7

261.6

titre

4.97

218

(3009214) Lutropin [Units/volume] in Serum or Plasma

209

1454

1.42

5.63

1.2

23.9

22.4

u/l

0.62

173

1175

(3000919) Neutrophils/100 leukocytes in Pleural fluid

250

2.05

5.62

1.3

1.4

9.9

20.4

3.44

230

(3042733) HLA Ab [Presence] in Serum

278

0.21

5.60

4.5

5.0

—

(3024172) Erythropoietin (EPO) [Units/volume] in Serum or Plasma

111

1726

0.63

5.54

1.2

31.2

33.8

u/l

0.13

1502

(3027450) Sjogrens syndrome-B extractable nuclear Ab [Units/volume] in Serum

347

4424

0.77

5.52

1.2

1.3

9.8

43.4

u/ml

6.55

292

(40761536) Microorganisms panel - Urine sediment

1222

10515

1.16

5.51

4.2

4.4

—

(3003338) MCHC [Mass/volume]

10293

104116

0.92

5.42

24.1

18.3

330.0

330.3

g/l

3.48

10245

103402

(3021879) Hepatitis B virus core Ab [Presence] in Serum

602

7178

0.82

5.33

1.2

1.3

—

(3019309) Folate [Moles/volume] in Red Blood Cells

2340

25249

0.90

5.33

1.7

1.8

1158.8

1196.5

nmol/l

1.11

1678

18824

(3024980) IgG subclass 4 [Mass/volume] in Serum

142

2078

0.67

5.33

1.3

1.5

0.6

g/l

0.09

1564

(21494755) Public health laboratory ask at order entry panel

742

8672

0.84

5.31

1.3

1.4

—

(3009445) Proteinase 3 Ab [Units/volume] in Serum

443

5452

0.79

5.29

1.4

1.5

26.6

16.1

u/ml

—

129

(3008230) Borrelia burgdorferi IgM Ab [Units/volume] in Serum

817

9453

0.84

5.22

2.4

29.9

28.7

au/ml

0.07

496

(3016293) Bicarbonate [Moles/volume] in Serum or Plasma

812

6797

1.19

5.17

4.5

6.1

25.2

25.1

mmol/l

0.19

800

6735

(3013727) Leukocytes other/100 leukocytes in Blood

370

1.82

5.16

1.8

3.8

49.5

52.3

0.38

361

(3017895) Helicobacter pylori Ab [Units/volume] in Serum

440

5393

0.80

5.08

1.6

—

(3006999) Ribonucleoprotein extractable nuclear Ab [Units/volume] in Serum

317

4042

0.77

5.08

1.2

1.3

6.1

7.0

u/ml

0.11

708

(3016921) Smith extractable nuclear Ab [Units/volume] in Serum

312

3983

0.77

5.05

1.2

1.3

5.7

5.6

u/ml

0.01

447

(3008757) Leukocyte morphology finding [Identifier] in Blood

187

1303

1.42

5.04

2.2

3.7

—

(3012501) Base excess in Blood by calculation

336

2568

1.30

4.98

3.4

3.5

2.5

2.8

mmol/l

0.91

242

1853

(3000330) Specific gravity of Urine by Test strip

581

6902

0.82

4.98

4.1

3.6

—

(3013290) Carbon dioxide [Partial pressure] in Blood

336

2569

1.30

4.97

3.4

3.5

5.0

5.1

kpa

0.81

323

2512

(40758310) Human epididymis protein 4 [Moles/volume] in Serum or Plasma

586

4781

1.22

4.93

1.4

119.2

166.9

pmol/l

2.66

573

4667

(3029287) Urinalysis microscopic panel [#/volume] - Urine by Automated count

4676

43576

1.08

4.90

2.8

3.2

—

0.1

—

(3036428) Adenosine deaminase [Enzymatic activity/volume] in Pleural fluid

104

648

1.59

4.83

1.3

11.9

11.6

u/l

0.06

587

(3017354) Segmented neutrophils/100 leukocytes in Blood

174

1210

1.42

4.77

2.1

3.3

56.1

58.6

0.64

104

796

(3027238) Thyroperoxidase Ab [Units/volume] in Serum or Plasma

856

9790

0.85

4.76

1.2

171.6

147.7

iu/ml

0.95

343

3807

(3035880) pH of Pleural fluid

513

1.66

4.76

1.2

—

(3025468) Yersinia sp identified in Specimen by Organism specific culture

243

1789

1.34

4.72

1.3

1.4

—

(43054914) Glucose tolerance 2 hours panel - Serum or Plasma

1179

13152

0.87

4.66

1.5

1.6

—

(3027315) Oxygen [Partial pressure] in Blood

336

2596

1.28

4.62

3.4

3.5

8.6

kpa

0.40

323

2539

(42529201) Cancer Ag 19-9 [Units/volume] in Serum or Plasma by Immunoassay

349

2712

1.28

4.58

2.8

3.2

168.1

853.7

u/ml

2.50

320

2448

(21493466) Plesiomonas shigelloides DNA [Presence] in Stool by NAA with non-probe detection

242

1790

1.34

4.57

1.3

1.4

—

(3014300) Beta 2 glycoprotein 1 IgM Ab [Units/volume] in Serum

257

1.92

4.56

1.1

—

(3024522) Salmonella sp identified in Specimen by Organism specific culture

244

1808

1.34

4.56

1.3

1.4

—

(3019539) Treponema pallidum Ab [Titer] in Serum by Hemagglutination

1004

0.57

4.54

1.1

1.4

—

10512.0

—

(44816844) Macroprolactin [Units/volume] in Serum or Plasma

889

0.54

4.53

1.4

1.7

—

(3023939) Sjogrens syndrome-A extractable nuclear Ab [Units/volume] in Serum

257

3313

0.76

4.52

1.2

1.3

27.0

47.9

u/ml

2.53

390

(3006804) Neuronal Ab [Presence] in Cerebral spinal fluid

2.80

4.52

1.0

—

(3001893) Eosinophils/100 leukocytes in Pleural fluid

272

1.89

4.51

1.4

1.3

3.1

1.88

228

(3005988) Vibrio sp identified in Specimen by Organism specific culture

242

1794

1.34

4.51

1.3

1.4

—

(3005532) Lymphocytes/100 leukocytes in Pleural fluid

329

1.80

4.49

1.3

72.6

62.2

1.93

272

(3051552) Clostridioides difficile toxin genes [Presence] in Stool by NAA with probe detection

1125

9774

1.15

4.47

1.5

1.6

—

(3016888) Borrelia burgdorferi IgG Ab [Units/volume] in Serum

748

8599

0.85

4.45

1.2

1.3

57.7

50.7

au/ml

0.26

360

(3043453) Neutrophil cytoplasmic Ab.perinuclear [Titer] in Serum

1010

0.57

4.45

1.3

1.2

212.0

184.5

titre

—

170

(586526) SARS-CoV-2 (COVID-19) RNA [Presence] in Nasopharynx by NAA with probe detection

812

6898

1.17

4.38

1.4

1.5

—

(42868716) Shigella species+EIEC invasion plasmid antigen H ipaH gene [Presence] in Stool by NAA with probe detection

242

1805

1.33

4.34

1.3

1.4

—

(3014051) Protein [Presence] in Urine by Test strip

263

3360

0.77

4.34

2.3

2.2

—

(3028271) Lactate [Moles/volume] in Capillary blood

248

1858

1.32

4.32

1.8

1.7

mmol/l

0.66

243

1812

(3018980) carBAMazepine [Moles/volume] in Serum or Plasma

490

0.40

4.31

2.6

3.0

26.8

28.0

umol/l

0.18

367

(3050449) Albumin [Mass/time] in Urine collected for unspecified duration

191

2550

0.74

4.31

1.9

2.3

40.3

70.1

ug/min

1.30

1376

(3027475) Erythrocytes [#/volume] in Cerebral spinal fluid

203

2684

0.74

4.29

1.3

1.5

865.1

2100.0

e6/l

1.40

150

2191

(3023421) Hepatitis B virus surface Ab [Units/volume] in Serum

231

2996

0.76

4.27

1.3

252.5

217.6

miu/ml

0.74

108

1382

(3016543) Leukocytes [#/volume] in Cerebral spinal fluid

203

2680

0.74

4.25

1.3

1.4

13.3

40.4

e6/l

2.40

138

2073

(3021584) Pregnancy associated plasma protein A [Units/volume] in Serum or Plasma

1228

0.62

4.22

1.3

1.5

—

(3038177) Helicobacter pylori Ab [Presence] in Serum

158

2166

0.72

4.22

1.3

1.2

—

(3027529) Toxoplasma gondii IgM Ab [Units/volume] in Serum

892

0.56

4.18

1.1

1.2

—

(3050238) Crystals [Presence] in Synovial fluid by Light microscopy

276

3484

0.78

4.16

1.4

1.5

—

(3012320) Pathologist interpretation of Cerebral spinal fluid tests

245

1.89

4.15

1.2

1.1

—

(3026008) Bacteria identified in Urine by Culture

4965

46621

1.08

4.12

3.3

—

(3051714) Fibrin D-dimer FEU [Mass/volume] in Platelet poor plasma

3150

29058

1.09

4.12

1.6

1.7

1.2

1.1

mg/l

0.30

2422

22408

(3016771) Amylase [Enzymatic activity/volume] in Serum or Plasma

4040

42065

0.93

4.04

2.3

2.5

57.3

58.1

u/l

0.31

3698

38376

(40766189) Gliadin peptide IgG Ab [Units/volume] in Serum by Immunoassay

297

3697

0.79

4.01

1.1

1.8

8.6

u/ml

5.75

384

(3012568) Campylobacter sp identified in Specimen by Organism specific culture

245

1855

1.31

3.99

1.3

1.4

—

(3013115) Eosinophils [#/volume] in Blood

6976

66353

1.07

3.95

4.8

6.1

0.2

e9/l

12.66

5987

58023

(43055089) Myosin Ab [Presence] in Serum or Plasma by Immunoblot

659

0.51

3.95

1.0

1.1

—

(3018095) Leukocytes [#/volume] in Urine

4724

44342

1.07

3.92

3.3

3.6

104.2

117.0

e6/l

0.54

3211

30155

(3014959) Toxoplasma gondii IgG Ab [Units/volume] in Serum

923

0.59

3.90

2.2

2.4

—

(3003329) Lymphocytes/100 leukocytes in Synovial fluid

1263

0.65

3.89

1.5

33.5

33.8

0.02

733

(40768797) Stomach Pathology biopsy report

1883

20227

0.91

3.88

1.2

—

(40764127) Haemophilus influenzae DNA [Presence] in Specimen by NAA with probe detection

605

1.54

3.87

1.6

1.5

—

(40767503) Oxygen content in Capillary blood by calculation

312

2448

1.26

3.85

2.3

2.4

15.9

16.0

0.05

138

1223

(3025245) SCL-70 extractable nuclear Ab [Units/volume] in Serum by Immunoassay

264

3313

0.78

3.83

1.2

1.3

1.0

5.2

u/ml

2.82

268

(3009804) Carcinoembryonic Ag [Mass/volume] in Pleural fluid

231

1.88

3.83

1.3

636.4

224.9

ug/l

0.52

137

(3028029) Mesothelial cells/100 leukocytes in Pleural fluid

137

2.16

3.81

1.4

1.3

9.6

15.1

0.88

(3003327) Ova and parasites identified in Stool by Light microscopy

380

4573

0.81

3.79

1.6

1.7

—

(3037875) Bordetella parapertussis DNA [Presence] in Specimen by NAA with probe detection

617

1.52

3.77

1.7

1.4

—

(3000492) Spirometry study

1038

11507

0.88

3.76

1.5

—

(40766800) Mycobacterium tuberculosis stimulated gamma interferon release by CD4+ T-cells [Units/volume] corrected for background in Blood

1359

0.67

3.75

1.1

—

1.7

—

(3000475) Leukocytes [#/volume] in Synovial fluid

273

3395

0.79

3.69

1.6

1.7

17575.6

11079.7

e6/l

1.01

193

2462

(42869547) Procollagen type III.N-terminal propeptide [Mass/volume] in Serum

425

0.42

3.61

1.4

1.7

9.1

8.7

ug/l

0.18

425

(40768443) Skin Pathology biopsy report

739

6337

1.16

3.59

1.2

—

(3027135) IgG subclass 1 [Mass/volume] in Serum

1358

0.68

3.46

1.2

1.4

6.8

6.7

g/l

0.08

959

(3024139) IgG subclass 3 [Mass/volume] in Serum

1357

0.68

3.44

1.2

1.4

0.4

g/l

0.23

958

(3028192) IgG subclass 2 [Mass/volume] in Serum

1357

0.68

3.44

1.2

1.4

2.8

g/l

0.09

957

(3000515) Antithrombin actual/normal in Platelet poor plasma by Chromogenic method

425

3496

1.20

3.41

1.8

2.0

96.3

94.8

0.68

374

3213

(3002482) Mycoplasma pneumoniae DNA [Presence] in Specimen by NAA with probe detection

255

1986

1.27

3.40

1.4

—

(3020148) Glutamate decarboxylase 65 Ab [Units/volume] in Serum

110

1533

0.71

3.33

1.1

59.9

8049.6

iu/ml

0.55

297

(3013527) Hepatitis B virus core IgM Ab [Presence] in Serum

148

1965

0.74

3.32

1.1

1.2

—

(3011951) Aspergillus fumigatus IgE Ab [Units/volume] in Serum

1075

0.65

3.31

1.3

4.2

1.1

u/ml

0.40

510

(3006571) Polymorphonuclear cells/100 leukocytes in Synovial fluid

128

1736

0.72

3.29

1.5

1.6

55.0

54.1

0.10

1056

(3025159) Blasts/100 leukocytes in Blood

1109

9830

1.12

3.28

3.0

4.2

0.6

0.3

0.50

384

2205

(3017918) Cytomegalovirus IgG Ab [Titer] in Serum or Plasma

149

1972

0.74

3.27

1.1

1.3

—

(3000570) Elastase.pancreatic [Mass/mass] in Stool

368

4371

0.83

3.27

1.4

277.7

280.6

ug/g

0.10

229

2500

(3003031) Transferrin.carbohydrate deficient.disialo/Transferrin.total in Serum or Plasma

986

10864

0.89

3.26

1.5

1.6

1.4

0.05

849

9402

(40763480) Human metapneumovirus Ag [Presence] in Specimen

2.79

3.26

1.1

—

(3045783) Sodium and Potassium panel [Moles/volume] - Serum or Plasma

1608

17257

0.91

3.25

6.8

6.7

—

(4062490)

1351

0.69

3.24

1.2

1.4

—

(3032699) Streptococcus pneumoniae DNA [Presence] in Specimen by NAA with probe detection

100

680

1.45

3.23

1.6

1.4

—

(3023150) Myeloperoxidase Ab [Units/volume] in Serum

154

2022

0.75

3.21

1.3

1.5

—

(3019198) Lymphocytes [#/volume] in Blood

6860

65491

1.06

3.19

4.8

6.0

1.7

1.9

e9/l

30.34

5899

57446

(3020565) Legionella pneumophila DNA [Presence] in Specimen by NAA with probe detection

194

1473

1.30

3.18

1.4

—

(44790048)

158

1168

1.34

3.13

1.2

1.5

—

(44806118)

158

1168

1.34

3.13

1.2

1.5

—

(44790049)

158

1168

1.34

3.13

1.2

1.5

—

(44790047)

158

1168

1.34

3.13

1.2

1.5

—

(3034770) Mitochondria Ab [Titer] in Serum

308

3703

0.82

3.12

1.2

635.7

975.0

titre

0.90

167

(1001926) Buprenorphine [Presence] in Urine by Screen method

102

1420

0.71

3.10

1.6

1.5

—

(3003265) Liver kidney microsomal Ab [Titer] in Serum by Immunofluorescence

1081

0.66

3.09

1.2

—

(3010130) Cytomegalovirus IgG Ab [Units/volume] in Serum or Plasma

132

1759

0.74

3.06

1.2

1.3

120.8

120.9

u/ml

0.01

421

(3020779) Urea [Moles/volume] in Serum or Plasma

842

9314

0.88

3.00

4.7

6.4

8.5

9.3

mmol/l

3.01

802

8833

(3049804) Myeloperoxidase IgG Ab [Units/volume] in Serum

287

3458

0.81

2.98

1.2

1.5

9.5

20.3

iu/ml

—

(3048929) Epstein Barr virus Ab [Presence] in Serum

209

2607

0.79

2.98

1.1

1.2

—

(3007080) Epstein Barr virus nuclear IgG Ab [Units/volume] in Serum

132

1750

0.74

2.97

1.1

1.2

266.9

297.1

u/ml

0.50

1098

(3027944) Amphetamines [Presence] in Urine

139

1826

0.75

2.94

1.6

1.5

—

(3010144) Erythrocytes [#/volume] in Synovial fluid

1266

0.70

2.93

1.4

1.5

233667.9

110891.4

e6/l

0.68

857

(3016650) Hepatitis A virus Ab [Presence] in Serum

140

1833

0.75

2.90

1.1

—

(3016251) Hemoglobin.gastrointestinal [Presence] in Stool

699

7802

0.88

2.88

2.4

2.5

—

(3025271) CD3-CD16+CD56+ (Natural killer) cells [#/volume] in Blood

753

0.61

2.87

2.2

2.4

0.2

e9/l

0.05

659

(3041870) Hepatitis C virus IgG Ab [Presence] in Serum or Plasma by Immunoassay

161

1.90

2.86

1.0

1.1

—

(3022621) pH of Urine by Test strip

829

9147

0.89

2.84

3.4

3.2

—

(21492888) Glucose tolerance 2 hours gestational panel - Serum or Plasma

487

0.53

2.82

1.7

—

(3012202) Varicella zoster virus DNA [Presence] in Specimen by NAA with probe detection

521

1.48

2.81

1.1

—

(3036669) Protein S actual/normal in Platelet poor plasma by Coagulation assay

506

1.48

2.78

1.1

101.7

95.8

1.21

382

(3039162) Centromere protein B Ab [Units/volume] in Serum

159

2032

0.77

2.78

1.2

1.3

75.0

59.5

u/ml

—

162

(3041096) Erythrocytes [Presence] in Urine by Automated

3219

33394

0.94

2.76

3.7

—

(36305771) Cryptosporidium sp DNA [Presence] in Stool by NAA with probe detection

907

0.66

2.69

1.2

—

(3012220) Varicella zoster virus IgM Ab [Presence] in Serum by Immunoassay

1289

0.72

2.67

1.1

—

(3030408) 3-Methoxytyramine [Moles/volume] in Serum or Plasma

178

2228

0.79

2.65

1.4

1.3

0.2

nmol/l

—

145

(3014599) Egg white IgE Ab [Units/volume] in Serum

602

0.59

2.64

1.1

1.0

0.5

0.9

u/ml

—

142

(3008401) Mugwort IgE Ab [Units/volume] in Serum

122

1604

0.75

2.64

1.1

1.6

0.8

u/ml

0.30

580

(3021788) Differential panel - Synovial fluid

209

2566

0.80

2.64

1.4

1.5

—

(3007844) Epstein Barr virus capsid IgM Ab [Units/volume] in Serum by Immunoassay

146

1871

0.77

2.63

1.1

1.2

—

(3003888) Timothy IgE Ab [Units/volume] in Serum

128

1669

0.75

2.62

1.1

2.9

2.8

u/ml

0.04

709

(3014148) Varicella zoster virus Ab [Titer] in Serum

1204

0.71

2.62

1.2

1.1

—

(3004616) Nuclear Ab [Presence] in Serum

148

1892

0.77

2.62

1.3

—

(1761868) Lipid panel - Serum or Plasma

4121

42365

0.94

2.61

2.7

3.0

—

(37020937) Giardia lamblia DNA [Presence] in Stool by NAA with probe detection

900

0.67

2.60

1.2

1.3

—

(3001964) Herpes simplex virus Ag [Presence] in Specimen

363

1.55

2.59

1.1

1.4

—

(3016879) Cocaine [Presence] in Urine

131

1698

0.76

2.57

1.6

1.5

—

(3018171) Choriogonadotropin [Units/volume] in Serum or Plasma

226

1802

1.24

2.56

1.8

1.7

774.6

2575.0

u/l

1.63

680

(3009340) Metanephrine [Moles/volume] in Serum or Plasma

153

1940

0.78

2.55

1.4

1.2

—

nmol/l

—

(3027953) Aldolase [Enzymatic activity/volume] in Serum or Plasma

801

0.65

2.55

1.6

1.5

6.0

5.3

u/l

0.43

670

(40760007) HIV 1+2 Ab+HIV1 p24 Ag [Presence] in Serum or Plasma by Immunoassay

154

1.86

2.54

1.0

1.1

—

(3024932) HLA-DR beta [Type]

298

0.43

2.53

1.5

1.2

—

(3026515) Parvovirus B19 IgM Ab [Units/volume] in Serum

298

0.43

2.53

1.3

1.1

—

(3025839) Triglyceride [Moles/volume] in Serum or Plasma

3558

36687

0.94

2.48

1.6

1.7

1.4

1.3

mmol/l

0.65

2919

30567

(3020321) Streptococcus agalactiae [Presence] in Vaginal fluid by Organism specific culture

577

0.60

2.46

1.2

1.4

—

(3011960) Natriuretic peptide B [Mass/volume] in Serum or Plasma

995

10770

0.90

2.44

2.4

2.8

163.6

177.0

ng/l

0.66

906

9871

(3007566) Smooth muscle Ab [Titer] in Serum

313

3660

0.84

2.44

1.2

113.9

153.2

titre

0.37

296

(3031478) Chlamydophila pneumoniae DNA [Presence] in Specimen by NAA with probe detection

201

1592

1.25

2.44

1.4

—

(3026179) Normetanephrine [Moles/volume] in Serum or Plasma

180

2223

0.80

2.43

1.4

1.3

5.2

1.3

nmol/l

0.39

174

2135

(3004716) Salmonella sp identified in Stool by Organism specific culture

578

6450

0.88

2.43

1.4

—

(3024471) HLA-A [Type]

306

0.45

2.42

1.1

1.0

—

(3019060) Gas panel - Arterial blood

700

7709

0.89

2.38

4.1

4.4

—

(3004775) Volume in Urine collected for unspecified duration

857

0.68

2.36

1.6

2.3

644.5

638.4

0.04

596

(3028300) Cannabinoids [Presence] in Urine

149

1864

0.79

2.27

1.5

—

(3022145) Colonoscopy Study observation

1461

15484

0.92

2.26

1.3

—

(3016407) Fibrinogen [Mass/volume] in Platelet poor plasma by Coagulation assay

378

3205

1.17

2.26

2.0

2.3

3.5

3.6

g/l

1.18

365

3046

(3020874) Milk IgE Ab [Units/volume] in Serum

623

0.63

2.25

1.1

1.0

0.4

1.1

u/ml

0.78

184

(1002102) Choriogonadotropin.intact+Beta subunit [Mass/volume] in Serum or Plasma

362

0.52

2.24

1.3

1.4

—

(3012477) Bordetella pertussis DNA [Presence] in Specimen by NAA with probe detection

211

1698

1.23

2.24

1.4

—

(42528615) Etanercept [Mass/volume] in Serum or Plasma by Immunoassay

0.00

2.24

0.0

1.2

—

1.7

—

(3006315) Basophils [#/volume] in Blood

6694

64266

1.05

2.24

4.7

5.9

0.0

e9/l

3.27

5679

55276

(3045414) Leukocytes [Presence] in Urine

585

6483

0.89

2.23

1.9

—

(46237023) Hepatitis B virus core and surface Ab and surface Ag panel - Serum

238

2823

0.83

2.21

1.2

1.3

—

(3027008) Opiates [Presence] in Urine

149

1857

0.79

2.21

1.5

—

(3016750) Collection duration of Urine

643

0.64

2.19

1.5

2.2

512.9

499.8

min

0.39

490

(3001405) CD3+CD8+ (T8 suppressor) cells [#/volume] in Blood

785

0.68

2.19

2.1

2.3

477.4

537.2

e6/l

0.29

663

(3037692) Legionella sp identified in Specimen by Organism specific culture

411

1.47

2.18

1.0

1.4

—

(3000764) Benzodiazepines [Presence] in Urine

149

1851

0.79

2.16

1.5

—

(3019145) Choriogonadotropin.beta subunit free [Mass/volume] in Serum or Plasma

676

0.66

2.16

1.3

1.4

—

(3023430) Cat dander IgE Ab [Units/volume] in Serum

1206

0.74

2.15

1.1

1.6

3.1

u/ml

1.57

433

(3005136) Cladosporium herbarum IgE Ab [Units/volume] in Serum

1034

0.72

2.13

1.1

1.0

0.1

0.5

u/ml

1.25

198

(4094501)

311

3589

0.85

2.12

1.1

—

(3000060) B lymphocytes [#/volume] in Blood

288

0.48

2.10

1.4

2.0

3608.3

209.7

e6/l

—

165

(3023183) Ammonium ion [Moles/volume] in Plasma

246

2026

1.20

2.10

2.0

2.6

37.8

32.9

umol/l

1.67

198

1720

(3023351) European house dust mite IgE Ab [Units/volume] in Serum

151

1864

0.80

2.08

1.1

1.8

1.1

u/ml

0.35

630

(3020229) Cytomegalovirus DNA [Presence] in Specimen by NAA with probe detection

311

1.52

2.08

1.2

—

(3011335) Digoxin [Mass/volume] in Serum or Plasma

101

1.95

2.07

2.6

2.3

—

(3001604) Monocytes [#/volume] in Blood

6654

63960

1.05

2.06

4.7

5.9

0.5

0.6

e9/l

4.36

5647

55044

(1002224) Polysomnography panel

395

4465

0.87

2.06

1.1

—

(3009550) Parvovirus B19 IgG Ab [Titer] in Serum

258

0.46

2.04

1.3

1.1

—

(1175715) Chlamydophila pneumoniae IgM Ab [Presence] in Serum by Immunoassay

154

1890

0.80

2.03

1.2

1.1

—

(3028707) Methadone [Presence] in Urine by Screen method

887

0.71

2.02

1.8

—

(3032155) Metanephrine Free [Moles/volume] in Serum or Plasma

168

2042

0.81

2.02

1.4

1.2

—

(3019800) Troponin T.cardiac [Mass/volume] in Serum or Plasma

4794

48809

0.95

2.02

3.3

3.5

29.9

56.2

ng/l

1.53

3387

32187

(3026470) Cobalt [Mass/volume] in Blood

817

0.70

2.02

2.0

2.1

4.2

4.1

ug/l

0.07

724

(3010726) Horse dander IgE Ab [Units/volume] in Serum

115

1460

0.77

2.01

1.1

u/ml

0.05

295

(40760888) Immunoglobulin light chains.free panel - Serum

262

3050

0.84

2.01

3.3

3.5

—

(3037756) Immunofixation for Serum or Plasma

228

2686

0.83

2.00

1.8

1.7

—

(36032419) SARS-CoV-2 (COVID-19) Ag [Presence] in Upper respiratory specimen by Immunoassay

286

3304

0.85

2.00

1.8

1.7

—

(3025577) Chromium [Mass/volume] in Blood

792

0.70

1.99

2.0

2.1

3.0

2.8

ug/l

0.13

674

(3014133) Dog dander IgE Ab [Units/volume] in Serum

100

1290

0.76

1.98

1.0

1.1

3.1

3.2

u/ml

0.03

432

(3019250) Coagulation factor VIII activity actual/normal in Platelet poor plasma by Coagulation assay

383

3289

1.15

1.98

2.5

2.2

192.6

191.8

0.05

365

3081

(3019473) Protein [Mass/volume] in Cerebral spinal fluid

260

3023

0.85

1.97

1.3

540.6

539.1

mg/l

0.01

246

2875

(3046861) Legionella sp Ag [Presence] in Urine

2.37

1.96

1.3

1.0

—

(40763531) Fetal Nuchal fold [Multiple of the median] Thickness adjusted for maternal weight

637

0.66

1.96

1.3

1.4

—

(46235831) Pregnancy associated plasma protein A [Multiple of the median] adjusted in Serum or Plasma

636

0.67

1.94

1.3

1.4

—

(4281824)

264

2207

1.18

1.93

1.1

—

(3036535) Thyroglobulin [Mass/volume] in Serum or Plasma

130

1010

1.27

1.93

5.6

6.1

—

(3008714) Choriogonadotropin [Multiple of the median] adjusted in Serum or Plasma

635

0.67

1.93

1.3

1.4

—

(3049207) Fetal Trisomy 21 risk [Likelihood] Based on maternal age

635

0.67

1.93

1.3

—

(37021247) Adenovirus 40+41 DNA [Presence] in Stool by NAA with probe detection

640

1.34

1.92

1.2

1.4

—

(37020445) Astrovirus RNA [Presence] in Stool by NAA with probe detection

640

1.34

1.92

1.2

1.4

—

(3023601) Vancomycin resistant enterococcus [Presence] in Specimen by Organism specific culture

136

1064

1.26

1.91

2.2

2.8

—

(3043409) Potassium [Moles/volume] in Arterial blood

319

3639

0.86

1.91

3.0

4.0

3.8

mmol/l

0.45

302

3445

(3006653) Thiamine [Moles/volume] in Blood

586

0.66

1.91

1.2

1.3

127.7

134.5

nmol/l

0.63

586

(3009466) Valproate [Moles/volume] in Serum or Plasma

127

1579

0.79

1.90

5.2

5.0

362.9

375.7

umol/l

0.43

107

1372

(3028369) Herpes simplex virus 1+2 DNA [Presence] in Specimen by NAA with probe detection

151

1200

1.24

1.86

1.1

1.2

—

(3010254) Herpes simplex virus identified in Specimen by Organism specific culture

312

1.49

1.85

1.2

1.1

—

(3036489) Thrombin time

504

4432

1.13

1.84

1.8

22.0

21.4

0.59

430

3842

(3013166) Neutrophils/100 leukocytes in Synovial fluid

400

0.59

1.84

1.5

44.1

50.8

0.35

338

(3020287) Protein C actual/normal in Platelet poor plasma by Coagulation assay

201

1649

1.20

1.83

1.1

125.0

124.9

0.02

183

1465

(3030306) Epithelial cells.non-squamous [#/volume] in Urine by Automated count

2287

21456

1.06

1.82

2.4

2.6

2.9

1.4

e6/l

0.55

1171

12058

(3028167) CD3+CD4+ (T4 helper) cells [#/volume] in Blood

777

0.71

1.82

2.0

2.5

502.3

844.4

e6/l

1.62

348

(3024263) Appearance of Synovial fluid

684

0.69

1.81

1.4

1.8

—

(3038071) Oxygen [Partial pressure] in Mixed venous blood

179

0.44

1.80

17.9

8.7

—

(3017569) Oxygen content in Arterial blood

512

1.37

1.80

2.5

2.1

—

(42868418) European tick borne encephalitis virus IgG Ab [Presence] in Cerebral spinal fluid by Immunoassay

121

1.79

1.80

1.0

1.1

—

(3037826) lamoTRIgine [Moles/volume] in Serum or Plasma

182

0.43

1.79

2.1

1.9

13.5

17.9

umol/l

—

182

(3014891) Appearance of Pleural fluid

129

1.76

1.77

1.4

1.6

—

(3022575) Varicella zoster virus IgG Ab [Units/volume] in Serum

480

0.64

1.77

1.1

1054.5

1586.0

miu/ml

2.49

480

(3033670) Parathyrin related protein [Moles/volume] in Serum or Plasma

276

1.50

1.75

1.2

1.1

2.7

2.9

pmol/l

—

(42868766) Dientamoeba fragilis DNA [Presence] in Stool by NAA with probe detection

394

0.60

1.75

1.3

1.2

—

(3021197) Magnesium Ionized [Moles/volume] in Serum or Plasma

466

0.63

1.74

2.6

2.9

—

(3034274) Bile acid [Moles/volume] in Serum --fasting

803

0.72

1.72

1.3

1.5

7.5

8.8

umol/l

0.14

577

(3007625) Streptococcus pneumoniae Ag [Presence] in Specimen

2.31

1.72

1.1

—

(3007778) Kappa light chains/Lambda light chains [Mass Ratio] in Serum

349

3920

0.87

1.72

3.0

3.4

4.1

4.5

ratio

0.04

304

(42528593) TIF1-gamma Ab [Presence] in Serum by Line blot

342

0.58

1.71

1.0

1.1

—

(42529598) SUMO-activating enzyme subunit 1 Ab [Presence] in Serum by Line blot

342

0.58

1.71

1.0

1.1

—

(3013637) Mi-2 Ab [Presence] in Serum

342

0.58

1.71

1.0

1.1

—

(42529582) MDA5 Ab [Presence] in Serum by Line blot

342

0.58

1.71

1.0

1.1

—

(42529188) 25-Hydroxyvitamin D3+25-Hydroxyvitamin D2 [Moles/volume] in Serum or Plasma by Immunoassay

262

1.51

1.70

1.2

—

(3047007) Chlamydophila sp Ab [Presence] in Serum

153

1837

0.82

1.69

1.3

1.2

—

(40768446) Kidney Pathology biopsy report

353

0.59

1.69

1.3

1.6

—

(706163) SARS-CoV-2 (COVID-19) RNA [Presence] in Respiratory system specimen by NAA with probe detection

7331

73727

0.96

1.66

2.6

2.7

—

(3034780) Angiotensin converting enzyme [Enzymatic activity/volume] in Serum or Plasma

510

5584

0.90

1.66

1.9

2.0

41.9

40.2

u/l

1.15

454

4914

(3009613) Erythrocytes [#/volume] in Peritoneal fluid

379

1.41

1.63

1.3

1.7

2252.7

15738.3

e6/l

1.43

179

(21492711) Cytomegalovirus IgG Ab avidity [Presence] in Serum or Plasma by Immunoassay

576

0.68

1.63

1.0

1.1

—

(3017446) Testosterone [Moles/volume] in Serum or Plasma

564

0.68

1.63

1.4

2.0

1.1

nmol/l

0.44

431

(3048518) aPTT.lupus sensitive actual/normal (normalized LA screen)

695

1.29

1.60

1.1

1.0

1.1

ratio

1.96

242

(37020300) Entamoeba histolytica DNA [Presence] in Stool by NAA with probe detection

491

0.66

1.59

1.3

1.2

—

(3034860) Kappa light chains.free [Mass/volume] in Serum

364

4052

0.88

1.58

3.0

3.5

47.4

79.4

mg/l

0.77

287

3303

(3002523) Influenza virus A Ag [Presence] in Specimen

174

1432

1.20

1.58

1.1

—

(3003740) Influenza virus B Ag [Presence] in Specimen

174

1432

1.20

1.58

1.1

—

(3011288) Drugs identified in Urine by Screen method

1235

0.79

1.58

2.3

1.8

—

(21494890) Protein electrophoresis panel - 24 hour Urine

1224

0.79

1.58

2.0

2.1

—

(3030429) Borrelia sp DNA [Identifier] in Specimen by NAA with probe detection

478

0.66

1.58

1.1

—

(3012336) Haptoglobin [Mass/volume] in Serum or Plasma

469

5142

0.90

1.58

1.4

1.7

1.6

g/l

1.05

380

4370

(36306090) Helicobacter pylori [Presence] in Tissue by Organism specific culture

641

0.71

1.57

1.0

1.1

—

(3010566) Parathyrin.intact [Moles/volume] in Serum or Plasma

321

2776

1.14

1.57

2.0

2.5

—

(3012494) Peanut IgE Ab [Units/volume] in Serum

320

0.58

1.56

1.1

1.0

0.5

0.8

u/ml

—

158

(3043238) Trisomy 21 risk [Likelihood] in Fetus

558

0.69

1.55

1.3

1.4

—

(3033799) Differential panel - Peritoneal fluid

350

1.41

1.55

1.2

1.8

—

(37020957) Sapovirus genogroups I+II+IV+V RNA [Presence] in Stool by NAA with probe detection

109

856

1.26

1.55

1.3

1.4

—

(3020876) Protein [Mass/time] in 24 hour Urine

955

0.76

1.55

1.6

2.0

0.3

0.6

g/24h

—

(3043525) Herpes simplex virus Ab [Presence] in Cerebral spinal fluid

166

1.60

1.53

1.0

1.2

—

(3023419) Bacteria identified in Sputum by Culture

127

1533

0.82

1.52

2.4

2.7

—

(3042010) Triglyceride [Moles/volume] in Pleural fluid

151

1.63

1.52

1.3

1.2

2.9

2.0

mmol/l

0.15

(3028433) Virus identified in Specimen by Culture

410

1.37

1.51

1.1

1.2

—

(3046426) Aquaporin 4 water channel IgG Ab [Presence] in Serum or Plasma

140

0.42

1.51

1.3

1.2

—

(3047169) Lambda light chains.free [Mass/volume] in Serum or Plasma

364

4036

0.89

1.50

3.0

3.5

36.6

40.7

mg/l

0.22

285

3286

(3026989) Triiodothyronine (T3) Free [Moles/volume] in Serum or Plasma

934

9890

0.93

1.49

3.1

3.2

4.5

4.4

pmol/l

1.03

831

8666

(36033641) SARS-CoV-2 (COVID-19) Ag [Presence] in Upper respiratory specimen by Rapid immunoassay

167

1960

0.84

1.49

1.4

1.6

—

(37019628) Gastrointestinal bacterial pathogens panel - Stool by NAA with probe detection

351

3067

1.13

1.49

1.3

1.4

—

(3044941) Cell count panel - Synovial fluid

186

2161

0.85

1.48

1.4

1.5

—

(3013803) Aspergillus fumigatus IgG Ab [Mass/volume] in Serum

201

0.49

1.48

1.8

1.2

—

(3020891) Body temperature

438

4799

0.90

1.48

3.4

4.4

—

(3021960) Folate [Moles/volume] in Serum or Plasma

3045

31118

0.96

1.47

1.5

21.7

21.9

nmol/l

0.41

2504

26108

(3020044) Glucose [Moles/volume] in Cerebral spinal fluid

234

2667

0.86

1.46

1.2

3.6

3.7

mmol/l

1.09

220

2507

(3018921) Toxoplasma gondii IgA Ab [Units/volume] in Serum

301

0.59

1.46

1.0

1.1

—

(3040363) Hepatitis A virus IgG Ab [Presence] in Serum by Immunoassay

978

0.78

1.45

1.1

—

(42868415) European tick borne encephalitis virus IgM Ab [Presence] in Cerebral spinal fluid by Immunoassay

281

1.44

1.1

—

(21494567) Legionella sp IgM Ab [Presence] in Serum

1.92

1.43

1.0

—

(3032743) Legionella sp IgG Ab [Presence] in Serum

1.92

1.43

1.0

—

(3050129) First trimester maternal screen panel - Serum or Plasma

764

0.75

1.43

1.4

1.5

—

(3013327) Hepatitis A virus IgM Ab [Presence] in Serum

161

1886

0.84

1.42

1.1

—

(40760109) Toxoplasma gondii IgG Ab avidity [Ratio] in Serum by Immunoassay

323

0.61

1.42

1.0

1.1

—

(3026285) Alpha 1 antitrypsin [Mass/volume] in Serum or Plasma

137

1626

0.83

1.40

1.0

1.1

1.6

1.5

g/l

1.25

123

1449

(3047352) Trisomy 18 risk [Likelihood] in Fetus

534

0.70

1.40

1.2

1.4

—

(40762119) U1 small nuclear ribonucleoprotein 70kD Ab [Units/volume] in Serum

101

1235

0.80

1.39

1.1

—

36.7

—

(4015189)

369

0.64

1.39

1.9

2.6

—

(3014037) CD3+CD4+ (T4 helper) cells/100 cells in Blood

578

0.72

1.37

2.0

2.8

40.2

41.9

0.13

199

(3005033) Fetal Nuchal fold Thickness US

532

0.70

1.37

1.2

1.3

—

(3026910) Gamma glutamyl transferase [Enzymatic activity/volume] in Serum or Plasma

8262

80184

1.04

1.37

2.9

3.0

54.9

44.3

u/l

10.91

7620

73841

(3012110) Lysozyme [Mass/volume] in Serum or Plasma

322

3570

0.89

1.36

2.0

2.1

10.2

11.2

mg/l

1.63

296

3279

(3017044) Thyrotropin receptor Ab [Units/volume] in Serum

350

3861

0.89

1.36

1.7

1.8

29.4

14.8

iu/l

0.25

133

1371

(42869457) Rotavirus RNA [Identifier] in Stool by NAA with probe detection

109

872

1.23

1.35

1.3

1.4

—

(3023520) Reticulocytes [#/volume] in Blood

926

9765

0.93

1.35

2.2

2.6

71.0

e9/l

0.00

687

7329

(4198724)

244

0.57

1.34

1.1

1.3

—

(3044927) Protein electrophoresis panel - Urine

108

1304

0.82

1.33

1.2

—

(3025941) Bacteria identified in Stool by Culture

710

7557

0.92

1.33

1.3

—

(4027681)

630

0.73

1.32

1.4

1.2

—

(3010464) Parainfluenza virus 1 Ag [Presence] in Specimen

150

1.58

1.30

1.1

—

(3042111) Morphology [Interpretation] in Bone marrow Narrative

167

1932

0.85

1.30

1.6

—

(3042975) Streptococcus sp identified in Isolate by Organism specific culture

397

1.34

1.29

1.1

—

(3005880) Parainfluenza virus 3 Ag [Presence] in Specimen

151

1.57

1.27

1.1

—

(3021578) Parainfluenza virus 2 Ag [Presence] in Specimen

151

1.57

1.27

1.1

—

(3034891) Synovial lining cells/100 cells in Synovial fluid

682

0.75

1.27

1.2

1.5

2.7

3.7

0.47

130

(3002621) Streptococcal DNAse B [Units/volume] in Serum

1.78

1.25

1.1

1.0

—

(40761539) Cells [Type] in Urine sediment by Light microscopy

298

1.39

1.25

1.0

1.2

—

(3044242) Glucose [Moles/volume] in Arterial blood

521

1.29

1.23

2.1

2.0

—

(3025927) Herpes simplex virus IgG Ab [Units/volume] in Cerebral spinal fluid by Immunoassay

129

1.61

1.23

1.0

1.1

—

(3014702) Chromogranin A [Moles/volume] in Serum or Plasma

176

1490

1.17

1.22

3.5

3.1

4.7

8.9

nmol/l

0.55

170

1435

(3042631) Mycobacterium sp identified in Specimen

189

1610

1.16

1.21

2.1

2.7

—

(3004588) Protein electrophoresis panel - Serum or Plasma

843

8878

0.93

1.21

2.1

2.4

—

(3016417) Amylase.pancreatic [Enzymatic activity/volume] in Serum or Plasma

1311

12266

1.06

1.21

2.2

2.4

49.1

38.4

u/l

0.74

1120

10360

(3023487) Leukocytes [#/volume] in Peritoneal fluid

428

1.31

1.20

1.4

1.9

793.2

2933.0

e6/l

0.94

268

(3011985) Renin [Units/volume] in Plasma

169

1938

0.86

1.20

1.4

32.0

50.8

mu/l

1.97

148

1718

(3016628) Fibrinogen Ag [Mass/volume] in Platelet poor plasma by Immunoassay

284

0.62

1.20

1.2

1.3

0.8

17.4

mg/l

0.50

211

(3009991) Angiotensin converting enzyme [Enzymatic activity/volume] in Cerebral spinal fluid

606

0.75

1.18

1.0

1.1

1.0

1.1

u/l

1.28

286

(43055225) Phosphorylated tau 181 [Mass/volume] in Cerebral spinal fluid by Immunoassay

916

0.80

1.18

1.0

38.9

46.2

ng/l

0.94

639

(3013566) Clostridioides difficile [Presence] in Stool by Organism specific culture

526

1.28

1.16

1.1

1.2

—

(3036048) Francisella tularensis Ab [Titer] in Serum

233

0.59

1.16

1.0

1.2

—

874.7

—

(3003181) Sodium [Moles/volume] in Urine

238

2655

0.88

1.15

1.4

55.9

61.1

mmol/l

1.41

185

2099

(3042810) Amyloid beta 42 peptide [Mass/volume] in Cerebral spinal fluid

913

0.80

1.15

1.0

729.8

733.0

ng/l

0.02

622

(3036071) Salmonella sp Ab [Titer] in Serum

340

0.67

1.15

1.0

1.1

—

(3015183) Erythrocyte sedimentation rate

546

0.74

1.14

1.1

1.2

—

(3017962) TCRG gene rearrangements [Presence] in Blood or Tissue by Molecular genetics method

150

0.53

1.13

1.1

1.4

—

(3041067) Sjogrens syndrome-A extractable nuclear 52kD Ab [Units/volume] in Serum

101

1203

0.83

1.13

1.2

19.8

47.3

u/ml

—

112

(3006044) Creatine kinase.total/Creatine kinase.MB [Enzymatic activity ratio] in Serum or Plasma

2.47

1.13

1.0

1.1

2.2

1.9

—

(3014591) Smooth Alder IgE Ab [Units/volume] in Serum

0.00

1.13

0.0

1.0

—

(3000850) Epithelial cells [#/volume] in Urine

2695

25708

1.04

1.13

2.2

2.5

7.8

7.4

e6/l

0.45

2337

22255

(1616796) Gas panel - Central venous blood

275

2418

1.12

1.13

3.1

3.3

—

(3010521) Mycoplasma pneumoniae IgM Ab [Presence] in Serum by Immunoassay

312

3418

0.90

1.12

1.1

1.2

—

(3041423) Sjogrens syndrome-A extractable nuclear 60kD Ab [Units/volume] in Serum

101

1200

0.83

1.11

1.2

107.3

68.4

u/ml

—

(3022948) Iron [Moles/volume] in Serum or Plasma

1892

19408

0.96

1.10

2.0

2.4

12.9

12.7

umol/l

0.57

1749

17783

(3000242) Tau protein [Mass/volume] in Cerebral spinal fluid

906

0.80

1.09

1.0

324.9

382.1

ng/l

0.59

641

(3034037) Hematocrit [Volume Fraction] of Mixed venous blood

135

0.51

1.09

4.0

6.8

—

(3032700) Glomerular basement membrane Ab [Units/volume] in Serum

136

0.51

1.09

1.1

1.6

—

129.9

—

(3016701) Glucose [Moles/volume] in Serum or Plasma --2 hours post dose glucose

129

1496

0.85

1.08

1.2

7.5

mmol/l

0.05

109

1085

(42529406) Shigella sp [Presence] in Stool by Culture

380

4112

0.91

1.08

1.2

—

(3021125) Hepatitis C virus RNA [Presence] in Serum or Plasma by NAA with probe detection

585

0.76

1.08

1.5

1.2

—

(40766048) U1 small nuclear ribonucleoprotein 70kD Ab [Units/volume] in Serum by Immunoassay

1142

0.83

1.08

1.2

1.9

10.2

u/ml

—

(4146454)

123

1430

0.85

1.07

2.7

—

(3037121) Protein [Mass/volume] in Urine

396

4272

0.91

1.06

2.4

2.9

0.2

0.3

g/l

2.91

126

1417

(3006418) Campylobacter sp identified in Tissue by Organism specific culture

376

4065

0.91

1.06

1.2

—

(3005895) Myoglobin [Mass/volume] in Serum or Plasma

364

3941

0.91

1.06

1.9

2.1

317.2

495.2

ug/l

1.19

328

3663

(3000924) Streptococcus pyogenes [Presence] in Throat by Organism specific culture

891

0.81

1.06

1.1

1.2

—

(21494815) CD4 cells/100 lymphocytes in Specimen

891

0.81

1.06

1.9

2.0

37.3

42.4

0.94

122

(3011412) CD3 cells [#/volume] in Blood

1117

0.83

1.05

2.0

2.3

1.3

1.1

e9/l

0.50

673

(3002823) Mycoplasma pneumoniae IgG Ab [Units/volume] in Cerebral spinal fluid

309

1.34

1.05

1.1

—

(3027945) Reticulocytes/100 erythrocytes in Blood

1257

13005

0.95

1.05

2.0

2.5

1.9

1.8

1.80

1103

11415

(3034426) Prothrombin time (PT)

378

1.31

1.04

1.2

1.1

—

(3002331) Protein [Mass/volume] in Peritoneal fluid

242

1.39

1.04

1.1

1.4

28.8

29.0

g/l

0.02

190

(3044007) Cell count panel - Peritoneal fluid

344

1.32

1.03

1.3

1.9

—

(3023365) Varicella zoster virus Ab [Titer] in Cerebral spinal fluid

168

1.47

1.03

1.0

1.1

—

(3027955) HFE gene mutations tested for in Blood or Tissue by Molecular genetics method Nominal

148

0.53

1.03

1.0

—

(3014765) Yersinia sp identified in Stool by Organism specific culture

381

4107

0.91

1.02

1.2

—

(3041918) Cholesterol [Moles/volume] in Pleural fluid

193

1.43

1.02

1.3

1.2

2.3

1.9

mmol/l

1.52

106

(3005229) Alpha 2 globulin [Mass/volume] in Serum or Plasma by Electrophoresis

473

5050

0.92

1.02

2.0

2.3

7.7

7.5

g/l

0.86

356

3702

(3037677) Mycoplasma pneumoniae IgM Ab [Titer] in Cerebral spinal fluid

311

1.33

1.01

1.1

—

(3008152) Bicarbonate [Moles/volume] in Arterial blood

698

7338

0.93

1.00

5.6

6.5

25.3

24.9

mmol/l

2.53

650

6827

(3043747) Beta 2 globulin [Mass/volume] in Serum or Plasma by Electrophoresis

472

5033

0.92

0.99

2.0

2.3

3.8

3.7

g/l

0.38

332

3531

(3043723) Beta 1 globulin [Mass/volume] in Serum or Plasma by Electrophoresis

473

5042

0.92

0.99

2.0

2.3

—

(3050099) BK virus DNA [#/volume] (viral load) in Specimen by NAA with probe detection

0.00

0.97

0.0

3.4

—

(3015665) Acarus siro IgE Ab [Units/volume] in Serum

0.00

0.97

0.0

1.0

—

0.0

—

(3042206) Streptococcus agalactiae Ag [Presence] in Vaginal fluid

209

0.61

0.97

1.4

1.2

—

(40758292) HTLV I+II Ab panel - Serum

159

0.56

0.97

1.3

1.5

—

(44816559) Phosphatidylethanol [Mass/volume] in Blood

149

1690

0.87

0.97

1.2

—

(3027545) Mycoplasma pneumoniae Ab [Presence] in Serum by Immunoassay

340

3672

0.91

0.96

1.4

—

(42868544) Hantavirus puumala IgM Ab [Presence] in Serum or Plasma by Immunofluorescence

143

1625

0.87

0.96

1.2

1.1

—

(3024474) Albumin [Mass/volume] in Cerebral spinal fluid

814

0.81

0.95

1.2

1.1

323.6

257.3

mg/l

0.53

708

(3011166) Borrelia burgdorferi Ab [Presence] in Cerebral spinal fluid

1029

0.83

0.95

1.0

1.1

—

(3027831) CD3-CD16+CD56+ (Natural killer) cells/100 cells in Blood

855

0.82

0.93

1.7

1.9

12.0

15.0

1.72

368

(3007368) IgG [Mass/volume] in Cerebral spinal fluid

844

0.82

0.93

1.2

45.5

40.1

mg/l

0.19

707

(40759040) C peptide [Moles/volume] in Serum or Plasma --post meal

941

0.83

0.93

1.4

1.3

1.6

1.5

nmol/l

0.38

847

(3006922) Hepatitis E virus Ab [Presence] in Serum

833

0.82

0.93

1.1

—

(3036670) Protein [Mass/volume] in Synovial fluid

425

0.74

0.92

1.5

1.3

37.8

38.9

g/l

0.19

210

(3010517) Carboxyhemoglobin/Hemoglobin.total in Venous blood

516

5461

0.93

0.91

2.2

2.7

1.1

1.2

3.77

516

5429

(40771527) Human papilloma virus E6+E7 mRNA [Presence] in Cervix by NAA with probe detection

634

0.79

0.90

1.8

—

(3047189) Immunofixation for 24 hour Urine

523

0.77

0.89

2.4

1.9

—

(3014271) Vancomycin [Susceptibility]

655

1.21

0.88

2.6

3.1

—

(3027273) Bicarbonate [Moles/volume] in Venous blood

533

5625

0.93

0.88

2.7

3.1

25.9

25.6

mmol/l

1.51

523

5480

(44806071)

153

0.58

0.88

1.1

—

(3004119) Hemoglobin [Mass/volume] in Venous blood

667

6984

0.94

0.88

2.5

3.1

124.7

126.5

g/l

1.58

646

6839

(3014111) Lactate [Moles/volume] in Serum or Plasma

1074

10105

1.05

0.87

4.5

6.1

1.3

mmol/l

0.01

1039

9796

(3017732) Neutrophils [#/volume] in Blood

977

9172

1.05

0.86

3.2

2.9

3.8

3.9

e9/l

0.58

781

6823

(3050794) Legionella sp Ab [Presence] in Serum

1.57

0.86

1.1

—

(1761482) Bacteria [#/volume] in Urine by Culture

310

3339

0.91

0.86

5.4

4.6

—

(40757349) CD3+CD4+ (T4 helper) cells/CD3+CD8+ (T8 suppressor cells) cells [# Ratio] in Blood

363

0.73

0.85

2.7

2.9

—

(3020191) Ethanol [Moles/volume] in Serum or Plasma

661

0.80

0.85

1.2

1.4

1.1

promille

0.61

478

(40759844) Sjogrens syndrome-B extractable nuclear Ab [Presence] in Serum by Immunoblot

1143

0.85

1.1

1.2

—

(3023465) Gamma globulin [Mass/volume] in Serum or Plasma by Electrophoresis

444

4706

0.93

0.84

1.9

2.3

9.8

10.0

g/l

0.49

354

3847

(40759842) Ribonucleoprotein extractable nuclear Ab [Presence] in Serum by Immunoblot

1142

0.85

0.84

1.1

1.2

—

(40759843) Sjogrens syndrome-A extractable nuclear Ab [Presence] in Serum by Immunoblot

1142

0.85

0.84

1.1

1.2

—

(3001019) Free T4 and TSH panel - Serum or Plasma

618

6475

0.94

0.84

1.7

1.8

—

(3013293) Extractable nuclear Ab [Presence] in Serum

282

0.70

0.84

1.3

1.5

—

(3001684) Respiratory syncytial virus Ag [Presence] in Specimen

219

1.35

0.83

1.1

—

(3023709) Somatotropin [Mass/volume] in Serum or Plasma

349

0.73

0.82

1.5

2.2

2.5

1.1

ug/l

1.14

336

(3009306) Alpha-1-Fetoprotein [Mass/volume] in Serum or Plasma

257

0.69

0.81

2.1

2.2

—

(40759812) SCL-70 extractable nuclear Ab [Presence] in Serum by Immunoblot

1138

0.86

0.81

1.1

1.2

—

(40759849) Smith extractable nuclear Ab [Presence] in Serum by Immunoblot

1138

0.86

0.81

1.1

1.2

—

(3008832) Norclozapine [Moles/volume] in Serum or Plasma

448

0.77

0.80

9.6

10.5

694.0

3065.4

nmol/l

0.54

431

(40759836) Histone Ab [Presence] in Serum by Immunoblot

1136

0.86

0.80

1.1

1.2

—

(3014162) Mycobacterium tuberculosis DNA [Presence] in Specimen by NAA with probe detection

425

3899

1.08

0.79

2.2

2.7

—

(3001788) Aldosterone [Moles/volume] in Serum or Plasma

162

1796

0.89

0.79

1.4

1.3

270.7

299.8

pmol/l

0.55

129

1425

(3021337) Troponin I.cardiac [Mass/volume] in Serum or Plasma

2454

24861

0.97

0.79

3.2

3.6

119.8

259.0

ng/l

6.02

1893

18792

(3009883) Potato IgE Ab [Units/volume] in Serum

0.00

0.79

0.0

1.0

—

0.2

—

(3052912) Proteinase 3 IgG Ab [Units/volume] in Serum

0.00

0.79

0.0

1.1

—

24.3

—

(3044290) Cell count panel - Cerebral spinal fluid

230

2499

0.91

0.78

1.2

1.4

—

(3051101) Glucose [Moles/volume] in Cord blood

220

0.67

0.78

4.9

5.7

—

(3035320) C reactive protein [Mass/volume] in Body fluid

117

1003

1.15

0.78

2.2

2.4

—

(3052592) Norovirus Ag [Presence] in Stool

256

1.31

0.78

1.5

1.3

—

(3000494) Fungus identified in Specimen by Culture

1601

15248

1.04

0.77

1.3

1.4

—

(3006257) Acetylcholine receptor Ab [Moles/volume] in Serum

781

0.83

0.77

1.1

1.4

6.0

nmol/l

—

151

(3011897) Casein IgE Ab [Units/volume] in Serum

160

0.62

0.77

1.0

1.1

—

2.2

—

(3045716) Anion gap in Serum or Plasma

522

1.21

0.76

2.2

2.6

9.8

9.1

mmol/l

1.09

383

(40757373) Influenza virus identified in Isolate

214

1.34

0.76

1.2

1.6

—

(3003458) Phosphate [Moles/volume] in Serum or Plasma

1547

15788

0.96

0.76

3.3

4.8

1.0

mmol/l

0.65

1411

14497

(3010380) Borrelia burgdorferi IgG Ab [Units/volume] in Cerebral spinal fluid

104

1182

0.87

0.75

1.2

1.1

—

90.0

—

(3006441) Cardiolipin IgM Ab [Presence] in Serum by Immunoassay

390

1.24

0.74

1.1

—

(44813793)

1022

0.86

0.74

1.1

—

(3008295) Osmolality of Serum or Plasma

119

1337

0.88

0.73

1.2

1.4

273.0

275.1

mosm/kgh2o

0.47

1025

(3033923) Metanephrine [Moles/time] in 24 hour Urine

375

0.76

0.73

1.1

0.5

0.6

umol/24h

2.07

178

(3016913) Creatine kinase.MM [Enzymatic activity/volume] in Serum or Plasma by Electrophoresis

1.64

0.73

1.0

1.2

411.2

648.5

u/l

—

(3017704) Immunofixation for Urine

680

0.83

0.73

1.8

1.7

—

(3027923) C peptide [Moles/volume] in Serum or Plasma

604

0.82

0.73

1.2

1.5

1.2

nmol/l

1.19

477

(3002619) Bacteria identified in Specimen by Culture

262

0.71

0.73

1.2

1.3

—

(4133840)

262

0.71

0.73

1.3

1.2

—

(3010657) Triiodothyronine (T3) Free [Mass/volume] in Serum or Plasma by Dialysis

1.82

0.73

1.0

1.7

—

(3009224) EGFR gene mutations found [Identifier] in Blood or Tissue by Molecular genetics method Nominal

1.82

0.73

1.0

1.1

—

(3025130) Human papilloma virus identified in Specimen

247

2227

1.10

0.72

1.4

1.7

—

(4306422)

193

1719

1.11

0.72

1.1

1.2

—

(3024889) Methemoglobin/Hemoglobin.total in Venous blood

512

5362

0.94

0.72

2.1

2.7

0.7

0.22

492

5133

(3035929) Mycoplasma pneumoniae Ab [Units/volume] in Cerebral spinal fluid

140

1.41

0.72

1.1

—

(1175426) CD3 cells/100 lymphocytes in Blood

870

0.85

0.71

1.7

2.0

72.5

73.1

0.12

830

(3020630) Protein [Mass/volume] in Serum or Plasma

1109

10511

1.04

0.70

2.5

2.6

66.5

66.4

g/l

0.18

984

9405

(42868417) European tick borne encephalitis virus IgG Ab [Presence] in Serum by Immunoassay

270

1.28

0.69

1.1

—

(3048469) 10-Hydroxycarbazepine [Moles/volume] in Serum or Plasma

448

0.79

0.69

1.9

2.3

40.7

55.5

umol/l

2.74

341

(3008909) Norovirus RNA [Presence] in Stool by NAA with probe detection

411

3792

1.07

0.69

1.2

1.3

—

(3022756) Ceruloplasmin [Mass/volume] in Serum or Plasma

930

0.86

0.69

1.1

1.0

320.4

628.0

mg/l

0.46

813

(3033306) Mononuclear cells/100 leukocytes in Cerebral spinal fluid

567

0.82

0.69

1.2

1.3

54.0

58.5

—

(3041806) Other cells [#/volume] in Blood by Manual count

1.53

0.68

1.4

1.5

—

(40759883) Oligoclonal Bands IgG [Presence] in Cerebral spinal fluid by Isoelectric focusing

770

0.84

0.68

1.1

—

(1175310) Leucine-rich glioma-inactivated protein 1 Ab [Presence] in Cerebral spinal fluid by Cell binding immunofluorescent assay

1.83

0.67

1.0

—

(3010838) Calcium [Moles/time] in 24 hour Urine

100

860

1.15

0.67

1.5

1.7

5.8

5.4

mmol/24h

0.16

(3000213) Normetanephrine [Moles/time] in 24 hour Urine

177

0.67

0.66

1.2

1.1

1.7

1.6

umol/24h

0.24

177

(3014973) Borrelia burgdorferi IgM Ab [Units/volume] in Cerebral spinal fluid

107

1199

0.88

0.66

1.2

1.1

—

6.8

—

(3026389) Candida sp identified in Specimen by Organism specific culture

218

2347

0.91

0.65

1.3

1.4

—

(3029790) Creatine kinase.MB [Enzymatic activity/volume] in Serum or Plasma

1.51

0.65

1.1

6.8

11.4

u/l

0.68

(3020485) Acetaminophen [Moles/volume] in Serum or Plasma

498

0.81

0.65

1.5

1.8

224.8

128.8

umol/l

0.46

274

(3012447) Hantavirus puumala IgG Ab [Titer] in Serum

1071

0.87

0.64

1.1

—

(3037467) Urinalysis macro (dipstick) panel - Urine

8994

89416

0.98

0.64

4.3

4.8

—

(3043405) Microscopic observation [Identifier] in Specimen by Non-gynecological cytology method

156

1385

1.11

0.64

1.2

—

(3000855) Microscopic observation [Identifier] in Vaginal fluid by Gram stain

112

1248

0.88

0.64

1.4

—

(40766183) Gliadin peptide IgA Ab [Units/volume] in Serum by Immunoassay

158

1725

0.90

0.63

1.0

1.1

2.0

3.4

u/ml

1.48

726

(40758895) Direct antiglobulin test.complement C3d specific reagent [Presence] on Red Blood Cells

553

1.18

0.63

1.2

1.5

—

(40758897) Direct antiglobulin test.IgG specific reagent [Presence] on Red Blood Cells

553

1.18

0.63

1.2

1.5

—

(3011831) Apolipoprotein B/Apolipoprotein A-I [Percentile]

517

1.18

0.62

1.3

1.4

—

(3016845) Adenovirus Ag [Presence] in Specimen by Immunofluorescence

257

1.27

0.62

1.2

1.1

—

(3018559) Microscopic observation [Identifier] in Buccal smear by Cyto stain

167

1492

1.10

0.62

1.1

—

(44806420)

363

0.79

0.60

2.0

2.4

—

(3025547) Thyroglobulin Ab [Units/volume] in Serum or Plasma

161

1438

1.10

0.60

4.7

4.8

113.4

135.8

u/ml

0.15

405

(3007695) Herpes simplex virus 2 IgG Ab [Presence] in Cerebral spinal fluid

135

0.66

0.60

1.2

1.0

—

(3042602) Urea [Moles/volume] in Serum or Plasma --post dialysis

136

0.65

0.60

11.6

10.8

4.4

4.5

mmol/l

—

136

(3003752) BK virus DNA [Units/volume] (viral load) in Urine by NAA with probe detection

0.00

0.60

0.0

1.3

—

(3039183) Clostridium tetani toxoid IgG Ab [Units/volume] in Serum or Plasma by Immunoassay

0.00

0.60

0.0

1.1

—

(21494434) Karyotype in Bone marrow

1011

0.88

0.59

1.2

1.1

—

(3005715) Vancomycin [Mass/volume] in Serum or Plasma

155

1384

1.11

0.59

5.2

6.3

12.7

12.3

mg/l

0.43

139

1262

(3000510) Lepidoglyphus destructor IgE Ab [Units/volume] in Serum

0.00

0.59

0.0

1.0

—

0.1

—

(3012920) Ethanol [Mass/volume] in Serum or Plasma

0.00

0.59

0.0

1.4

—

(3009471) Fatty acids.nonesterified [Moles/volume] in Serum or Plasma

0.00

0.59

0.0

5.2

—

0.2

—

(46235128) Lupus anticoagulant aPTT and dRVVT screening panel W Reflex

641

0.85

0.59

1.1

1.2

—

(3020650) Glucose [Presence] in Urine

286

1.24

0.59

1.4

1.6

—

(3009871) Measles virus Ab [Titer] in Serum

426

0.81

0.58

1.7

—

(3023410) Appearance of Cerebral spinal fluid

112

1238

0.89

0.58

1.3

1.5

—

(3045142) Bone marrow Pathology biopsy report

148

1320

1.11

0.58

1.2

1.3

—

(40758990) Choriogonadotropin.beta subunit [Mass/volume] in Serum or Plasma

0.00

0.58

0.0

1.1

—

(3020393) Adenovirus Ag [Presence] in Stool

111

0.62

0.58

1.0

—

(3019601) Blood group antibody investigation [Interpretation] in Plasma or RBC

855

1.13

0.56

1.7

—

(43055120) Cytomegalovirus DNA [Units/volume] (viral load) in Serum or Plasma by NAA with probe detection

203

2173

0.92

0.56

2.5

5.0

1022.6

784.1

iu/ml

0.11

332

(3020073) CD3+CD4+ (T4 helper) cells/CD3+CD8+ (T8 suppressor cells) cells [# Ratio] in Specimen

387

1.20

0.56

1.7

1.9

—

(3013466) aPTT in Blood by Coagulation assay

1.51

0.56

1.0

1.1

35.2

36.5

0.38

(3018387) Mycoplasma pneumoniae IgG Ab [Units/volume] in Serum

185

1987

0.92

0.56

1.1

6.7

13.3

au/ml

—

(3025315) Body weight

0.56

0.55

4.0

4.7

—

(3019083) Insulin-like growth factor [Moles/volume] in Serum or Plasma

158

0.69

0.55

1.1

1.7

—

(3004409) Coagulation factor X activity actual/normal in Platelet poor plasma by Coagulation assay

397

1.19

0.55

1.2

1.1

91.5

94.7

0.21

168

(3036955) Alkaline phosphatase.liver/Alkaline phosphatase.total in Serum or Plasma

1.60

0.55

2.7

2.0

—

(3016426) Methylmalonate [Moles/volume] in Serum or Plasma

1.60

0.55

1.0

1.1

318.3

330.1

nmol/l

—

(3023511) Choriogonadotropin [Units/volume] in Urine

982

0.88

0.54

2.0

1.2

—

(4212803)

123

0.64

0.54

1.0

—

(3022907) Direct antiglobulin test.polyspecific reagent [Presence] on Red Blood Cells

280

0.77

0.54

1.1

1.3

—

(3003171) Aldosterone [Moles/volume] in Serum or Plasma --upright

367

0.81

0.53

1.1

1.2

230.0

340.1

pmol/l

1.84

258

(3035544) Cardiolipin IgG Ab [Units/volume] in Serum or Plasma

380

1.19

0.53

1.2

1.1

—

(3002222) Hepatitis E virus IgM Ab [Presence] in Serum

750

0.87

0.53

1.1

—

(3015322) Alpha 1 globulin [Mass/volume] in Serum or Plasma by Electrophoresis

459

4764

0.95

0.53

1.9

2.4

3.2

3.1

g/l

1.04

343

3603

(3020951) Lymphocytes/100 leukocytes in Cerebral spinal fluid

179

0.72

0.53

1.7

1.4

53.7

48.2

—

(3022689) Creatine [Moles/volume] in Urine

388

0.81

0.53

1.3

1.5

—

(3024403) Complement+Immunoglobulin [Units/volume] in Red Blood Cells

266

2807

0.93

0.52

1.4

1.7

—

(3021513) Carbon dioxide [Partial pressure] in Mixed venous blood

201

0.74

0.52

11.6

9.1

—

(3019977) pH of Arterial blood

601

1.15

0.52

2.8

2.7

7.4

0.69

212

(3016273) Islet cell 512 Ab [Units/volume] in Serum

1.52

0.52

1.0

—

(44816893) Food Allergen Mix 50 (Kiwi+Pineapple+Banana+Mango) IgE Ab [Units/volume] in Serum by Multidisk

322

0.80

0.52

1.0

—

(3000285) Sodium [Moles/volume] in Blood

176

1.29

0.51

1.2

—

(3024666) Lithium, Blood [Moles/volume] in Serum or Plasma

547

0.85

0.51

12.3

12.0

0.7

0.6

mmol/l

0.89

496

(3031072) Herpes simplex virus 1 IgG Ab [Presence] in Cerebral spinal fluid

130

0.68

0.51

1.2

1.0

—

(36659890) Mycobacterial identification panel - Specimen by Molecular genetics method

0.60

0.51

1.8

1.6

—

(3015479) Mycobacterium sp identified in Blood by Organism specific culture

159

1.30

0.51

1.3

1.5

—

(3011547) Coagulation factor VII activity actual/normal in Platelet poor plasma by Coagulation assay

411

1.18

0.49

1.2

1.1

113.4

114.4

0.07

367

(3045683) HLA typing for celiac disease panel - Blood or Tissue

755

0.87

0.49

1.0

—

(3046870) Tissue transglutaminase IgG Ab [Units/volume] in Serum

606

5727

1.05

0.49

1.1

1.2

1.6

u/ml

—

(3000093) Morphology [Interpretation] in Blood Narrative

1088

0.90

0.49

1.2

1.1

—

(3029023) Hepatitis E virus IgG Ab [Presence] in Serum by Immunoassay

744

0.87

0.49

1.1

—

(3010156) C reactive protein [Mass/volume] in Serum or Plasma by High sensitivity method

452

4242

1.05

0.49

1.7

2.4

3.2

mg/l

2.26

364

3054

(3003245) Complement C1 esterase inhibitor [Mass/volume] in Serum or Plasma

439

1.17

0.49

1.2

0.3

g/l

0.56

358

(3028371) Actinomyces sp identified in Specimen by Organism specific culture

117

1.35

0.48

1.0

1.2

—

(3011363) Streptococcus pneumoniae Ag [Presence] in Urine

671

1.13

0.48

1.1

—

(3022217) INR in Platelet poor plasma by Coagulation assay

1682

16196

1.03

0.48

21.1

22.6

1.3

inr

0.30

248

2240

(3018993) Complement total hemolytic CH100 [Units/volume] in Serum or Plasma

241

0.78

0.47

1.2

—

(3000081) cloZAPine [Moles/volume] in Serum or Plasma

477

0.85

0.46

12.2

14.4

1265.5

6736.9

nmol/l

0.83

457

(3037556) Urate [Mass/volume] in Serum or Plasma

338

0.82

0.46

2.1

1.2

—

(3005353) Prothrombin activity actual/normal in Platelet poor plasma by Coagulation assay

405

1.17

0.46

1.1

90.9

91.2

0.02

167

(3002148) Methylenedioxymethamphetamine [Presence] in Urine by Screen method

229

0.77

0.46

1.4

—

(3015401) Amylase [Enzymatic activity/volume] in Pleural fluid

127

1.32

0.46

1.3

33.3

339.1

u/l

0.64

(3000504) BK virus DNA [Units/volume] (viral load) in Serum or Plasma by NAA with probe detection

118

0.67

0.45

3.8

5.1

—

(3040151) Glucose [Moles/volume] in Capillary blood

141

1276

1.09

0.45

3.6

6.4

7.1

7.4

mmol/l

0.79

117

1046

(3045424) Erythrocytes [Presence] in Urine

256

2372

1.07

0.45

1.4

1.6

—

(3034092) Cytoplasmic Ig cells/100 cells in Blood

150

0.72

0.44

12.4

10.0

—

(3015816) F5 gene p.Arg506Gln [Presence] in Blood or Tissue by Molecular genetics method

190

1744

1.08

0.44

1.1

—

(40763634) TCRG gene rearrangements [Presence] in Bone marrow by Molecular genetics method

120

1.31

0.42

1.1

—

(3030313) Adrenal Ab [Titer] in Serum

0.66

0.42

1.0

—

(3014038) Collagen crosslinked N-telopeptide [Moles/volume] in Urine

263

1.20

0.42

1.6

—

(3000034) Microalbumin [Mass/volume] in Urine

109

1178

0.91

0.42

2.6

2.9

70.9

32.5

mg/l

0.37

785

(3044212) Herpes simplex virus 1+2 IgM Ab [Presence] in Cerebral spinal fluid

309

1.18

0.41

1.1

—

(3002079) Sodium [Moles/time] in 24 hour Urine

0.00

0.41

0.0

1.1

—

130.6

—

(3046682) IgA [Presence] in Skin by Immunofluorescence

0.00

0.41

0.0

1.1

—

(36660697) Celiac disease serology panel - Serum

1087

11007

0.97

0.41

1.2

—

(3029379) Protein.monoclonal band 4 [Mass/volume] in Serum or Plasma by Electrophoresis

330

3420

0.95

0.40

2.0

2.4

0.0

g/l

0.00

292

3114

(3043849) Epstein Barr virus DNA [Units/volume] (viral load) in Serum or Plasma by NAA with probe detection

155

1645

0.93

0.40

1.5

2.3

8244.5

631.7

u/ml

—

(3000012) Reticulocyte production index

672

1.12

0.40

1.5

1.6

—

(3002719) Hemoglobin [Mass/volume] in Urine

0.00

0.40

0.0

1.1

—

(3032390) JC virus DNA [#/volume] (viral load) in Urine by NAA with probe detection

0.00

0.40

0.0

1.3

—

(42868674) Cholesterol in HDL/Cholesterol.total [Molar ratio] in Serum or Plasma

1772

17127

1.02

0.39

4.4

4.7

33.5

0.00

1121

11262

(3027035) Albumin [Mass/time] in 24 hour Urine

104

0.66

0.39

1.1

1.3

—

96.1

—

(3029338) Protein.monoclonal band 3 [Mass/volume] in Serum or Plasma by Electrophoresis

335

3464

0.95

0.38

2.0

2.4

0.0

g/l

0.18

292

3125

(3029713) Protein.monoclonal band 1 [Mass/volume] in Serum or Plasma by Electrophoresis

416

4279

0.96

0.38

2.1

2.5

0.7

0.8

g/l

0.41

344

3608

(3004789) Transferrin [Mass/volume] in Serum or Plasma

1767

17760

0.98

0.38

2.0

2.4

g/l

1.95

1618

16282

(3048821) Cortisol [Moles/volume] in Serum or Plasma --post 1 mg dexamethasone PO overnight

180

1661

1.07

0.38

1.2

1.3

—

36.4

—

(3002067) Lambda light chains [Mass/time] in 24 hour Urine

189

0.78

0.37

2.8

—

(3023659) Complement C1 esterase inhibitor.functional/Complement C1 esterase inhibitor.total in Serum or Plasma

405

1.14

0.37

1.2

111.4

114.2

0.29

353

(3045156) Carbon dioxide [Partial pressure] adjusted to patient's actual temperature in Arterial blood

339

0.84

0.37

2.3

2.7

—

(3022803) Oxygen [Partial pressure] adjusted to patient's actual temperature in Arterial blood

339

0.84

0.37

2.3

2.7

—

(40760435) Tropomyosin IgE Ab [Units/volume] in Serum

112

0.70

0.37

1.0

—

(3036432) Mycobacterium tuberculosis genotype [Identifier] in Isolate

538

0.88

0.36

3.7

4.1

—

(3022475) Manganese [Moles/volume] in Blood

1.32

0.36

1.6

1.2

—

(3004915) Chlamydophila pneumoniae IgA Ab [Units/volume] in Serum

704

0.90

0.36

1.3

1.1

—

(21493690) Lymphocyte T-cell and B-cell and Natural killer subsets panel - Blood

817

0.90

0.36

1.6

2.0

—

(3035797) Protein.monoclonal band 2 [Mass/volume] in Serum or Plasma by Electrophoresis

362

3727

0.96

0.36

2.0

2.3

0.0

g/l

0.82

318

3373

(3036312) Salmon IgE Ab [Units/volume] in Serum

0.65

0.35

1.0

1.1

0.0

0.2

u/ml

—

(3039429) Cortisol [Moles/volume] in Saliva (oral fluid)

620

0.89

0.35

1.4

1.7

2.3

3.5

nmol/l

1.01

506

(3001850) Coagulation factor XI activity actual/normal in Platelet poor plasma by Coagulation assay

241

1.19

0.35

1.2

1.1

78.6

91.9

—

(3028717) Thiamine [Mass/volume] in Blood

120

0.74

0.35

1.1

—

(3029187) Natriuretic peptide.B prohormone N-Terminal [Mass/volume] in Serum or Plasma

3769

37579

0.99

0.35

2.6

2.8

1011.5

1163.5

ng/l

1.62

3208

31964

(42868414) European tick borne encephalitis virus IgM Ab [Presence] in Serum by Immunoassay

504

0.88

0.34

1.1

—

(3044491) Cholesterol non HDL [Mass/volume] in Serum or Plasma

597

6079

0.97

0.34

1.5

—

(3008733) Herpes simplex virus DNA [Presence] in Cerebral spinal fluid by NAA with probe detection

671

1.10

0.34

1.1

—

(40758047) Lysozyme [Mass/volume] in Pleural fluid

1.34

0.33

1.1

11.5

10.3

mg/l

0.10

(3020491) Glucose [Moles/volume] in Blood

861

1.09

0.33

1.7

1.8

7.0

mmol/l

0.06

578

(3004451) EKG impression Narrative

606

0.89

0.33

1.2

1.3

—

(3043870) Heparin induced platelet Ab [Units/volume] in Serum

1.29

0.32

1.2

—

(3035999) Lactate [Moles/volume] in Cerebral spinal fluid

900

1.09

0.32

1.2

1.3

2.1

2.2

mmol/l

0.39

832

(3018572) Chloride [Moles/volume] in Blood

251

2597

0.95

0.32

6.1

105.4

104.9

mmol/l

1.03

225

2340

(3020629) Protein S Free Ag actual/normal in Platelet poor plasma by Immunoassay

133

1225

1.07

0.32

1.1

99.0

94.5

1.10

126

1146

(3039000) Anion gap in Blood

251

2596

0.95

0.31

6.1

10.6

11.0

mmol/l

1.09

225

2339

(3019420) Tryptase [Mass/volume] in Serum or Plasma

707

0.91

0.31

1.3

1.6

7.3

9.2

ug/l

0.67

641

(42868691) Thyroxine (T4) free [Moles/volume] in Serum or Plasma by Dialysis

571

1.11

0.31

1.5

14.9

15.4

pmol/l

0.46

479

(3005757) Coagulation factor V activity actual/normal in Platelet poor plasma by Coagulation assay

644

0.90

0.31

1.3

1.8

111.1

100.2

1.40

588

(40771901) t(9;22)(q34.1;q11)(ABL1,BCR) b2a2+b3a2 fusion transcript/control transcript (International Scale) [# Ratio] in Blood or Tissue by Molecular genetics method

1.33

0.31

11.9

7.6

—

(3034603) RHD gene allele [Genotype] in Blood or Tissue by Molecular genetics method Nominal

140

0.77

0.30

1.0

1.4

—

(3026048) Bordetella pertussis IgG Ab [Units/volume] in Serum

200

1.18

0.30

1.1

—

(40762814) Titanium [Mass/volume] in Blood

257

0.84

0.29

2.0

2.3

4.8

3.7

ug/l

0.30

102

(3029715) Chromosome analysis.interphase [Interpretation] in Bone marrow by FISH Narrative

182

1.19

0.29

1.4

1.2

—

(42868647) JC virus Ab [Presence] in Serum or Plasma by Immunoassay

106

0.74

0.29

1.1

2.4

—

(3003721) Smooth muscle Ab [Units/volume] in Serum

107

0.74

0.29

1.0

1.1

—

2.0

—

(3022250) Lactate dehydrogenase [Enzymatic activity/volume] in Serum or Plasma by Lactate to pyruvate reaction

1310

13153

0.98

0.28

3.4

4.1

266.3

245.2

u/l

2.28

1230

12346

(3001729) Color of Synovial fluid

109

0.72

0.28

1.7

1.9

—

(3003396) Base excess in Arterial blood by calculation

1332

13370

0.98

0.28

5.3

6.3

1.2

1.3

mmol/l

0.18

1102

10755

(723473) SARS-CoV-2 (COVID-19) IgA Ab [Presence] in Serum or Plasma by Immunoassay

1.27

0.27

1.0

1.1

—

(3045781) Inhibin B [Mass/volume] in Serum or Plasma

369

1.12

0.27

2.7

2.8

62.9

126.8

ng/l

—

103

(3018851) Theophylline [Moles/volume] in Serum or Plasma

118

0.75

0.27

1.8

1.6

38.9

50.5

umol/l

—

118

(3016018) Differential panel - Cerebral spinal fluid

142

1322

1.06

0.26

1.2

1.5

—

(3023091) Interleukin 6 [Mass/volume] in Serum or Plasma

166

1.19

0.26

1.3

1.2

134.3

74.9

ng/l

0.52

106

(3027801) Oxygen [Partial pressure] in Arterial blood

1335

13384

0.98

0.26

5.3

6.3

13.5

12.6

kpa

5.38

1271

12780

(3021447) Carbon dioxide [Partial pressure] in Venous blood

1040

10450

0.98

0.26

2.6

3.5

5.8

kpa

0.47

1005

10166

(3019497) Choriogonadotropin.beta subunit free [Moles/volume] in Serum or Plasma

147

0.80

0.25

1.4

1.2

—

(3027946) Carbon dioxide [Partial pressure] in Arterial blood

1336

13389

0.98

0.25

5.3

6.3

5.2

5.1

kpa

0.97

1271

12793

(1175553) Vedolizumab and Vedolizumab Ab panel [Mass/volume] - Serum or Plasma

1.23

0.25

1.8

2.0

—

(3002032) Base excess in Venous blood by calculation

1038

10426

0.98

0.25

2.6

3.5

2.2

mmol/l

0.22

864

8699

(3041145) Herpes simplex virus IgM Ab [Presence] in Serum by Immunoassay

644

0.92

0.24

1.1

—

(3042391) t(9;22)(q34.1;q11)(ABL1,BCR) e1a2 fusion transcript/control transcript [# Ratio] in Blood or Tissue by Molecular genetics method

1.18

0.24

4.4

5.0

—

(4024509)

154

1597

0.95

0.24

1.7

—

(3027544) Mycobacterium sp identified in Sputum by Organism specific culture

110

1152

0.94

0.24

3.6

3.8

—

(3013784) Calcium.ionized [Moles/volume] in Serum or Plasma by Ion-selective membrane electrode (ISE)

272

0.87

0.24

1.0

1.3

—

(3051387) C reactive protein [Mass/volume] in Capillary blood

266

2722

0.96

0.24

3.8

3.6

22.1

23.8

mg/l

0.38

146

1696

(3020123) Porphyrins [Interpretation] in Serum or Plasma

0.71

0.24

1.0

1.1

—

(3024354) Oxygen [Partial pressure] in Venous blood

862

8668

0.98

0.24

2.4

3.0

4.4

4.5

kpa

0.58

827

8418

(44816808) CXCL13 Ag [Mass/volume] in Cerebral spinal fluid

506

1.09

0.23

1.1

501.6

750.9

ng/l

0.24

110

(3002670) Multiple inhalant allergen IgE Ab [Units/volume] in Serum

406

0.90

0.23

1.2

1.6

—

(3020427) Coagulation factor X inhibitor [Units/volume] in Platelet poor plasma by Coagulation assay

380

3635

1.03

0.23

2.4

2.8

0.4

u/ml

0.79

233

2113

(3005772) Bilirubin.conjugated [Moles/volume] in Serum or Plasma

1533

14905

1.02

0.23

2.5

8.8

7.3

umol/l

1.53

1305

12699

(40769539) Bacteria identified based on 16S rRNA gene [Identifier] in Specimen by Sequencing

250

2375

1.04

0.22

1.5

1.6

—

(3009677) Dengue virus Ab [Presence] in Serum

1.26

0.22

1.6

1.2

—

(42868421) Varicella zoster virus IgM Ab [Presence] in Cerebral spinal fluid by Immunoassay

309

1.12

0.22

1.1

—

(40763571) Iron/Transferrin [Ratio] in Serum or Plasma

1653

16512

0.99

0.22

2.1

2.5

21.6

21.5

0.10

1440

13935

(3009041) Cardiolipin IgG Ab [Units/volume] in Serum by Immunoassay

167

1723

0.96

0.22

1.2

3.9

3.7

u/ml

0.08

730

(3031659) Enterovirus NOS Ab [Titer] in Cerebral spinal fluid

1.23

0.22

1.2

1.1

—

(3036604) Creatine kinase isoenzymes [Interpretation] in Serum or Plasma by Electrophoresis

1.26

0.22

1.1

1.2

—

(42868497) Enterovirus IgM Ab [Presence] in Cerebral spinal fluid by Immunoassay

1.26

0.22

1.1

1.2

—

(3040370) OLANZapine [Moles/volume] in Serum or Plasma

311

0.89

0.22

1.7

2.4

201.0

158.4

nmol/l

1.46

272

(3000876) Codfish IgE Ab [Units/volume] in Serum

0.00

0.21

0.0

1.0

—

(3003593) Leptospira sp IgG Ab [Units/volume] in Serum

0.00

0.21

0.0

1.0

—

(3001409) Leptospira sp IgM Ab [Units/volume] in Serum

0.00

0.21

0.0

1.0

—

(3027859) Formaldehyde IgE Ab [Units/volume] in Serum

0.00

0.21

0.0

1.0

—

(3020893) t(14;18)(q32;q21.3)(IGH,BCL2) fusion transcript [Presence] in Blood or Tissue by Molecular genetics method

0.00

0.21

0.0

1.0

—

(3046896) Herpes virus 6 DNA [Presence] in Cerebral spinal fluid by NAA with probe detection

320

1.11

0.21

1.1

—

(3044936) Clostridioides difficile toxin A+B [Presence] in Stool by Immunoassay

320

1.11

0.21

1.1

1.2

—

(3007147) Virus identified in Stool by Electron microscopy

0.00

0.21

0.0

1.0

—

(3017986) Aspergillus versicolor IgE Ab [Units/volume] in Serum

0.00

0.21

0.0

1.0

—

(3041184) Isoniazid [Presence] in Urine

0.00

0.21

0.0

2.8

—

(40760087) Plasmodium sp Ab [Presence] in Serum by Immunofluorescence

0.00

0.21

0.0

1.1

—

(3007463) Buprenorphine [Presence] in Urine

0.00

0.21

0.0

7.1

—

(3044009) aPTT.lupus sensitive (LA screen)

101

0.78

0.21

1.0

1.2

—

(3009876) Amylase isoenzyme 3 panel - Serum or Plasma

103

0.77

0.21

1.3

1.2

—

(40763629) HC gene rearrangements [Presence] in Bone marrow by Molecular genetics method

0.00

0.20

0.0

1.0

—

(3000690) Aldosterone [Moles/time] in 24 hour Urine

0.00

0.20

0.0

1.2

—

18.7

—

(40760848) Basement membrane zone BP180 Ab [Units/volume] in Serum by Immunoassay

105

1093

0.95

0.20

1.2

1.5

30.6

22.6

u/ml

0.44

214

(3022192) Triglyceride [Mass/volume] in Serum or Plasma

511

1.08

0.20

2.3

2.5

—

(3035637) Corticotropin [Mass/volume] in Plasma

163

1540

1.04

0.20

1.4

1.5

—

(3018688) Ampicillin IgE Ab [Units/volume] in Serum

1.21

0.20

1.0

—

(3047181) Lactate [Moles/volume] in Blood

362

3663

0.97

0.19

5.2

5.3

1.3

mmol/l

0.14

323

3239

(4268621)

123

1157

1.05

0.18

2.3

2.2

—

(3014576) Chloride [Moles/volume] in Serum or Plasma

1510

14713

1.01

0.18

5.0

6.3

104.3

104.1

mmol/l

1.09

1482

14414

(3009015) Lactate [Moles/volume] in Synovial fluid

162

0.85

0.18

1.1

1.3

7.4

5.8

mmol/l

—

(3041365) Herpes simplex virus IgG Ab [Units/volume] in Serum by Immunoassay

141

0.84

0.18

1.1

—

(3019768) Coxiella burnetii Ab [Presence] in Serum

1.21

0.18

1.3

1.1

—

(43055514) Macroprolactin [Presence] in Serum or Plasma

161

0.86

0.17

2.0

1.5

—

(3044355) Beta 2 glycoprotein 1 IgG Ab [Units/volume] in Serum or Plasma by Immunoassay

186

1771

1.04

0.17

1.2

2.9

3.6

u/ml

0.33

582

(1001833) Epstein Barr virus DNA [Units/volume] (viral load) in Blood by NAA with probe detection

183

1.13

0.17

1.0

1.2

—

(3006695) Toxoplasma gondii DNA [Presence] in Specimen by NAA with probe detection

155

1.15

0.17

1.1

1.8

—

(40762482) Peach recombinant (rPru p) 3 IgE Ab [Units/volume] in Serum

0.76

0.17

1.0

0.0

0.3

u/ml

—

(3034368) Herpes virus 6 IgM Ab [Presence] in Cerebral spinal fluid

0.75

0.17

1.0

—

(3017509) Phencyclidine [Presence] in Urine

0.74

0.17

1.2

—

(3008116) Ketones [Moles/volume] in Urine by Test strip

221

1.12

0.17

1.0

1.3

—

(3000991) Gas panel - Venous blood

977

9501

1.01

0.16

5.2

7.2

—

(3047166) Epithelial cells [#/area] in Urine sediment by Automated count

191

0.88

0.16

2.5

2.7

0.4

0.8

u/field

1.88

191

(37021550) Renin [Units/volume] in Plasma --upright

304

0.91

0.16

1.1

1.3

23.7

70.2

mu/l

3.51

216

(40761849) Varicella zoster virus IgG Ab [Units/volume] in Cerebral spinal fluid by Immunoassay

288

1.10

0.16

1.1

—

(3024928) Oxygen saturation in Venous blood

227

2304

0.97

0.16

2.0

3.0

—

(4211845)

739

1.05

0.15

4.3

3.4

—

(3016502) Oxygen saturation in Arterial blood

1174

11710

0.99

0.15

5.5

6.7

96.0

95.8

0.31

1127

11278

(40761516) BRAF gene p.Val600Glu [Presence] in Tissue by Molecular genetics method

1.15

0.15

1.1

1.0

—

(1002183) Plasma cells monotypic population [Identifier] in Bone marrow by Flow cytometry (FC)

157

1.13

0.14

1.2

—

(3043410) Blood group antigens tested for on Red Blood Cells

290

1.09

0.14

1.5

1.7

—

(3030981) Hyaline casts [#/volume] in Urine by Automated count

583

5841

0.98

0.14

2.4

2.5

0.2

0.3

e6/l

0.81

564

5626

(43055554) Base excess.100% oxygenated [Moles/volume] standard in Capillary blood by calculation

652

6525

0.98

0.14

2.6

3.4

2.2

2.1

mmol/l

0.32

519

5038

(3030366) Cystatin C [Mass/volume] in Serum or Plasma

273

2756

0.98

0.14

2.5

2.8

1.4

1.6

mg/l

3.67

242

2504

(3036603) Volume of Urine

917

0.96

0.14

1.4

1.5

2238.4

1850.0

1.29

212

(21494814) CD8 cells/100 lymphocytes in Specimen

464

1.06

0.13

1.8

2.0

—

(3048879) Bone marrow aspiration report

351

0.93

0.13

1.3

1.8

—

(3025149) Bordetella pertussis IgA Ab [Units/volume] in Serum

905

0.96

0.13

1.1

8.3

9.2

iu/ml

0.14

197

(3014444) EGFR gene mutations tested for in Blood or Tissue by Molecular genetics method Nominal

106

0.84

0.13

1.1

—

(3008799) Glucose [Moles/volume] in Serum or Plasma --30 minutes post dose glucose

107

0.83

0.13

1.0

1.1

8.8

8.3

mmol/l

—

107

(3049506) Microalbumin [Mass/time] in Urine collected for unspecified duration

525

1.05

0.11

2.0

2.1

17.2

61.6

ug/min

1.24

(40762366) Oxygen capacity [Volume Fraction] in Arterial blood

610

6090

0.99

0.11

6.9

8.3

—

(3053028) Streptococcus sp identified in Specimen by Organism specific culture

679

0.96

0.10

1.4

1.3

—

(3048402) Erythrocytes [#/area] in Urine sediment by Automated count

740

1.04

0.10

2.1

1.9

2.2

2.0

u/field

0.16

505

(3028286) Albumin [Mass/volume] in Serum or Plasma by Electrophoresis

394

3943

0.98

0.10

1.9

2.3

38.1

37.7

g/l

0.86

314

3313

(42870365) C reactive protein [Mass/volume] in Blood by High sensitivity method

189

1822

1.02

0.10

2.2

2.0

27.8

25.7

mg/l

0.19

486

(3007798) IgG/Albumin [Mass Ratio] in Cerebral spinal fluid

225

0.92

0.10

1.2

1.1

—

(40763476) Honey bee phospholipase A2 recombinant (rApi m) 1 IgE Ab [Units/volume] in Serum

1.12

0.10

1.0

—

(3016914) Bacteria identified in Cerebral spinal fluid by Culture

117

1187

0.97

0.09

1.3

1.7

—

(3018677) aPTT in Platelet poor plasma by Coagulation assay

1836

18210

0.99

0.09

1.9

29.2

29.3

0.35

1783

17643

(3040668) CNBP gene mutations found [Identifier] in Blood or Tissue by Molecular genetics method Nominal

1.07

0.09

1.2

1.0

—

(3033705) Calcium.ionized [Moles/volume] in Venous blood

154

1483

1.02

0.09

2.4

2.3

—

(3014218) Bicarbonate [Moles/volume] standard in Arterial blood

614

5990

1.01

0.09

6.3

8.0

24.6

mmol/l

0.10

570

5592

(42869858) Acute and chronic leukemia fusion transcript panel - Blood or Tissue by Molecular genetics method

105

1.13

0.09

1.1

—

(3009343) pH of Capillary blood

680

6771

0.99

0.09

2.6

3.4

7.4

1.40

106

906

(3005812) Immunoglobulin light chains [Presence] in 24 hour Urine

112

0.88

0.09

2.2

2.6

—

(3024135) Streptococcus.beta-hemolytic [Presence] in Throat by Organism specific culture

2035

20165

0.99

0.08

1.4

—

(723474) SARS-CoV-2 (COVID-19) IgG Ab [Presence] in Serum or Plasma by Immunoassay

288

1.06

0.08

1.1

—

(3045209) Lutropin/Follitropin [Ratio] in Serum or Plasma

0.82

0.08

1.0

1.1

—

(40760871) Heparin induced platelet Ab [Presence] in Serum or Plasma by Immunoassay

0.82

0.08

1.0

—

(3043257) Herpes virus 6 IgG Ab [Presence] in Cerebral spinal fluid

0.80

0.08

1.0

—

(3012984) Norclozapine [Mass/volume] in Serum or Plasma

0.80

0.08

5.4

6.1

—

(40761545) Erythrocytes.dysmorphic [Presence] in Urine sediment by Light microscopy

1.06

0.08

1.1

—

(40765096) Chromosome analysis panel by Banding

313

0.94

0.08

1.1

—

(40766799) MGMT gene methylation score in Tissue by Molecular genetics method

0.82

0.07

1.0

—

(3001334) Neutrophil cytoplasmic Ab [Units/volume] in Serum

0.81

0.07

1.0

—

(3026692) Albumin [Mass/volume] in Peritoneal fluid

270

1.06

0.07

1.1

1.3

14.3

14.0

g/l

0.06

210

(3016894) Varicella zoster virus DNA [Presence] in Cerebral spinal fluid by NAA with probe detection

678

1.03

0.07

1.1

—

(3001501) Glucose [Moles/volume] in Capillary blood by Glucometer

272

0.94

0.07

1.8

2.3

6.0

6.9

mmol/l

1.40

165

(40760892) CBC W Ordered Manual Differential panel - Blood

2803

27537

1.00

0.07

3.6

4.6

—

(43055222) Platelet function.collagen + Adenosine diphosphate induced and EPINEPHrine induced panel - Blood

161

0.92

0.07

1.6

1.2

—

(3035285) Chloride [Moles/volume] in Venous blood

155

1500

1.02

0.07

2.4

2.3

105.1

105.5

mmol/l

0.54

155

1491

(3023081) Carboxyhemoglobin/Hemoglobin.total in Blood

502

4904

1.01

0.07

4.5

1.5

1.6

5.91

476

4606

(3033319) Streptococcus pyogenes Ag [Presence] in Throat

868

8614

0.99

0.06

1.3

—

(3041354) Potassium [Moles/volume] in Venous blood

155

1501

1.02

0.06

2.4

2.3

4.0

mmol/l

0.00

155

1492

(3050898) Methicillin resistant Staphylococcus aureus [Presence] in Genital specimen by Organism specific culture

524

1.03

0.06

2.4

2.3

—

(3022493) Free Hemoglobin [Mass/volume] in Plasma

427

1.04

0.06

1.1

3.2

8041.1

587.1

mg/l

0.72

280

(3051014) Leukocytes [#/area] in Urine sediment by Automated count

113

1137

0.98

0.06

2.2

3.2

2.8

u/field

0.22

452

(3006462) Nitrate [Presence] in Urine

681

1.03

0.06

4.5

3.5

—

(3022313) Gas panel - Capillary blood

487

4842

0.99

0.06

2.6

3.5

—

(3029075) Extractable nuclear Ab panel - Serum

400

0.96

0.06

1.1

—

(3005411) Squamous cell carcinoma Ag [Mass/volume] in Serum or Plasma

360

0.96

0.06

1.2

2.0

18.2

3.2

ug/l

0.43

223

(3012413) Glucose [Moles/volume] in Serum or Plasma --2 hours post meal

848

0.98

0.06

1.2

10.9

11.8

mmol/l

0.43

220

(3008037) Lactate [Moles/volume] in Venous blood

272

2651

1.01

0.06

3.3

3.1

1.5

mmol/l

0.62

267

2605

(3028626) Oxygen [Partial pressure] in Capillary blood

235

2288

1.01

0.06

2.4

2.8

8.2

8.1

kpa

0.41

214

2121

(3027456) Digoxin [Moles/volume] in Serum or Plasma

278

2710

1.01

0.05

3.2

3.3

0.8

nmol/l

1.03

216

2153

(3012741) Chlamydophila pneumoniae IgA Ab [Titer] in Serum

119

0.91

0.05

1.2

1.1

—

(3007628) Bicarbonate [Moles/volume] standard in Venous blood

527

5159

1.01

0.05

2.6

3.8

24.6

24.5

mmol/l

0.39

467

4611

(3006576) Bicarbonate [Moles/volume] in Blood

303

1.04

0.04

3.6

5.9

24.3

25.5

mmol/l

0.93

281

(43055246) Days in therapeutic INR range/Days INR result determined [Ratio]

196

1.06

0.04

4.0

6.1

70.9

68.3

0.17

150

(3012215) Mononuclear cells/100 leukocytes in Synovial fluid

338

0.96

0.04

1.4

45.8

40.5

0.31

221

(3012544) pH of Venous blood

1091

10801

1.00

0.04

2.6

3.5

7.4

—

(3025018) Bordetella pertussis Ab [Titer] in Serum

805

0.98

0.04

1.3

—

(43055458) Rivaroxaban [Mass/volume] in Serum or Plasma

109

1.09

0.04

1.3

1.2

92.0

122.5

ug/l

—

(3006184) Hemoglobin [Mass/volume] in Capillary blood

282

2756

1.01

0.04

2.0

2.1

125.7

126.7

g/l

0.32

191

1936

(3032057) Clostridioides difficile [Presence] in Stool

317

0.96

0.04

1.7

—

(3015235) Bicarbonate [Moles/volume] in Capillary blood

271

2694

0.99

0.04

2.5

2.9

25.9

25.3

mmol/l

1.39

230

2371

(40760847) Basement membrane Ab [Titer] in Serum by Immunofluorescence

951

1.02

0.03

1.2

1.3

1024.0

440.8

titre

—

(3007821) Glucose [Moles/volume] in Serum or Plasma --baseline

664

0.98

0.03

1.2

1.3

5.9

mmol/l

0.18

618

(3046299) Protein.monoclonal [Mass/volume] in Serum or Plasma by Electrophoresis

117

0.93

0.03

6.9

6.7

—

(3004446) Plasmodium sp identified in Blood by Light microscopy

107

0.92

0.03

2.5

2.4

—

(3002173) Hemoglobin [Mass/volume] in Arterial blood

1108

10958

1.00

0.03

5.8

7.0

118.2

118.5

g/l

0.18

1064

10570

(3008536) Aspergillus sp Ab [Presence] in Serum

227

1.04

0.03

2.0

1.8

—

(3007930) Methemoglobin/Hemoglobin.total in Blood

493

4839

1.00

0.03

4.5

4.6

0.9

0.73

465

4544

(3041449) Collagen crosslinked C-telopeptide [Mass/volume] in Serum or Plasma

522

1.02

0.02

1.5

1.6

0.4

ug/l

0.45

339

(3021901) Oxygen saturation in Capillary blood

200

1957

1.01

0.02

2.5

2.8

—

(1001509) Gas and Carbon monoxide and Electrolytes panel - Arterial blood

866

1.01

0.02

1.7

1.8

—

(3023024) Carbon dioxide [Partial pressure] in Capillary blood

697

6850

1.00

0.02

2.7

3.4

5.2

kpa

0.18

629

6301

(3039355) Methicillin resistant Staphylococcus aureus [Presence] in Nose by Organism specific culture

126

0.94

0.02

1.9

—

(42868499) Enterovirus IgG Ab [Presence] in Cerebral spinal fluid by Immunoassay

126

0.94

0.02

1.1

—

(3051593) INR in Capillary blood by Coagulation assay

562

1.02

0.02

7.9

10.6

—

(3028679) Herpes simplex virus Ab [Presence] in Serum

513

1.02

0.02

1.2

—

(3016436) Lactate dehydrogenase [Enzymatic activity/volume] in Serum or Plasma

531

0.98

0.01

2.2

2.6

201.5

211.1

u/l

0.71

525

(3033386) Bacteria [Presence] in Cerebral spinal fluid by Light microscopy

662

1.01

0.01

1.3

1.8

—

(3049717) Cytology report of Urine Cyto stain

349

3429

1.00

0.01

2.5

2.3

—

(3004490) Bicarbonate [Moles/volume] standard in Capillary blood

434

4291

1.00

0.01

2.7

3.7

25.4

25.2

mmol/l

0.53

391

3929

(3016038) Potassium [Moles/volume] in Urine

959

1.01

0.01

1.2

32.7

33.2

mmol/l

0.07

793

(3028009) Chlamydia trachomatis IgG Ab [Units/volume] in Serum

134

0.96

0.00

1.2

1.0

—

(42870308) Desmosome IgG Ab [Titer] in Serum by Immunofluorescence

931

1.01

0.00

1.2

1.3

30.0

57.1

titre

2.33

(3004905) Lipase [Enzymatic activity/volume] in Serum or Plasma

240

0.99

0.00

6.6

5.2

44.1

45.2

u/l

—

104

(3002109) Cholesterol in LDL/Cholesterol in HDL [Mass Ratio] in Serum or Plasma

930

9169

1.00

0.00

1.7

1.8

—

(3035933) Granulocytes/100 leukocytes in Blood

260

0.99

0.00

3.3

1.7

—

(3005011) Chlamydia sp Ab [Titer] in Serum

186

1.01

0.00

1.8

1.7

—

(3006270) Folate [Moles/volume] in Blood

115

1135

1.00

0.00

1.1

1.2

343.8

366.2

nmol/l

0.62

960

(42869593) Oxyhemoglobin/Hemoglobin.total [Pure mass fraction] in Capillary blood

185

1.01

0.00

1.8

2.2

—

(3019174) dRVVT (LA screen)

100

0.99

0.00

1.0

1.2

—

(3035457) Cefaclor IgE Ab [Units/volume] in Serum

145

1.02

0.00

1.0

—

(46235760) Methicillin resistant Staphylococcus aureus [Presence] in Pharynx by Organism specific culture

121

0.98

0.00

2.0

—

(3025378) Microscopic observation [Identifier] in Cervix by Cyto stain

165

1.02

0.00

1.3

1.1

—

(3029396) Erythrocyte agglutination [Presence] in Blood

101

0.98

0.00

1.7

2.3

—

(3035947) Staphylolysin Ab [Units/volume] in Serum

544

1.00

0.00

1.1

—

3.6

iu/ml

—

(3042585) Pyridoxine [Moles/volume] in Serum or Plasma

291

0.98

0.00

1.2

1.3

89.5

124.8

nmol/l

1.71

189

(37021073) Hepatitis C virus genotype in Serum or Plasma by Sequencing

0.95

0.00

1.0

1.2

—

(3014178) Parietal cell Ab [Units/volume] in Serum

0.00

0.0

1.2

—

(3027505) Alpha-1-Fetoprotein [Units/volume] in Amniotic fluid

0.00

0.0

1.0

—

(40765089) Chromosome analysis panel - Blood by G-banded

0.88

0.00

1.0

—

(3002853) Influenza virus B Ab [Titer] in Serum

0.00

0.0

1.0

—

(3045759) Histamine [Moles/volume] in Serum or Plasma

0.00

0.0

2.2

—

(3040794) Aluminum [Moles/volume] in Urine

0.00

0.0

1.0

—

(3032185) JC virus DNA [#/volume] (viral load) in Serum or Plasma by NAA with probe detection

0.00

0.0

1.2

—

(3016184) Myelin associated glycoprotein Ab [Units/volume] in Serum

0.88

0.00

1.0

1.4

—

14639.2

—

(3013336) Amino acids [Identifier] in Serum or Plasma

0.00

0.0

2.4

—

(3003675) Hemoglobin [Mass/volume] in Cerebral spinal fluid

0.00

0.0

1.0

—

(3012898) Urea [Moles/volume] in Urine

0.91

0.00

1.1

1.3

171.2

164.8

mmol/l

—

(3030940) RBC casts [#/area] in Urine by Computer assisted method

0.00

0.0

1.0

—

(40768800) Prostate Pathology biopsy report

0.00

0.0

1.0

—

(3001218) Citrate [Mass/time] in 24 hour Urine

0.00

0.0

1.8

—

(3028917) Waxy casts [#/area] in Urine by Computer assisted method

0.00

0.0

1.0

—

(3037377) Propoxyphene + Norpropoxyphene [Presence] in Urine by Confirmatory method

0.00

0.0

1.3

—

(3020047) Haemophilus influenzae B Ab [Mass/volume] in Serum

0.00

0.0

1.5

—

(3017312) HC gene rearrangements [Presence] in Blood or Tissue by Molecular genetics method

0.88

0.00

1.2

1.0

—

(3014064) Pregnancy associated plasma protein A [Multiple of the median] in Serum or Plasma

0.00

-0.00

0.0

1.0

—

(3042628) Porphyrins [Moles/volume] in Urine

0.00

-0.00

0.0

1.0

—

Mortality – FinRegistry

↥

This endpoint is excluded from FinRegistry analyses (omitted endpoint).

Relationships between endpoints

↥

Index endpoint: C3_BREAST_ERPLUS – Malignant neoplasm of breast, HER-positive

GWS hits: -

This endpoint is excluded from FinRegistry analyses (omitted endpoint).

≡ Risteys

FG R12 + FR

FinnGen R11 + FinRegistry

FinnGen R10 + FinRegistry

FinnGen R10

FinnGen R9

FinnGen R8

FinnGen R7

FinnGen R6

FinnGen R5

FinnGen R4

FinnGen R3

Malignant neoplasm of breast, HER-positive

Endpoint definition

Endpoint definition steps

FinnGen

Phenotype data

1. Apply sex-specific rule

2. Check conditions

3. Check pre-conditions, main-only, mode, registry filters

4. Check minimum number of events

5. Include endpoints

6. Filter based on genotype QC (FinnGen only)

All original rules

Similar endpoints

Case counts by codes

Upset plot

Case counts by code for Malignant neoplasm of breast, HER-positive (C3_BREAST_ERPLUS)

Summary Statistics

-FinRegistry-

-FinnGen-

Key figures

-FinnGen-

Age distribution of first events

-FinnGen-

Year distribution of first events

-FinnGen-

Cumulative Incidence Function

CodeWAS (R11)

Matched cohort

LabWAS

Mortality – FinRegistry

Relationships between endpoints